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Background: HIV+ children and adolescents (CA-HIV) suffer from a considerable burden of internalizing 
mental disorders (IMDs), which are associated with negative outcomes, such as poor academic functioning 
and faster HIV disease progression. IMDs are complex disorders with unknown etiology, despite significant 
research efforts. This PhD study aimed to investigate whether acute stress interacts with vulnerability factors 
(genetic, acquired or a combination of both) to influence the occurrence of IMDs. 
Methods: The study used data from 736 Ugandan CA-HIV who were recruited into a larger study examining 
mental health among children and adolescents living with HIV/AIDS in Kampala and Masaka districts of 
Uganda (CHAKA Study). Cases (n = 368) were CA-HIV who had any internalizing mental disorder (IMD) 
(depressive disorders, anxiety disorders and PTSD). Controls (n = 368) were CA-HIV who did not have 
these disorders and were matched with cases on age, site, socio-economic status and sex. Psychiatric 
disorders were assessed using the Child and Adolescent Symptom Inventory-5 (CASI-5) and the Youth 
Inventory-4R. Chronic and acute stress classes were determined by hierarchical cluster analysis using an 
index derived from data on social disadvantage variables. DNA extracted from blood was used for targeted 
genetic investigations. Specifically, variants in the serotonin transporter gene (SLC6A4: 5-HTTLPR, 
rs25531, 5-HTTLPR/rs25531 and STin2 VNTR), and tryptophan hydroxylase gene (TPH2: (rs1843809, 
rs1386494, rs4570625 and rs345177220) were determined. Relative telomere length (TL) was also 
determined using these samples.  
Statistical analysis: Socio-demographic variables were compared between cases and controls. Linear 
regression was used to determine the association between TL and IMDs. Logistic regression was used to: i) 
determine the association between acute stress and IMDs, and ii) assess the moderating effect of each of the 
vulnerability factors on the associations identified in (i). 
Results: Presence of IMDs was associated with accelerated TL attrition over a 12-month period. The T-
allele of TERT rs2736100 and the C-allele of TERC rs16847897 were associated with accelerated TL attrition 
among cases of IMDs (p = 0.007 and p = 0.012, respectively). CA-HIV who experienced severe acute stress 
were twice as likely to have an IMD compared to CA-HIV who experienced mild acute stress (p = 0.001). 
Acute stress significantly interacted with chronic stress (p = 0.033) and 5-HTTLPR/rs25531 haplotype (p = 
0.049) to influence the likelihood of having an IMD. CA-HIV who experienced severe acute stress and 
severe chronic stress were four times more likely to be a case of IMDs as compared to those under mild 
acute stress and mild chronic stress. CA-HIV who possessed the S-A-S-A haplotype and experienced 
moderate or severe acute stress were respectively fifteen and twelve times more likely to be diagnosed with 
an IMD compared to CA-HIV who possessed the L-A-L-A haplotype and experienced mild acute stress. 
Conclusions: IMDs were associated with accelerated TL attrition. Severe chronic stress and 5-
HTTLPR/rs25531 haplotype independently interacted with acute stress to increase risk for IMDs among 
Ugandan CA-HIV. These data support previously identified relationships between IMDs and accelerated 
biological aging, and provide evidence for the role of serotonin gene-environment interactions in the risk of 





Agtergrond: MIV+ kinders asook adolessente (KA-MIV) lei aan hoë vlakke van internaliserende 
geestesversteurings (IGVs), wat geassosieer word met negatiewe uitkomstes soos swak akademiese prestasie 
en vinniger MIV vordering. IGVs is ‘n komplekse groep toestande, met ‘n onbekende etiologie, ten spyte 
van onlangse vordering in die navorsing. In hierdie PhD studie ondersoek ons of akute stres kan kombineer 
met ander kwesbaarheid faktore (geneties, verworwe of beide) om na ‘n verhoogde voorkoms van IGVs te 
lei. 
Metode: Die huidige studie vorm deel van ‘n groter projek wat geestesgesondheid in 736 kinders en 
adolessente met MIV/VIGS in Kampala en Masaka distrikte in Uganda (CHAKA studie) ondersoek. Gevalle 
(n=368) is positief vir KA-MIV en ly aan ‘n IGV (depressie, angs- en/of post-traumatiese stres versteurings). 
Kontroles is vry van geestesversteurings met vergelykbare ouderdom, perseel, sosio-ekonomiese status en 
geslag. Psigiatriese toestande was ondersoek met die “Child and Adolescent Symptom Inventory-5 (CASI-
5)” en die “Youth Inventory-4R”. Beide kroniese en onlangse stres groepe was bepaal deur ‘n hiërargiese 
groepontleding.  Sosiale benadeling veranderlikes was gebruik as ‘n indeks in die analise. Bloed DNS was 
gebruik in gerigte genetiese analises. Meer spesifiek, variante in die serotonienvervoerder geen (SLC6A4: 5-
HTTLPR, rs25531, 5-HTTLPR/rs25531 en STin2 VNTR), en tryptofaan-hidroksilase geen (TPH2: 
(rs1843809, rs1386494, rs4570625 en rs345177220) was bepaal. Relatiewe telomeer lengte (TL) was ook 
bepaal met dieselfde bloedmonsters.  
Statistiese analise: Sosio-demografiese veranderlikes was vergelyk tussen gevalle en kontroles. ‘n Lineêre 
regressie analise was gebruik om die assosiasie tussen TL en IGVs te bepaal. ‘n Logistieke regressie model 
was gebruik om: i) die assosiasie tussen onlangse stres en IGVs te bepaal, en ii) die modererende effek van 
elk van die kwesbaarheid faktore op assosiasies wat geïdentifiseer was in (i).  
Resultate: Die teenwoordigheid van IGVs was geassosieer met ‘n versnelde TL-verkorting oor ‘n 12 
maande periode.  Die T-aliel van TERT rs2736100 en die C-aliel van TERC rs16847897 was geassosieer met 
‘n versnelde TL-verkorting in IGV gevalle (p = 0.007 en p = 0.012, onderskeidelik). KA-MIV wat erge akute 
stress ondervind het was twee keer meer geneig om ‘n IGV te hê in vergelyking met KA-MIV wat ‘n ligte 
akute stres ervaring gehad het (p = 0.001). Akute stres het ‘n beduidende interaksie gehad met kroniese stres 
(p = 0.033) en 5-HTTLPR/rs25531 haplotipe (p = 0.049) wat bepaal het hoe waarskynlik die teenwoordigheid 
van ‘n IGV was. KA-MIV wie erge akute en kroniese stres ervaar het was vier keer meer geneig om ‘n IGV 
geval te gewees het, in vergelyking met ligte akute stres asook ligte kroniese stres. KA-MIV wie ‘n S-A-S-A 
haplotipe gehad het en wie matige of erge stres ervaar het was onderskeidelik vyftien en twaalf keer meer 
geneig om ‘n diagnose van ‘n IGV te gehad het, in vergelyking met KA-MIV wie ‘n L-A-L-A haplotipe en 
ligte akute stres ervaar het. 
Slotsom: IGVs was geassosieer met ‘n versnelde TL verkorting. Erge kroniese stres en 5-HTTLPR/rs25531 
haplotipe toon ‘n onafhanklike interaksie met akute stres en verhoogte risiko vir IGVs onder KA-MIV van 
Uganda. Die data ondersteun ‘n verhouding tussen IGVs en versnelde biologiese veroudering wat al van te 
vore geïdentifiseer is, en verskaf  bewyse vir ‘n interaksie tussen serotonien geen en die omgewing in die 
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1.1 Discussion of the central research theme 
Internalizing mental disorders (IMDs) (namely, depressive disorders, anxiety disorders and 
post-traumatic stress disorder (PTSD)) are leading causes of disability worldwide (World 
Health Organization, 2017; Akena et al., 2012; Murray et al., 2012). IMDs often develop in 
childhood and adolescence, and, if left untreated, can go on into adulthood and negatively 
impact psychosocial function and add to the healthcare burden (Jenkins et al., 2011). As such, 
early diagnosis and intervention are vital.  
 
The human immunodeficiency virus/acquired immunodeficiency disease syndrome 
(HIV/AIDS) is a significant global health burden, with approximately 37.9 million people 
living with the virus globally (UNAIDS, 2019). With an estimated 1.85 million infected, 
eastern and southern Africa accounts for more than 60% of children and adolescents living with 
HIV globally (UNAIDS, 2018).  In Uganda, the country with the fifth-highest HIV prevalence 
in the region, an estimated 140,000 children and adolescents are living with the virus 
(UNAIDS, 2018).  
 
HIV-positive (HIV+) children and adolescents suffer a considerable burden of IMDs 
(Kinyanda et al., 2019; Mellins et al., 2012; Nachman et al., 2012). Studies undertaken both in 
the developed world (Europe and the United States) and in sub-Saharan Africa have 
documented rates of depression of between 12.7 and 40% (Lwidiko et al., 2018; Kim et al., 
2014; Kamau et al., 2012; Gadow et al., 2012; Mellins et al., 2012; Nachman et al., 2012; 
Musisi & Kinyanda, 2009) and rates of anxiety disorders of 9 to 32.2% (Kinyanda et al., 2019; 
Kamau et al., 2012; Mellins et al., 2012; Nachman et al., 2012) among HIV+ children and 
adolescents. These estimates are far greater than the estimated worldwide prevalence of 2.6% 
and 6.5% for any depressive and anxiety disorder, respectively, among children and 
adolescents (Polanczyk et al., 2015). For IMDs alone, rates of 12% and 27% among HIV+ 
children and adolescents have been documented in Uganda and South Africa (Kinyanda et al., 
2019; Woollet, Cluver, Bandeira & Brahmbatt, 2017). Among persons living with HIV/AIDS 
(PLHIV), IMDs have been associated with a number of negative outcomes, including more 
rapid HIV disease progression (Chida & Vedhara, 2009; Ironson et al., 2005), poor adherence 




(Kinyanda et al., 2018; Springer, Dushaj & Azar, 2012), poor linkage to care for newly 
diagnosed HIV+ persons (Bhatia et al., 2011), increased HIV transmission (through the 
promotion of HIV drug resistance) (Remien & Mellins, 2007) and impaired academic and 
social functioning (Nachman et al., 2012).  
 
IMDs are multifactorial disorders with complex etiology, which is increasingly recognized as 
having both biological and psychosocial contributions. The role of stressful environments and 
the physiology of the stress response system have been broadly implicated in the 
pathophysiology of psychiatric disorders and have been most closely linked to three IMDs 
(depressive and anxiety disorders, and PTSD) (Smoller et al., 2016). Psychosocial stress 
represents the most prevalent environmental risk factor for IMDs (Popoli et al., 2012). The 
diathesis-stress hypothesis of neuropsychiatric disorders postulates that a lower stress threshold 
is required for psychiatric disease to occur in individuals who harbor certain vulnerability 
factors, which may be genetic and/or acquired (Caspi et al., 2003; Silberg et al., 2001; Monroe 
& Simons, 1991). However, the diatheses that lead to increased susceptibility to the harmful 
effects of psychosocial stress remain largely unknown. Exposure to chronic stress has been 
associated with an increased risk for IMDs (Adelman et al., 2014; Evans, Li, & Whipple, 2013; 
Revenson et al., 2016; Robles, Slatcher, Trombello, & McGinn, 2014; Charney & Manji, 2004; 
de Kloet et al., 2005). HIV+ children and adolescents have been reported to experience various 
chronic life stressors such as knowledge of their HIV-status, increased levels of stigma and 
poor parental mental health (Betancourt et al., 2014). These life stressors may thus exacerbate 
the occurrence of IMDs among HIV+ children and adolescents. 
 
Genetic factors have been found to contribute to the etiology of IMDs. Twin studies have 
estimated a genetic heritability of 35% for depression (Otte et al., 2016) and 30-50% for PTSD 
(Smoller et al., 2016), while a meta-analysis of family and twin studies estimated a genetic 
heritability of 10−48% for anxiety disorders among participants with unknown HIV status 
(Hettema et al., 2005; Hettema, Neale & Kendler, 2001). Despite this high heritability, the 
underlying etiology, biochemical or molecular events leading to IMDs are largely unknown 
(Sullivan et al., 2017; Levinson et al., 2014). Serotonergic neurotransmission has, however, 
been implicated in the etiology of IMDs due to the beneficial effects of selective serotonin re-
uptake inhibitors (SSRIs) in the treatment of IMDs (Jakubovski et al., 2019; Ernst, Mechawar, 
& Turecki, 2009). Genes encoding components of the serotonergic neurotransmission pathway 




(solute carrier family 6 member A4, SLC6A4) has been implicated in the development of IMDs 
(Arango et al., 2001; Malison et al., 1998), and polymorphisms within the human tryptophan 
hydroxylase 2 gene (TPH2), which is involved in serotonin synthesis, have also been associated 
with IMDs and have been reported to influence antidepressant response to SSRIs (Gassó et al., 
2017).  
 
Chronic stress exerts broad effects on physiology, which could act as objective markers of 
stress exposure or alternatively contribute to the pathoetiology of mental disorders. Chronic 
stress has been reported to increase oxidative stress in the central nervous system (CNS) 
(Schiavone et al., 2013), and prooxidative environments have, in turn, been associated with 
telomere shortening (Wolkowitz et al., 2011a). Telomeres are deoxyribonucleic acid (DNA) 
repeat structures at the ends of chromosomes that serve to protect chromosomes from fusing 
together during mitosis (Allsopp et al., 1992; Blackburn, Greider, & Szostak, 2006). Telomeres 
shorten at the end of each mitotic cycle, due to the inability of the DNA polymerase enzyme to 
fully replicate the 3’ end of the DNA strand, a process termed the “end replication problem” 
(Watson, 1972). Exposure to chronic stress has been associated with shorter telomeres 
(Damjanovic et al., 2007; Epel et al., 2004; Notterman & Mitchell, 2015; Parks et al., 2009; 
Shalev, 2012; Shalev et al., 2013). Increased maternal adverse childhood experiences have 
been reported to associate with shorter infant telomere length (TL), and TL attrition in infancy 
has been reported to interact with maternal adverse childhood experiences to predict higher 
problematic externalizing behaviors (Esteves et al., 2019). Shorter TL has also been associated 
with IMDs among children and adolescents (Verhoeven et al., 2015; Verhoeven et al., 2014; 
O’Donovan et al., 2011), and has been described as a risk factor for IMDs by some studies 
(Shalev et al., 2014; Gotlib et al., 2015) and a marker of increased stress exposure (Needham 
et al., 2015; Zhang et al., 2014; Houben, Moonen, van Schooten, & Hageman, 2008). There is 
thus a need to understand whether accelerated telomere shortening is causally linked to IMDs, 
or whether the development of IMDs and the shortening of telomeres are simultaneous effects 
of increased stress exposure. In addition to environmental exposures, TL is also at least partially 
genetically determined. Therefore, investigations into the role of telomeres in IMDs should 
take genetic variants in loci implicated in TL maintenance into account (Codd et al., 2013).  
 
Biological psychiatry studies investigating the molecular etiology of IMDs have been 
conducted in predominantly European and North American white populations. However, these 




levels of genetic diversity (Tishkoff et al., 2009; Ingman, Kaessmann, Pääbo & Gyllensten, 
2000). For this reason, studies investigating genetic risk for IMDs, as well as how genetic 
factors influence susceptibility to the harmful effects of stress need to be conducted in African 
populations.  
 
The present study utilizes the diathesis-stress model to investigate genetic and environmental 
risk for IMDs in an understudied, at-risk population i.e. HIV+ Ugandan children and 
adolescents. The following sections of the introduction will more closely examine the available 
literature on genetic and environmental determinants of IMDs and provide a rationale for the 
study approach employed. 
 
1.2 Background literature 
1.2.1 Occurrence of psychiatric disorders among HIV+ children and adolescents 
HIV/AIDS in children and adolescents is associated with both medical and psychiatric 
morbidity, in addition to delayed motor and cognitive development (Van Rie, Harrington, Dow, 
& Robertson, 2007). HIV+ children and adolescents experience high rates of psychiatric 
disorders, with estimates ranging from 17.4 – 61% (Kinyanda et al., 2019; Gadow et al., 2012; 
Gadow et al., 2010; Malee et al., 2011; Mellins et al., 2012; Musisi & Kinyanda, 2009; Pine et 
al., 1998; Reinherz et al., 2003), which is substantially higher than the worldwide pooled 
prevalence of 13.4% for any psychiatric disorder among children and adolescents (Polanczyk 
et al., 2015). Among a general population of children and adolescents, psychiatric disorders 
are associated with psychological distress and impaired quality of life (Weitkamp, Daniels, 
Romer & Wiegand-Grefe, 2013). Among HIV+ children and adolescents, psychiatric disorders 
are further associated with negative clinical and behavioral outcomes, non-adherence to anti-
retroviral treatment (Malee et al., 2011; Walkup et al., 2009), and increased stigma and 
isolation (Betancourt et al., 2014).  
 
Internalizing mental disorders (IMDs) are the most commonly reported psychiatric disorders 
among HIV+ children and adolescents (Kinyanda et al., 2019; Gadow et al., 2012; Gadow et 
al., 2010; Malee et al., 2011; Mellins et al., 2012; Musisi & Kinyanda, 2009), and were thus 
selected for further investigation in this study.  
1.2.2 Internalizing mental disorders: general classification and diagnosis 
Internalizing mental disorders are characterized by quiet, internal distress (Tandon, Si, & Luby, 




children with externalizing disorders, who display overtly socially negative or disruptive 
behavior (Tandon, Si & Luby, 2011). IMDs are associated with high levels of negative 
emotions (Regier, Kuhl, & Kupfer, 2013; Turygin, Matson, Beighley, & Adams, 2013), which 
include anger, contempt, disgust, guilt and fear (Koch, Forgas & Matovic, 2013). IMDs 
comprise a broad range of disorders, which have been classified as depressive or anxiety 
disorders, and PTSD. 
 
1.2.2.1 Depression 
Depression is characterized by persistent low mood, loss of interest in formerly pleasurable 
activities, feelings of worthlessness and hopelessness, suicidality, reduced psychomotor tone, 
poor concentration, changes in appetite and poor sleep (American Psychiatric Association, 
2013). Insomnia, excessive sleeping, fatigue, aches, pains, digestive problems and/or reduced 
energy may also be present (National Institute of Mental Health, 2019). Diagnosis of 
depression requires the presence of both core and associated symptoms. Core symptoms 
include sadness, unhappiness or irritability, and anhedonia, while associated symptoms include 
negative thinking, lack of energy, difficulty concentrating, and disturbances in sleep and 
appetite (American Psychiatric Association, 2013; Rey, Bella-Awusah & Liu, 2015). These 
symptoms must be present daily, for a duration of at least two weeks (American Psychiatric 
Association, 2013), must result in impaired functioning or significant subjective distress, and 
should not be a manifestation of the effects of a substance or an underlying medical condition 
(American Psychiatric Association, 2013; Rey, Bella-Awusah & Liu, 2015).  Among children 
(aged 5-11 years), depression presents with irritability (temper tantrums, noncompliance), 
reactive affect, somatic complaints and is frequently comorbid with anxiety, behavior 
problems, and attention-deficit/hyperactivity disorder (ADHD).  
 
Among adolescents (aged 12-17 years), depression presents with irritability (grumpiness, 
hostility, frustration and outbursts of anger), reactive affect, hypersomnia, increased appetite 
and weight gain, somatic complaints, and extreme sensitivity to rejection (Rey, Bella-Awusah 
& Liu, 2015). In adults, it presents with anhedonia, psychomotor agitation, diurnal variation, 
lack of affective reactivity and early morning waking (Rey, Bella-Awusah & Liu, 2015).  
 
Depression is the leading cause of disability worldwide (World Health Organization, 2017) and 
accounts for 40.5% of disability-adjusted life years (Whiteford et al., 2013). Depression is 




impacting on adherence to treatment, viral suppression, self-care and quality of life (Mutumba 
et al., 2017; Simoni et al., 2011). Prevalence rates of between 12.7 to 63% have been reported 
among HIV+ children and adolescents in various regions of the world (18.9% in Malawi (Kim 
et al., 2014), 17.8% in Kenya (Kamau et al., 2012), 18.5% in Malaysia (Rosliwati et al., 2008), 
35.5% in Ethiopia (Abebe et al., 2019), 40% in Uganda (Musisi & Kinyanda, 2009), 63% in 
Zimbabwe (Mavhu et al., 2013) and 12.7 -52% in the United States (Mellins & Malee, 2013; 
Mellins et al., 2012; Nachman et al., 2012)). The prevalence estimate observed in Uganda is 
almost double the estimated lifetime estimate of 23.2% for depression that was observed in the 
general population in the United States (Heo et al., 2008).  
 
Risk factors for depression among children and adolescents include, among others, a family 
history of depression, parental mental disorder, pubertal stage, childhood maltreatment, 
parental substance use or alcohol misuse, parental loss, medical illness, social rejection, chronic 
pain, parent-child conflict, female gender, previous history of depression, and bullying and 
trauma (Rey, Bella-Awusah & Liu, 2015; Lindert et al., 2014; Gardner, Thomas & Erskine 
2019; Sheng et al., 2017; Davey, Yücel, & Allen, 2008). Genetic factors have also been 
described as risk factors for depression in both adults and children (Sullivan, Neale MC & 
Kendler, 2000). An in-depth discussion of genetic mechanisms in depression is provided in 
Section 1.2.3. There are several assessment tools for measuring depression among children and 






















The CASI is an assessment tool for DSM-5 
defined psychiatric disorders in youth.  It has the 
advantage of having a symptom category that 
assesses both social and academic functioning of 
the child and is suitable for children aged 5 to 18 
years. It was deemed to be an ideal tool for the 
present study as it includes an assessment of 
impairment and is suited for the age category of 
participants in the present study (5-17 years). 
The CASI-5 has the disadvantage of lacking both 
scoring software and a computer-presented 
version. 
Locally adapted 
(Kinyanda et al., 







The YI-4R is an assessment tool for DSM-4 
defined psychiatric disorders in youth. It has the 
advantage of having a symptom category that 
assesses both social and academic functioning 
and is suitable for youths aged 12 to 18 years. 
The YI-4R has a disadvantage of lacking both 
scoring software and a computer-presented 
version. 
Locally adapted 
(Kinyanda et al., 
2019: Mpango et 
al., 2017) 









The CES-DC is a 20-item self-report depression 
inventory with possible scores ranging from 0 to 
60. The scale has good psychometric properties 
in adolescents despite its poor reliability and 
validity in younger children. The CES-DC was 
originally validated in a sample of 8-17 year old 
children in the United States (78% boys, 55% 










The MFQ has 26 items on the short form version 
and 66 items on the long form version, and is 
suitable for children aged 6 to 17 years. The MFQ 











The DRSS is a brief, simple to use self-report 
scale that takes a few minutes for a child to 
complete. This tool is suitable for children aged 









1.2.2.2 Anxiety disorders  
Anxiety disorders are characterized by significant feelings of anxiety and fear (American 
Psychiatric Association, 2013). Anxiety refers to a worry about the future, while fear is a 
reaction to current events (American Psychiatric Association, 2013). The average age of onset 
of anxiety disorders has been reported to be 21.3 years (de Lijster et al., 2017), but varies 
according to the specific type of disorder (Table 1.2).  
Table 1.2: Average age of onset for each anxiety disorder 
Anxiety disorder Age of onset Reference 
Separation anxiety disorder 7 – 8 years Rapee, 2018; American 
Psychiatric Association, 
2013 
Generalized anxiety disorder Mid-adolescence to 
adulthood 
Rapee, 2018; American 
Psychiatric Association, 
2013 
Social phobia 11 – 13 years Rapee, 2018; American 
Psychiatric Association, 
2013 
Specific phobias 6 -7 years Rapee, 2018; American 
Psychiatric Association, 
2013 
Panic disorder 20 – 24 years Rapee, 2018; American 
Psychiatric Association, 
2013 




Anxiety disorders impact heavily on physical, social, occupational and educational health, and 
account for 14.6% of disability-adjusted life years in a general population (Whiteford et al., 
2013). Prevalence rates of 9 to 58.5% for these disorders have been reported among HIV+ 
children and adolescents in different studies the United States and East Africa (Kinyanda et al, 




2003). In Uganda, a prevalence of 58.5% for anxiety disorders was reported among HIV+ 
adolescents (n = 82) (Musisi & Kinyanda, 2003). This is considerably higher than the 
prevalence rates of 16.7% and 12% that were reported among HIV-negative school-going 
orphans and non-orphans (10–13 years) (n = 420), respectively, in Rakai, a rural area of  
Uganda (Musisi, Kinyanda, Nakasujja & Nakigudde, 2007), and the 26.6% prevalence rate that 
was reported among a community sample of children and adolescents (n = 1,680) from war 
affected areas in north-eastern Uganda (Abbo et al., 2013). 
 
Risk factors for anxiety disorders include family history, life events, cognitive biases, genetic 
and temperamental factors (Rapee, 2018). The core features for each specific anxiety disorder 
are summarized in Table 1.3, below.  
 






Fear or concern that something bad will happen to the child or 
attachment figure (commonly a parent) when they are separated and as 




Tendency to worry about a wide range of negative possibilities, that 
something bad will happen. 
Social anxiety 
disorder 
Fear and avoidance of social interactions or social performance due to a 
belief that others will negatively evaluate the child. 
Specific phobias Fear and avoidance in response to a range of specific cues, situations, or 
objects. There is a common belief that the object or situation will lead to 
personal harm. 
Panic disorder Experience and fear of unexpected panic attacks, commonly involving 
several somatic symptoms and fears of dying or going crazy. 
Agoraphobia Additional fear and avoidance of several "agoraphobic" situations, 
commonly due to a fear of experiencing a panic attack in those situations. 





A number of assessment tools for anxiety disorders among children and adolescents have been 





Table 1.4: Assessment tools for anxiety disorders among children and adolescents 
Assessment Tool 
(Reference) 
Description Validation/ Local 
adaptation among CA-
HIV in Uganda 
The Child and Adolescent Symptom Inventory-
Edition 5 (CASI-5)ƒ 
 (Gadow & Sprafkin, 2013) 
Please see Table 1.1 Locally adapted (Kinyanda 
et al., 2019; Mpango et al., 
2017) 
The Youth’s Inventory-4 (YI-4)ƒ  
(Gadow & Sprafkin, 1999) 
Please see Table 1.1 Locally adapted (Kinyanda 
et al., 2019: Mpango et al., 
2017) 
The Spence Children’s Anxiety Scale (SCAS)  
(http://www.scaswebsite.com/) 
The SCAS assesses symptoms of various anxiety disorders 
using dimensions proposed by DSM-4. This tool assesses 44 
items in six domains of anxiety and is suitable for young people 
aged between 8-15 years.  
Neither validated nor 
locally adapted 




The SCARED is a child and parent self-report instrument for 
screening various childhood anxiety disorders which consists of 
41 items and five factors that parallel the DSM-IV classification 
of anxiety disorders. The SCARED has good internal test- retest 
reliability, discriminant validity and sensitivity to treatment 
response.  
Neither validated nor 
locally adapted 
The Multidimensional Anxiety Scale for Children. 
2nd Edition–Self-Report (MASC 2™–SR) 
(https://www.mhs.com/MHS-
Assessment?prodname=masc2) 
The MASC 2™–SR is a comprehensive assessment of anxiety 
dimensions in children and adolescents aged 8 to 19 years. It 
indexes the range and severity of anxiety symptoms, and is a 
useful tool for early identification of anxiety-prone youth, as 
well as in monitoring treatment effects.  
Neither validated nor 
locally adapted 





The PASR was adopted from the SCAS and is the only 
measure that specifically assesses a wide range 
of anxiety symptoms in preschool-aged children and utilizes 
parent report.  It is designed to assess symptoms of anxiety 
and fears in children aged 6 years and below. 
Neither validated nor 
locally adapted 
The Revised Children’s Manifest Anxiety Scale 
(RCMAS)  
(Reynolds & Richmond, 1985) 
 The RCMAS is a 37-item, self-report instrument with only 
“yes” and “no” options and is designed to assess the level and 












nature of anxiety among children between 6 and 9 years of age. 
It has a disadvantage of inconsistency of the reliability scale. 




The STAIC comprises of two 20-item scales for measuring state 
and trait anxiety in children between the ages of 8 and 14 years.  
Neither validated nor locally 
adapted 




The BAI-Y is a 21-item multiple-choice self-report inventory 
that measures the severity of an anxiety in adults and 
adolescents. It has an advantage of clearly discriminating 
anxiety from depression. 
Neither validated nor locally 
adapted 




The FSSC-R is a widely used self-report questionnaire that 
purports to measure the number of fears and the overall level of 
fearfulness in children. 
Neither validated nor locally 
adapted 
The Social Phobia and Anxiety Inventory for 
Children (SPAIC) 
(Beidel et al., 2000) 
The SPAIC is a 26-item tool that evaluates the somatic, 
cognitive, and behavioral aspects of Social Phobia and 
anxiety in children between the ages of 8 and 14. 
Neither validated nor locally 
adapted 
The Children’s Anxiety Sensitivity Index (CASI)  
(Silverman et al., 1991) 
The CASI has an 18-item scale and assesses for anxiety 
sensitivity by asking children to state how aversively they 
view anxiety symptoms. 





Anxiety disorders in childhood and adolescence have been associated with impaired quality of 
life, poor academic performance and recurrence later in life (Nachman et al., 2012; Ezpeleta et 
al., 2001; Mendlowicz & Stein, 2000; Woodward & Fergusson, 2001), as well as increased 
risk of suicide attempts and suicidal ideation (Ortin et al., 2019; Herres et al., 2019). Anxiety 
disorders also affect somatic health, and have been associated with irritable bowel syndrome, 
cardiovascular disease and chronic pain (Roy-Byrne et al., 2008). Among adults, anxiety 
disorders have been associated with loss of worker productivity (Kessler & Frank, 1997), 
elevated rates of general medical disorders (Zaubler & Katon, 1996), frequent comorbid mental 
disorders (Compton, Thomas, Stinson, & Grant, 2007; Conway, Compton, Stinson, & Grant, 
2006; Kessler & Frank, 1997), increased risk of suicide attempts and suicidal ideation 
(Pilowsky et al., 2006), and high mortality rates (Pratt, Druss, Manderscheid & Walker, 2016).  
 
1.2.2.3 Posttraumatic stress disorder (PTSD)  
Posttraumatic stress disorder can develop after exposure to a traumatic event, such as sexual 
assault, warfare, or traffic collisions (Bisson, Cosgrove, Lewis, & Roberts, 2015; American 
Psychiatric Association, 2013). Symptoms of PTSD may include disturbing thoughts, feelings, 
or dreams related to the events, mental or physical distress to trauma-related cues, attempts to 
avoid trauma-related cues, alterations in how a person thinks and feels, and an increase in the 
fight-or-flight response (American Psychiatric Association, 2013). A diagnosis of PTSD 
requires: i) one symptom of intrusion including recurrent distressing dreams, recurrent 
distressing memories of the trauma, dissociative reactions (e.g., flashbacks), or intense 
psychological or physiological reactivity to reminders of the trauma; ii) persistent avoidance 
of internal or external stimuli associated with the trauma; iii) two symptoms of negative 
alterations in cognitions and mood associated with the trauma including persistent, distorted 
blame of self or others, persistent negative emotional state (e.g., fear, horror, anger, shame or 
guilt), diminished interest or participation in significant activities, detachment or estrangement 
from others, or persistent inability to experience positive emotions (e.g., emotional numbing); 
and iv) two symptoms of alterations in arousal and reactivity, including irritability or 
aggressive behavior, reckless or self-destructive behavior, hypervigilance, exaggerated startle 
responding, problems with concentration, or sleep disturbance. The diagnosis requires that 
symptoms last at least one month, are associated with clinically significant distress or 
impairment, and are not associated with the effects of a substance or an underlying medical 
condition (American Psychiatric Association, 2013; Bui et al., 2014).  Posttraumatic stress 




elevated rates of age-related diseases (Šagud et al., 2017), frequent comorbid mental disorders 
(Mason, LeBouthillier & Asmundson, 2019), impaired physical functioning (Hall et al., 2014), 
and higher mortality (Boscarino, 2006). 
 
The lifetime prevalence of PTSD among the general population has been found to be 
approximately 7% in the United States (Kessler and Wang, 2008). Systematic reviews have 
documented prevalence rates of 20% among survivors of road traffic accidents in Europe, the 
United States and China (Dai et al, 2018), 23.7% among earthquake survivors (Bassuk, Richard 
& Tsertsvadze, 2015) and 47% among children exposed to war (Attanayake et al., 2009). In a 
representative population sample of 10-13 year old children followed up for at least 3 years in 
the United States, approximately 30% had experienced one or more traumatic events by age 
16, and 13% endorsed symptoms of PTSD (Copeland et al., 2007). From these data, it is 
apparent that not all individuals exposed to trauma develop the disorder and thus individual 
factors, including genetic background and environment, must influence risk and resilience to 
the harmful effects of trauma (Smoller et al., 2016).  
 
Numerous studies have investigated such differential vulnerability to PTSD. This research has 
indicated a role for genetic factors (Nievergelt et al., 2019) (discussed in Section 1.2.3), as well 
as individual differences and features specific to the trauma exposure. More specifically, 
exposure to trauma such as a natural disaster, war or a motor vehicle crash (Trickey et al., 2012; 
Attanayake et al., 2009), female sex (McLaughlin et al., 2013), family characteristics (Morris, 
Gabert-Quillen & Delahanty 2012) and cognitive and emotional responses to the traumatic 
event (Jenness et al., 2016; Trickey et al., 2012; Ehlers, Mayou, & Bryant 2003) have been 
identified as increasing the risk of developing PTSD. A meta-analysis of 64 studies that 
assessed risk factors for PTSD among children and adolescents predominantly from Europe 
and the United States revealed that factors relating to the subjective experience of the traumatic 
event (including peri-trauma fear and perceived life threat) and post-trauma variables 
(including low social support, social withdrawal, psychiatric comorbidity, poor family 
functioning, and the use of certain cognitive strategies such as distraction and thought 
suppression) accounted for medium-to-large effect sizes in the prediction of PTSD, while pre-
trauma factors (including female gender, low intelligence, low socio-economic status (SES), 
pre-trauma life events, pre-trauma low self-esteem, pre-trauma psychological problems in the 
youth and parents) accounted for only small-to-medium effect sizes. (Trickey et al, 2012). Of 




among adolescents and young adults (Radcliffe et al., 2007) and children orphaned by AIDs 
have been reported to be 67% more likely to suffer PTSD compared to those orphaned by other 
causes in South Africa (Cluver, Orkin, Gardner, & Boyes, 2012). Though living with HIV has 
been reported as a potential source of trauma among children and adolescents, further research 
on the prevalence of PTSD in this population is required (Ahlers, 2016).  
 
1.2.3  The diathesis-stress hypothesis 
The research referenced above provides clear support for the complex nature of psychiatric 
disorders and indicates that their etiology is likely mediated by a variety of factors producing 
individual, interactive and multiplicative effects. The diathesis-stress hypothesis of 
neuropsychiatric disorders postulates that a lower stress threshold is required for psychiatric 
disease to occur in individuals who harbor certain vulnerability factors, which may be genetic 
and/or acquired (Caspi et al., 2003; Silberg et al., 2001; Monroe & Simons, 1991). The 
hypothesis that inherent differences in vulnerability drive risk for IMDs has informed our 
approach to the current study and the following sections will examine the evidence for 
biological factors influencing vulnerability to the development of IMDs. 
 
1.2.4 Heritability of internalizing mental disorders  
Findings from numerous studies suggest that genetic predisposition contributes to the etiology 
of IMDs. Twin studies indicate an estimated genetic heritability of 35% for depression (Otte et 
al., 2016), 30-50% for PTSD (Smoller et al., 2016), and 30-67% for anxiety disorders 
(Domschke & Maron, 2013; Hettema, Neale & Kendler, 2001) among participants with 
unknown HIV status. Despite these findings, the diagnosis of IMDs is still largely based on 
clinical symptoms rather than biological markers. This is due to a number of limitations, 
including the complexity of the underlying pathophysiology; diverse manifestation and course 
of IMDs; heterogeneity of contributing genetic and non-genetic factors, and limited knowledge 
about genotype-phenotype relationships (Sullivan et al., 2017; Levinson et al., 2014). 
Nevertheless, the increasing number of studies in the field, the development of new approaches 
that allow for more detailed genetic examinations, and the founding of consortia that can 
analyze pooled data are greatly increasing the scope and potential of genetic studies. 
1.2.4.1 Genome-wide association studies in internalizing mental disorders 
Genome-wide association studies (GWASes) powered by large sample sizes allow for the 
investigation of genetic variants with relatively small effect sizes. An early mega-analysis of 




and 50,695 controls, failed to detect clear genetic variants associated with depression (Ripke et 
al., 2013). However, with an increasing number of studies with sufficiently large sample size, 
genetic variants associated with depression are being discovered (summarized in Table 1.5).  
For example, a genome-wide association study (GWAS) by Hyde et al. (2016) identified five 
independent genetic loci associated with risk of major depression in individuals of European 
descent (75,607 cases and 231,747 controls). Using a single population-based cohort of 
322,580 (113,769 cases and 208,811 controls) individuals from the UK Biobank cohort, a 
GWAS by Howard et al. (2018) identified 17 independent loci that significantly associated 
with depression in the UK Biobank phenotypes and the gene-set enrichment analyses 
implicated pathways in excitatory neurotransmission, mechanosensory behavior, post-
synaptic, neuronal dendritic spine and dendritic function.  
 
A more recent GWASes meta-analysis conducted by the Psychiatric Genetics Consortium 
Major Depressive Disorder Working Group analyzed seven cohorts (35,458 cases and 344,901 
controls of European descent) and identified 44 independent loci that were significantly 
associated with major depression Wray et al. (2018) (see Table 1.5). By demonstrating that the 
number of significant loci increased as additional cohorts were included in the analysis, this 
publication highlighted the value of large sample sizes in GWASes of complex disorders such 
as depression. Interestingly, the loci identified in a previous study of Han Chinese participants, 
which included 5,303 cases of major depressive disorder and 5,337 controls (Cai et al., 2015a), 
were uncommon in the Wray et al. combined seven cohort study group. This finding highlights 
the fact that genetic findings may not be broadly applicable across populations of different 
ethnicities, and underscores the value of conducting genetic investigations in diverse 
populations.  
 
GWASes have also been carried out on anxiety disorders, with early studies suggesting 
involvement of variants relating to neurotransmitter signaling (Schosser et al., 2013) and 
proprotein convertase 2 (PCSK2), which is involved in neuroendocrine peptide metabolism, 
for pre-school internalizing problems (Benke et al., 2014). A recent GWAS among adults with 
depression or anxiety (n = 972 for anxiety and n = 832 for depression) and children with anxiety 
(n = 920) failed to identify single nucleotide polymorphisms (SNPs) that significantly associate 
with treatment outcome following cognitive behavioral therapy (Rayner et al., 2019). In 
contrast, another recent GWAS (12,655 cases with various anxiety and stress-related diagnoses 




(PDE4B) to be significantly associated with both anxiety (agoraphobia, GAD, panic disorder, 
social phobia, specific phobia and other on unspecific anxiety disorder) and anxiety-related 
disorders (Meier et al., 2019). The PDE4B gene has been reported to regulate intracellular 
cyclic adenosine monophosphate signaling and is strongly expressed in the human brain (Meier 
et al., 2019).  
 
Several recent GWASes have been conducted on PTSD. A recent study by Katrinli et al. (2019) 
that utilized GWAS data on 50 SNPs reported associations between SNPs within the gene for 
human leucocyte antigen (HLA) and PTSD among samples from an African-American cohort 
in the United States. In their gene enrichment analysis, Katrinli et al. (2019) found the HLA 
variants implicated in PTSD were enriched in pathways relevant to neural and immune activity. 
Another GWAS by Wang et al. (2019) has also implicated perturbation of the inflammatory 
response in PTSD, with a region near 4q31, close to the interleukin 15 gene, associated with 
PTSD among a trauma-exposed sample of Danish soldiers deployed to war and conflict zones 
(n = 2,481). The corticotrophin-releasing hormone receptor 1 gene (CRHR1) was also recently 
associated with genetic risk to intrusive re-experiencing of trauma, the most characteristic 
symptom cluster of PTSD in a GWAS among adult US veterans of European ancestry (n = 
146,660) (Gelernter et al., 2019).  
 
Interestingly, there were no significant loci identified for the African American participants 
included in the study (n = 19,983) (Gelernter et al., 2019), highlighting that genetic risk for 
PTSD may vary across different ethnicities. Finally, similar evidence for ancestry-specific 
genetic risk was found in a recent GWAS of 30,000 PTSD cases and 170,000 controls 
(Nievergelt et al., 2019).  A total of three genome-wide significant loci (two in European (n = 
23,000) and one in African (n = 4,000) ancestry analyses) were identified with gene-based 
analyses implicating genes related to dopamine and immune pathways in PTSD (Nievergelt et 
al., 2019). 
 
Table 1.5: Genome-wide association study findings in internalizing mental disorders 
Reference IMD Study sample Genetic loci identified 




75,607 cases and 
231,747 controls of 
European descent 
Olfactomedin-4 (OLFM4); myocyte 
enhancer factor 2C (MEF2C); 







Depression 113,769 cases and 
208,811 controls 
from the UK 
Biobank Cohort 
Dopamine receptor D2 (DRD2); 
Sortilin Related VPS10 domain 
containing receptor 3 (SORCS3); 
glutamate metabotropic receptor 5 
(GRM5); ankyrin repeat and sterile 
alpha motif domain containing 1B 
(ANS1B); calcium binding protein 1 
(CABP1); teneurin transmembrane 
protein 2 (TENM2); ephrin type-B 
receptor 2 (EPHB2) 




35,458 cases and 
344,901 controls 
using data collected 
by PGC, UK, 
Icelandic, United 
States, and Danish 
studies 









cases with major 
depression and 
1,588 controls of 
European descent 
Cholecystokinin (CCK), dopamine D3 
receptor (DRD3), gamma-aminobutyric 
acid receptor gamma 2 (GABRG2), 
adrenergic beta-1 receptor (ADRB1), 
glyoxalase I (GLO1), ATP-binding 
cassette subfamily G member 1 
(ABCG1) 



















972 adults and 929 
children with 
anxiety, and 832 
adults with 
depression. All 
participants were of 
European descent 
No significant variants identified 





12,655 cases with 
anxiety- or stress-
related disorders 
and 7,308 controls. 
All participants 
were of European 
descent 
Phosphodiesterase 4B gene (PDE4B). 
Katrinli et 
al. (2019)  










Wang et al. 
(2019) 
PTSD 462 cases and 2,019 
controls of Danish 
descent 
Region 4q31, close to interleukin-15 
Gelernter et 
al. (2019) 
PTSD 146,660 European 
American and 
19,983 African 
American US war 
veterans 
Transcription factor 4 (TCF 4), KAT8 
Regulatory NSL Complex Subunit 1 
(KANSL1), Serine/Threonine-Protein 
Kinase (SRPK2), mitotic arrest 
deficient 1 like 1 (MAD1L1), 
Hydroxysteroid 17-Beta 
Dehydrogenase 11 (HSD17B11), 
Potassium Voltage-Gated Channel 
Interacting Protein 4 (KCNIP4), CaM 
Kinase Like Vesicle Associated 
(CAMKV), Long Intergenic Non-





PTSD. 30,000 cases and 
170,000 controls in 
a multi ethnic 
cohort 
 Parkin RBR E3 ubiquitin protein 
ligase (PARK2), Zinc Finger DHHC-
Type Containing 14 (ZDHHC14), Zinc 
Finger Protein 813 (ZNF813), (Kazrin, 
Periplakin Interacting Protein (KAZN), 
TMEM51 Antisense RNA 1 
(TMEM51-AS1), Long Intergenic Non-
Protein Coding RNA 2335 
(LINC02335), microRNA 5007 
(MIR5007), transcribed ultra-
conserved region 338 (TUC338), Long 
Intergenic Non-Protein Coding RNA 
2571 (LINC02571), major 
histocompatibility complex, class I, B 
(HLA-B) 
PTSD = post-traumatic stress disorder 
 
Combined, these results highlight several important themes. First, it is evident that the genetic 
etiology of IMDs is complex. The results of the studies conducted thus far have failed to 
identify consistent specific loci in cohorts. These disparate results may be due to a number of 
factors. For example, different genes may be involved in distinct processes investigated by 
specific research questions e.g. the likelihood of having an anxiety disorder versus therapeutic 
response.. Second, it is possible that inclusion of comorbid disorders, such as in studies that 
examine both anxiety and depression, may influence the results. Third, this review of GWAS 
findings included studies that examined a range of anxiety and depressive disorders, and it is 
possible that focus on specific disorders may yield results that are more likely to be replicated 
across samples. Finally, studies that examine specific age groups, such as internalizing 





Despite these inherent difficulties in cross study comparisons, these results do reinforce several 
important findings. First, these studies suggest that genetic variants do play a role in the 
etiology of IMDs, with the possibility of variants implicated in neurotransmission, stress 
response and inflammatory processes identified. Second, genetic studies need to be conducted 
in ethnically diverse populations. Bearing this in mind, and given the scarcity of studies 
conducted in African populations, our genetic investigations in HIV+ children and adolescents 
in Uganda is both novel and highly relevant. 
 
1.2.4.2 The serotonin transporter gene  
Though it has not been found to significantly associate with IMDs in GWASes, the serotonin 
(5-HT) system has been extensively studied in candidate gene approaches (Table 1.6). 
Furthermore, the benefit of antidepressant drugs that target the serotonin system in relieving 
depressive symptoms also supports the value of investigating serotonin-related genes in 
internalizing mental disorder (IMD) studies (Ernst, Mechawar, & Turecki, 2009). Encoded by 
the SLC6A4, the 5-HT transporter (5-HTT) is a target for SSRIs that competitively block 
substrate binding and thereby prolong neurotransmitter action at the synapse (Cipriani et al., 
2018; Kristensen et al., 2011). The 5-HTT-linked polymorphic region (5-HTTLPR) is located 
within the promoter region of the SLC6A4, 1 kb upstream from the transcription start site on 
chromosome 17 where it has been reported to influence SLC6A4 expression (Heils, Mössner 
& Lesch, 1997; Barca-Garcia et al., 2002; Ali et al., 2010; Martin et al., 2007). The 5-HTTLPR 
variant contains two alleles, comprising either the 14 (short, S-allele) or the 16 (long, L-allele) 
copies of a 22-23 base pair (bp) imperfect repeat (Heils et al., 1996). In vitro studies show that 
the L-allele has higher basal transcriptional activity compared to the S-allele (Seripa et al., 
2013; Iurescia et al., 2012; Hu et al., 2006; Baca-García et al., 2002). In close proximity to the 
5-HTTLPR is an A to G single nucleotide polymorphism (SNP) where the G-allele has been 
reported to alter expression of the SLC6A4 by creating a functional AP2 transcription-factor 
binding site (Ehli et al., 2012; Hu et al., 2006). The SLC6A4-rs25531 L-G haplotype has been 
reported to have transcription efficiency equivalent to that of the S-allele (Hu et al., 2006). 
  
As the therapeutic benefit of SSRIs relies on inhibiting the transporter, and therefore increasing 
synaptic 5-HT, it is possible that genetic influences on SLC6A4 expression and thus transporter 
activity may underlie some of the negative symptoms of IMDs. The 5-HTTLPR S-allele has 




Furthermore, in interaction analyses that account for stress, the S-allele has also been associated 
with elevated risk for  depression (Conway, Slavich & Hammen, 2014; Sharpley et al., 2014; 
Karg, Burmeister, Shedden & Sen, 2011; Caspi et al., 2003), anxiety disorders (Saul et al., 
2019; Stein, Schork, & Gelernter, 2008) and PTSD (Li et al., 2019; Guo et al., 2019; Liu et al., 
2018; Smoller et al., 2016; Gressier et al, 2013). 
 
Another widely studied polymorphism within SLC6A4 is a variable number of tandem repeats 
polymorphism in intron 2 (STin2 VNTR), which consists of multiple repeated copies of a 16-
17 bp element (Battersby et al., 1996; Furlong et al., 1998). Two major alleles have been 
described among a Ugandan sample of PLHIV, containing 10 (STin2.10) and 12 (STin2.12) 
copies of this VNTR (Kalungi et al., 2017), with the 9-repeat (STin2.9)  (Ogilvie et al., 1996) 
generally found  at a lower frequency.   The STin2 VNTR has been found to interact with the 
5-HTTLPR polymorphism to regulate expression of SLC6A4 (Ali et al., 2010; Haddley et al., 
2011). Specifically, the STin2.9 allele directed increased transcription of the SLC6A4 compared 
to the STin2.10 allele, while the STin2.10 allele directed higher SLC6A4 transcription than the 
STin2.12 allele (Haddley et al., 2011; Ali et al., 2010). Both 5-HTTLPR and STin2 VNTR 
polymorphisms have been widely investigated in IMDs (Smoller et al., 2016). The combination 
of the S/S 5-HTTLPR and STin2.10 alleles has also been associated with nicotine dependence 
in Vietnamese men (Koks et al., 2018). The STin2.9 and STin2.10 alleles have both been found 
to be associated with anxiety in patients with self-harming behaviors (Evans, Li, & Whipple, 
2013) while the STin2.12 allele has associated with depression, neuroticism and suicide 
(Kalungi et al., 2017;de Lara et al., 2007; O’Gara et al., 2008). In addiiton, possessing the 
STin2.10 allele has been associated with protection against PTSD (Xiao et al., 2019). Table 1.6 
gives a summary of studies that have been carried out on SLC6A4 5-HTTLPR and STin2 VNTR 
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IMD = internalizing mental disorder, L = Latino, B = mixed race, A = Asian, NA = Native 
American, O = Others, C = North American/European white, NR = not reported, EA = 
European American, AA = African American, PTSD = post-traumatic stress disorder, 5-
HTTLPR = serotonin transporter gene-linked polymorphic region 
 
1.2.4.3 The tryptophan hydroxylase 2 gene 
The tryptophan hydroxylase enzyme (TPH2) exists as two isoforms, TPH1 and TPH2, which 
are independently encoded on the TPH1 and TPH2 genes (Hasegawa & Nakamura, 2010). 
TPH2 catalyzes the rate-limiting step in 5-HT biosynthesis (Carkaci-Salli et al., 2006; Walther 
et al., 2003) and is found exclusively in the brainstem (Kennedy et al., 2012), an area which is 
the major locus of serotonin-producing neurons (Kennedy et al., 2012). Polymorphisms in 
TPH2 have been associated with IMDs (Reuter, Kuepper, & Hennig, 2007; Van Den Bogaert 
et al., 2006; Zhang et al., 2005). To this end, a meta-analysis of 27 studies that studied 74 SNPs 
within TPH2 confirmed the involvement of this gene in depression (Gao et al., 2012). 
rs34517220, an intronic variant located within transcription factor binding sites of TPH2 
(Gassó et al., 2017), has also been reported as a functional variant that modulates human TPH2 
expression in antidepressant response to SSRIs (Gassó et al., 2017). In addition, rs4570625, 
located in the 5’ regulatory region (Latsko et al., 2016), and rs1386494, located approximately 
2 kb from the 5’ end of TPH2 (Zill et al., 2004), have been associated with reduced transcription 
rates of TPH2 (Porcelli et al., 2011) and thus may have an effect on 5-HT turnover in the brain.  
 
A functional brain imaging study (eighteen cases and six controls) found evidence for increased 
5-HT synthesis in the hippocampus and basal nuclei of participants with social anxiety disorder 
(Furmark et al., 2016). Interestingly, this increased synthesis capacity was linked to the TPH2 




T-allele, and therefore need to be interpreted with caution, they nevertheless suggest a 
functional impact of this SNP on brain structures relevant to emotional processing (Furmark et 
al., 2016). Moreover, in the longitudinal Estonian Children Personality, Behaviour and Health 
Study (n = 1234), the rs4570625 TT genotype was also associated with reduced prevalence of 
anxiety disorders at age 25 years (Laas et al., 2017). 
 
A study among adult Chinese participants who experienced an earthquake (n = 326) reported 
the rs11178997 T-allele as a significant predictor of severity of PTSD avoidance symptoms in 
women (Cao et al., 2014). In addition, the T-allele of rs11178997 was significantly associated 
with PTSD symptoms among a sample of 200 adults exposed to the 1988 Spitak earthquake 
from twelve multigenerational families (Goenjian et al., 2012). However, findings on the 
association between TPH2 variants and PTSD are mixed. A study by Goçi et al. (2019) reported 
no association between TPH2 rs11178997 and rs1386494 on either depression or PTSD among 
participants who experienced war-related trauma in Bosnia and Herzegovina, Kosovo and 
Croatia. It is thus possible that the genotype-dependent effects found by Cao et al. (2014) and 
Goenjian et al. (2012) may have been associated with shared qualitative aspects of the trauma 
experienced following exposure to an earthquake.  
 
As TPH2 encodes for the rate-limiting enzyme in 5-HT synthesis, there is a strong biological 
rationale for its investigation as a candidate gene in studies of IMD etiology. This is further 
supported by evidence for associations between TPH2 SNPs and depressive disorders, anxiety 
disorders and PTSD. However, very few of the studies summarized above investigated the 
interactive effects of stress and genetic variation in TPH2 on anxiety and depressive disorders. 
Furthermore, the studies were limited to adult participants. However, the findings of the 
longitudinal Estonian birth cohort study also suggest TPH2 variants may influence 
vulnerability to IMDs during developmental periods (Laas et al., 2017) and may thus be 
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1.2.5 Telomere length and internalizing mental disorders 
1.2.5.1 Telomeres and telomere length 
Targeted investigations of the genetic contributions to IMDs have examined multiple 
candidates beyond 5-HT. One such candidate, telomere length, is an especially intriguing 
option for exploration. Telomeres are protein-bound deoxyribonucleic acid (DNA) repeat 
structures at the ends of chromosomes. They are important in protecting chromosomes from 
fusing together during mitosis, thus preventing loss of genetic data (Allsopp et al., 1992; 
Blackburn, Greider, & Szostak, 2006). They also regulate cellular replicative capacity (Allsopp 
et al., 1992; Blackburn, Greider, & Szostak, 2006). During each somatic cell replication, TL 
progressively shortens due to the inability of DNA polymerase enzyme to fully replicate the 3’ 
end of the DNA strand, a process termed the “end replication problem” (Watson, 1972). This 
results in a gradual decline in TL over time. Once a critical TL is reached, the cell is triggered 
to enter a phase of replicative senescence and subsequently cell death (Allsopp et al., 1992; 
Blackburn, Greider, & Szostak, 2006).  
 
In germ cells and other stem cells that require replenishing, TL is maintained by a telomerase 
enzyme component known as telomerase RNA component (TERC) and a reverse transcriptase 
enzyme known as the telomerase reverse transcriptase (TERT) (Blackburn, Greider, & Szostak, 
2006; Wang & Meier., 2004). The ataxia-telangiectasia mutated (ATM) kinase enzyme has 
also been recently reported to play a role in TL maintenance through phosphorylation and 
removal of the telomeric repeat-binding factor 1 (TRF1) protein from telomeres (Lee et al., 
2015). Shorter TL has been related to both dampened telomerase activity (Epel et al., 2004) 
and, paradoxically, elevated telomerase activity (Damjanovic et al., 2007). These contradictory 
results may be due to whether elevated telomerase activity is able to compensate for TL attrition 
or may be overwhelmed if the causes of the TL attrition are sufficiently potent (Lindqvist, 
Simon & Wolkowitz, 2019). 
 
Importantly, TL is subject to multiple environmental influences and therefore may offer a 




to this study, TL is influenced by stress exposure and infectious diseases, such as HIV (Epel & 
Prather, 2018; Shiau et al., 2018).  As a marker of cellular aging, TL has also been linked to 
many age-related diseases such as cardiovascular disease (Rehkopf et al., 2016) and 
neurodegenerative disorders (Forero et al., 2016), as well as psychopathology (Epel & 
Pranther, 2018).  Studies have associated reduced TL with accelerated cellular aging, age-
related disease and reduced years of survival (Sanders & Newman, 2013; Epel et al., 2009) 
while longer telomeres have been associated with increased years of healthy life (Njajou et al., 
2007).  
 
Telomere length may thus link environmental exposure to risk of IMDs and their associated 
effects on physical health. Indeed, it has been reported that patients with IMDs have higher 
mortality rates compared to the general population, and that the mortality is mainly due to the 
same age-related diseases (such as cancer, heart and cerebrovascular disease) as the general 
population (Pratt, Druss, Manderscheid & Walker, 2016; Druss et al., 2011; Colton & 
Manderscheid, 2006; Cuijpers & Smit, 2002). The biochemical processes that underlie the 
comorbidity between IMDs and age-related diseases require investigation and future genetics 
studies among patients with comorbid IMDs and metabolic diseases may provide insights into 
the association between IMDs and metabolic disease. 
 
Telomere length has been shown to shorten rapidly from birth to age five years, and then enter 
a period of relative stability until young adulthood (defined as early 20s), after which more 
gradual attrition occurs (Wojcicki et al., 2016; Frenck, Blackburn & Shannon, 1998). 
Therefore, identifying TL differences in studies of children and adolescents, an age of expected 
TL stability and therefore lower variability, could offer a more accurate insight into the causal 
determinants of the observed changes. The value of studying TL in younger samples is borne 
out by the numerous investigations reporting associations between adverse childhood 
experiences and shorter TL (Bürgin et al., 2019; Chen et al., 2019; Wade et al., 2019; Xavier 





Figure 1.1: A schematic of pathways linking internalizing mental disorders to telomere 
shortening (Adapted from Yu & Woo, 2016). 
 
In an effort to elucidate mechanisms underlying IMDs, studies have explored the role of TL in 
the etiology of IMDs. Besides associations with IMDs, TL have also been found to be 
associated with exposure to chronic stress (Epel et al., 2004; Notterman & Mitchell, 2015) and 
early life stress (Tyrka et al., 2016), known risk factors for IMDs (Adelman et al., 2014; Evans, 
Li, & Whipple, 2013; Revenson et al., 2016; Robles, Slatcher, Trombello, & McGinn, 2014). 
These associations point to an underlying biological embedding of TL in the etiology of IMDs 
that warrant investigation. The following section gives an overview of these associations. 
 
1.2.4.2 Telomere length and etiology of internalizing mental disorders 
Several studies in children and adolescents of unknown HIV status have reported associations 
between experiencing adversity and telomere shortening (Bürgin et al., 2019; Mayer et al., 
2019; Alexeeff et al., 2019; Shalev et al., 2013; Theall et al., 2013; Drury et al., 2014; Mitchell 
et al., 2014). Adversity experienced in childhood and adolescence ranges from exposure to 
traumatic stressors, such as sexual and physical abuse, to social adversities that relate to family 
structure, parental mental distress, and SES (Shalev et al., 2013; Theall et al., 2013; Drury et 
al., 2014; Mitchell et al., 2014). Living with HIV has also been reported as a potential source 





Many studies have associated IMDs with shorter TL (Avetyan, Zakharyan, Petrek & 
Arakelyan, 2019; Malouff & Schutte, 2017; Verhoeven et al., 2014, 2015, 2017; Lin, Huang 
& Hung, 2016; Garcia-Rizo et al., 2013; Shalev et al., 2014; Zhang et al., 2014; Douillard-
Guiloux et al., 2013; Kinser et al., 2013; Kananen et al., 2010; O’Donovan et al., 2011). 
Among adult samples, shorter TL has been associated with depression (Lin, Huang & Hung, 
2016; Schutte & Malouff, 2015), anxiety disorders  (Verhoeven et al., 2015, 2017; Malouff & 
Schutte, 2017) and PTSD (Avetyan, Zakharyan, Petrek & Arakelyan, 2019; O’Donovan et al., 
2011; Zhang et al., 2014). Although the nature of the association between IMDs and TL is not 
well known, several biological mechanisms have been proposed. IMDs have been reported as 
chronic stressors (McEwen, 2003), which can lead to long-term alterations to the 
hypothalamic-pituitary-adrenal (HPA) axis, and thus impact on the stress response. In the first 
study to examine the associations between TL, stress reactivity and risk for depression, Gotlib 
et al. (2015) found that shorter TL was associated with increased stress-induced cortisol 
reactivity in children born to mothers with a history of recurrent depressive episodes. 
 
Internalizing mental disorders could also result in TL attrition through inflammatory pathways. 
Depression has, for example, been reported to prime massive cytokine responses to stressors 
(Kiecolt-Glaser, Derry & Fagundes, 2015). Increased systemic inflammation has also been 
associated with decreased TL among a prospective cohort of workers exposed to high levels of 
fine particulate matter (Wong et al., 2014).  Finally, both HPA axis dysregulation and 
inflammation have been linked to increased oxidative stress, which has emerged as a common 
finding across a range of IMDs and which is in turn associated with TL attrition (Shafiee et al., 
2018; Czarny, Wigner, Galecki & Sliwinski, 2018; Miller, Lin, Wolf & Miller, 2018; Spiers, 
Chen, Sernia, & Lavidis, 2015; Epel & Lithgow, 2014). Increased oxidative stress (Yu & Woo, 
2016) has been proposed as the biological processes through which IMDs lead to accelerated 
TL shortening (Figure 1.1).  
 
IMDs may thus be mediating accelerated TL attrition, or accelerated TL attrition may causally 
be involved in IMDs (Yu & Woo, 2016). Table 1.8 summarizes various studies that have 




1.2.4.2 Genetic polymorphisms and telomere length 
Since TL is partially genetically determined, with heritability estimates ranging from 44% to 
80%, and highly variable between individuals (Njajou et al., 2007; Vasa-Nicotera et al., 2005), 
it is likely that genetic variation contributes to telomere maintenance (Codd et al., 2013). This 
genetic variation may present as a stable marker confering risk for IMDs or accelerated TL 
attrition. In an effort to identify loci that affect mean TL, a genome-wide meta-analysis that 
involved 37,684 individuals of European descent and replication in 10,739 European 
individuals was carried out, in which numerous loci were identified as being associated with 
mean TL: rs2736100 of TERT, rs755017 of regulator of telomere elongation helicase 1 gene 
(RTEL1), rs11125529 of acyclophosphatase-2 gene (ACYP2), rs10936599 TERC, rs7675998 
of nuclear assembly factor 1 gene (NAF1), rs9420907 of oligonucleotide/oligosaccharide 
binding fold 1 gene (OBFC1) and rs8105767 of zinc finger 208 gene (ZNF208).  
 
Within TERT, rs10069690 has been reported to regulate expression of the gene, rs2736100 has 
been associated with shorter TL among individuals of European descent from fifteen cohorts 
(Codd et al., 2013) and rs7726159 and rs2853669 have been associated with longer TL among 
participants from Seoul and Copenhagen respectively (Ko et al., 2016; Rode, Nordestgaard & 
Bojesen, 2016). In TERC, rs16847897 and rs12696304 have been associated with shorter TL 
among participants of European descent (Codd et al., 2010; Melin, Nordfjäll, Andersson & 
Roos, 2012), while rs10936599 has been associated with longer TL (Jones et al., 2012). TERT 
rs2736100 has also been associated with PTSD and the T-allele has been reported to confer 





Table 1.8 Studies investigating the association of telomere length and internalizing mental disorders 




Depression Adults from the 
Netherlands Study of 
Depression and Anxiety 
(NESDA)  
2,032 GWAS PRS for depression was associated with 
lifetime depression but not TL;  
PRS for TL associated with TL & 6-year 
TL attrition rate  
Avetyan, 
Zakharyan, Petrek 
& Arakelyan, 2019 
PTSD Adult Armenian combat 
veterans  
90 Case-control PTSD patients had shorter TL compared 
to controls; rs2736100 T-allele a risk 
factor for PTSD 
Chang et al., 2018 Depression 
& anxiety 
Adult female European 
ancestry participants from 
the US’s Nurses' Health 
Study in the  
17,693 Polygenic risk 
score 
Genetic predisposition to shorter TL not 
a risk factor for depression and anxiety 
Michalek et al., 
2017 
Depression Adult UK sample 2,768 Mendelian 
randomization 
T-allele of rs10936599, a SNP near the 
telomerase RNA component, predicted 
increased risk for childhood-onset 
depression 
Lin, Huang & 
Hung, 2016 
Depression 3,414 cases and 3,793 
controls 




Shalev et al., 2014 Depression, 
anxiety & 
PTSD 
Adults samples from 
Dunedin Multidisciplinary 
Health and Development 
Study 
1,037 Prospective Persistence of IMDs predicted shorter 
TL 
Wolkowitz et al., 
2011a 
Depression 18 subjects with depression 
and 18 controls matched by 
sex, age and ethnicity 
36 Case-control TL inversely correlated with lifetime 
depression exposure 




Adult participants from the 
Netherlands Study of 
Depression and Anxiety  
2,936 Prospective 
cohort 
Lifetime depression or anxiety 
associated with shorter TL 
Malouff & 
Schutte, 2017 
Anxiety 17 different samples 19,424 Meta-analysis Higher anxiety associated with shorter 
TL 




Adult participants from the 
Netherlands Study of 
Depression and Anxiety  
2,324 Case-control Anxiety disorders associated with 
accelerated cellular ageing, which in 
part may be reversible after remission 
Schutte & Maouff, 
2015 
Depression Systematic review on the 
relationship between 
depression and TL 
21,040 Meta-analysis Depression associated with shorter TL 
Yu & Woo, 2016 Depression Systematic review study NR Systematic 
review 





Simon et al., 2006 Anxiety, 
Depression 
Adults with depression or 
anxiety, with age-matched 
controls, recruited at MGH. 
88 Case-control TL was significantly shorter in those 
with mood disorders, representing as 
much as 10 years of accelerated aging 
Verhoeven et al., 
2014 
Depression Data on adult samples from 
the Netherlands Study of 
Depression and Anxiety 
2,407 Case-control Depressed patients show accelerated 
cellular aging according to a ‘dose–
response’ gradient 
Shin, Shin & Lee, 
2019 
Depression Young adult data from the 
National Health and 
Nutrition Examination 
Survey (NHANES), United 
States 
1,141 Case-control A significant and decreasing linear trend 
in TL was found as CRP levels 
increased in men, regardless of the 
depression status, and women with 
major depression or depressed affect 
Roberts et al., 
2017 
PTSD Probable PTSD cases & 
matched controls (all 
trauma exposed), from the 
Nurses’ Health Study 11 in 
the US.  
2,112 Case-control PTSD was associated with shorter TL 
CVD = cardiovascular disease; CRP = C-reactive protein; GWAS = genome-wide association study; MGH = Massachusetts General Hospital; 






1.2.5 Telomere length and human immunodeficiency virus infection 
In addition to stress exposures, TL is also heavily influenced by a range of biological factors, 
including infectious disease such as HIV. Evidence from a range of studies (summarized in 
Table 1.9) provides evidence for shorter TL in people with HIV compared to uninfected peers.  
Although nucleoside reverse transcriptase inhibitors have been reported to inhibit human 
telomerase in vitro (Hukezalie et al., 2012; Leeansyah et al., 2013), no associations have been 
reported between TL and exposure to nucleoside reverse transcriptase inhibitors in vivo 
(Solomon et al., 2014; Montejano et al., 2017). Studies have in fact associated exposure to 
combination antiretroviral therapy with longer TL in individuals living with HIV among 
participants who were predominantly of European descent, recruited from 15 European 
countries (Montejano et al., 2018; Stella-Ascariz et al., 2018). The gain in TL due to ART in 
these two studies has been suggested to be due to immune reconstitution, presumably resulting 
in a larger subset of less mature T cells harboring longer telomeres and, hence, increased TL 
(Côté & Hsieh, 2018).  
 
Table 1.9: Studies of the association between HIV-infection and telomere length 
Reference Study characteristics Key findings 
Alejos et al., 
2019 
201 randomly selected samples belonging to 
ART naïve patients from 15 European 
countries 
HIV-infection and age 
associated with shorter 
TL 
Auld et al., 
2016 
Ugandan patients with suspected tuberculosis 
(118 HIV infected patients against 66 HIV-
uninfected patients) 
HIV-infection associated 
with shorter TL 
Pathai et al., 
2013 
South African Xhosa patients (200 HIV 
infected against 200 HIV-uninfected patients, 
median ages 39 and 40 respectively) 
HIV-infection associated 
with shorter TL 
Zanet et al., 
2014 
Canadian adults (220 HIV-infected against 
199 HIV-uninfected participants, aged 20 - 76 
years) 
HIV-infection associated 
with shorter TL 
Srinivasa et al., 
2014 
United States adults (102 HIV-infected 
against 41 HIV-uninfected men, aged 18 – 55 
years) 
HIV-infection associated 
with shorter TL 
Shiau et al., 
2018 
South African children in a cohort study (120 
HIV-infected, 33 HIV-exposed uninfected 
and 25 HIV-unexposed uninfected, mean age 
6.4 years) 





Gianesin et al., 
2016 
71 HIV-infected (HIV+), 65 HIV-exposed-
uninfected (HEU), and 56 HIV-unexposed-
uninfected (HUU) children, aged 0-5 years 
Shorter TL in HIV+ than 
in HEU and HUU 
children 
HEU = HIV-exposed uninfected; HIV = human immunodeficiency virus; HUU = HIV-exposed 




Though shortening of TL has been reported to occur early after infection (Gonzalez-Serna et 
al., 2017), the mechanisms through which TL changes following acute HIV infection or ART 
initiation are yet to be elucidated. However, long-term TL attrition could occur partially as a 
result of the chronic stress that is associated with HIV infection. Chronic stress has been linked 
to shorter telomeres (Damjanovic et al., 2007; Epel et al., 2004; Notterman & Mitchell, 2015; 
Parks et al., 2009; Shalev, 2012; Shalev et al., 2013). TL has therefore been proposed as a 
marker for chronic stress (Needham et al., 2015; Zhang et al., 2014; Houben, Moonen, van 
Schooten, & Hageman, 2008). As HIV/AIDS may be viewed as a chronic psychological 
stressor due to the illness and stigma that are associated with the disease (Varni, Miller, McCuin 
& Solomon, 2012), this offers a further line of evidence to support TL attrition in HIV infection  
(Alejos et al., 2019; Auld et al., 2016; Gianesin et al., 2016; Oeseburg, de Boer, van Gilst & 
van der Harst, 2010; Pathai et al., 2013; Shiau et al., 2018; Srinivasa et al., 2014; Zanet et al., 
2014).  
 
1.2.6. Justification for the present study 
The diathesis-stress hypothesis of neuropsychiatric disorders postulates that a lower stress 
threshold is required for psychiatric disease to occur in individuals who harbor certain 
vulnerability factors, which may be genetic and/or acquired (Caspi et al., 2003; Silberg et al., 
2001; Monroe & Simons, 1991). Given the highlighted role of stress in IMDs, the conceptual 
framework of the present study was based on the diathesis-stress hypothesis. We postulated 
that acute stress leads to IMDs through vulnerability among Ugandan HIV+ children and 
adolescents.  
 
Vulnerability was considered in terms of both genetic and acquired factors. IMDs that occur in 
early life show higher level of familial aggregation than those with a later onset (Rapee, 2018; 
Wickramaratne & Weissman, 1998; Weissman et al., 1984), hence the importance of molecular 
genetic studies of childhood-onset IMDs.  
 
Since they encode components of the serotonergic neurotransmission pathway, SLC6A4 and 
TPH2 represent ideal candidates to investigate in IMDs. IMDs have been associated with 
polymorphisms within the SLC6A4 (Saul et al., 2019; Sharpley et al., 2014; Conway, Slavich 
& Hammen, 2014; Arango et al., 2001; Malison et al., 1998) and TPH2 (Gassó et al., 2017; 
Gao et al., 2012; Reuter, Kuepper, & Hennig, 2007; Van Den Bogaert et al., 2006). 




IMDs. We further investigated SLC6A4 and TPH2 as potential sources of genetic vulnerability 
to IMDs by assessing the moderating role of selected polymorphisms within these genes on the 
association between acute stress and IMDs.   
 
Numerous studies discussed above have reported on the robust association between TL and 
IMDs (Verhoeven et al., 2015; Verhoeven et al., 2014; O’Donovan et al., 2011; Shalev et al., 
2014; Gotlib et al., 2015; Malan et al., 2011; Zhang et al., 2014). Some studies have suggested 
that accelerated telomere shortening is a risk factor for IMDs (Gotlib et al., 2015; Malan et al., 
2011; Shalev et al., 2014), while others have found that the development of IMDs and 
shortening of telomeres are simultaneous effects of increased stress exposure (Zhang et al., 
2014). We hypothesized that shorter TL would be associated with IMDs in our population, and 
that genetic variants would moderate the association between TL and IMDs. To test this 
hypothesis, we investigated the association between TL at IMDs both at baseline and after 12 
months. As genetic variations within the TERC and TERT have also been reported both confer 
risk for IMDs (Avetyan, Zakharyan, Petrek & Arakelyan, 2019) and influence mean TL (Codd 
et al., 2013), the present study sought to understand whether genetic variations in these genes 
would moderate the association between TL and IMDs. 
 
With respect to acquired vulnerability, we used the results of previous studies to guide our 
selection of factors to investigate. In line with previous studies that have reported chronic stress 
as a risk factor for IMDs (Adelman et al., 2014; Evans, Li, & Whipple, 2013; Revenson et al., 
2016; Robles, Slatcher, Trombello, & McGinn, 2014), the present study considered chronic 
stress as an acquired vulnerability factor for IMDs in the conceptual framework. 
 
1.3 Problem statement 
The etiology of IMDs is poorly understood. There are currently no reliable biomarkers for 
IMDs, and diagnosis is based on clinical symptoms, increasing the possibility of misdiagnosis. 
This is especially so given that patients with the same underlying pathophysiology may present 
differently, as well as the possibility of misinterpretation of symptoms and signs due to cultural 
differences. Understanding the genetic and environmental risk factors for IMDs is central in 
providing insights into pathways that could be involved in the etiology of IMDs. Understanding 
the etiology of IMDs will inform the development of new more therapeutically meaningful 






1.4 Hypotheses  
Our overarching hypothesis is that acute stress leads to IMDs through vulnerability (chronic 
stress or TL and genetic variants in SLC6A4 and TPH2). We further hypothesized that shorter 
TL is associated with the occurrence of IMDs among HIV+ children and adolescents and that 
this association is moderated by vulnerability (chronic stress or genetic variants in TERT and 
TERC). 
 
1.5 Study objectives 
1.5.1 General aim 
The primary aim of the present study was to determine the association between acute stress and 
internalizing mental disorders and investigate factors that moderate this relationship, among 
HIV+ children (aged 5-11 years) and adolescents (aged 12-17 years) in Uganda.  
 
We hypothesized that there would be a significant association between acute stress exposure 
and IMDs and that this would be moderated a vulnerability factor (genetic and/or acquired). 
Although we hypothesized that shorter TL would be associated with the occurrence of IMDs, 
the nature of association between TL and IMDs, we sought to first investigate that association 
to determine whether to model TL as a vulnerability factor for IMDs (Figure 1.2, F). 
 
1.5.2 Objectives 
1) To investigate the association between relative TL and IMDs among HIV+ children 
 and adolescents in Uganda and whether this association is moderated by vulnerability. 
1.1   To investigate the longitudinal association between IMDs and TL (Figure 1.2, F). 
1.2   To determine whether the association in 1.1 (if any) is moderated by vulnerability   
        (genetic and/or acquired) (Figure 1.2, G). 
2)    To investigate the association between acute stress and IMDs among HIV+ children 
 and adolescents in Uganda and whether this association is moderated by vulnerability  
        (Figure 1.2, B). 
2.1   To investigate the association between acute stress and IMDs (Figure 1.2, A). 
2.2  To investigate whether the association in 2.1 (if any) is moderated by acquired    
 vulnerability (chronic stress, TL) (Figure 1.2, E). 
2.3  To investigate whether the association in 2.1 (if any) is moderated by genetic 





1.6 Conceptual framework 
The conceptual framework for the present study, as shown in Figure 2 was adapted from the 
diathesis-stress hypothesis for depression by Monroe & Simons (1991), which states that 
depression will occur when stress acts on an underlying vulnerability (genetic or acquired). 
 
 
Figure 1.2: The conceptual framework of the study, based on the diathesis-stress 
hypothesis. 
 
The conceptual model for the present study was based on the diathesis-stress model for 
depression by Monroe & Simons (1991), that states that depression will only occur when stress 
acts on an underlying vulnerability (genetic or acquired). In line with the diathesis-stress 
model, we postulated that acute stress leads to IMDs through vulnerability (B).  
Vulnerability can be acquired (E; Objective 2.2) or genetic (C; Objective 2.3), or an individual 
may have both genetic and acquired vulnerabilities (D).  
The aim of the present study was to investigate the association between acute stress and IMDs 
(A; Objective 2.1), and to determine whether this association was moderated by vulnerability 
factors (B), namely, genetic factors, TL and/or chronic stress exposure. In addition, we 




an association we hypothesized would be moderated by vulnerability factors (genetic and 
chronic stress exposure) (G; Objective 1.2).  
 
1.7 Layout of the thesis 
Chapter 2 contains a manuscript that answers Objective 1.1 of the study. The manuscript is 
entitled: “Internalizing mental disorders and accelerated cellular aging among perinatally 
HIV-infected youth in Uganda”. Work contained in this manuscript was published in Frontiers 
in Genetics (see Addendum B for the web version of the article). The PhD candidate played 
the following roles in the publication of the article: conceived the idea of the study, participated 
in data collection, carried out TL assays, participated in data analysis, prepared both the first 
draft and the final revised copy. 
 
Chapter 3 contains a manuscript that answers Objective 1.2 of the study. The manuscript is 
entitled: “The rs2736100 within the telomerase reverse transcriptase gene and rs16847897 
within the telomerase RNA component gene moderate the association between internalizing 
mental disorders and accelerated telomere length attrition among HIV+ children and 
adolescents in Uganda”. This manuscript has been submitted to BMC Medical Genetics and is 
currently editorial assessment. The PhD candidate played the following roles in the preparation 
of the manuscript: conceived the idea for the study, participated in data collection, carried out 
TL assays, participated in data analysis, and prepared both the first draft and the final revised 
copy. 
 
Chapter 4 contains a manuscript that answers Objectives 2.1 – 2.3 of the study.  
The manuscript is entitled: “The 5-HTTLPR/rs25531 S-A-S-A haplotype and chronic stress 
moderate the association between acute stress and internalizing mental disorders among HIV+ 
children and adolescents in Uganda”. This manuscript is yet to be submitted to a peer-reviewed 
journal for publication. The PhD candidate played the following roles in the study; conceived 
the idea of the study, participated in data collection, carried out laboratory assays for 
genotyping the serotonin transporter gene polymorphisms, constructed a composite index for 
both acute and chronic stress, participated in data analysis, prepared both the first draft and the 






This chapter reports the association between IMDs and TL among the study participants. It  is 
a modified version of the publication in Frontiers in Genetics (Impact factor 3.517) (See 
Addendum B for the web version of the article). 
 
Internalizing mental disorders and accelerated cellular aging among perinatally HIV+-
infected youth in Uganda 
Allan Kalungi1,2,3*, Jacqueline S. Womersley1, Eugene Kinyanda2,4, Moses L. Joloba3,5, Wilber 
Ssembajjwe2,6, Rebecca N. Nsubuga6, Jonathan Levin7, Pontiano Kaleebu8, Martin Kidd9, 
Soraya Seedat1 and Sian M. J. Hemmings1  
1Department of Psychiatry, Stellenbosch University, Cape Town, South Africa, 2Mental Health 
Section, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda, 3Department of 
Medical Microbiology, Makerere University, Kampala, Uganda, 4Department of Psychiatry, 
College of Health Sciences, Makerere University, Kampala, Uganda, 5School of Biomedical 
Sciences, College of Health Sciences, Makerere University, Kampala, Uganda, 6Statistics and 
Data Science Section, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda, 
7School of Public Health, University of Witwatersrand, Johannesburg, South Africa, 
8MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda, 9Centre for Statistical 
Consultation, Department of Statistics and Actuarial Sciences University of Stellenbosch, Cape 
Town, South Africa  
 
2.1 Abstract 
Introduction: Internalizing mental disorders (IMDs) in HIV+ children and adolescents are 
associated with impaired quality of life and non-adherence to anti-retroviral treatment. 
Telomere length is a biomarker of cellular aging, and shorter telomere length has been 
associated with IMDs. However, the nature of this association has yet to be elucidated.  
Objective: We determined the longitudinal association between IMDs and relative telomere 
length (rTL) and the influence of chronic stress among Ugandan perinatally HIV-infected 
youth (PHIY).  
Methods: IMDs (depressive disorders, anxiety disorders, and post-traumatic stress disorder) 




PHIY with any IMD and 368 age- and sex-matched PHIY controls without any psychiatric 
disorder, rTL was assessed using quantitative polymerase chain reaction. Hierarchical cluster 
analysis was used to generate the three chronic stress classes (mild, moderate, and severe). T-
tests were used to assess the difference between baseline and 12 month rTL and the mean 
difference in rTL between cases and controls both at baseline and at 12 months. Linear 
regression analysis was used to model the effects of chronic stress on the association between 
IMDs and rTL, controlling for age and sex.  
Results: We observed longer rTL among cases of IMDs compared with controls (p < 0.001). 
We also observed a statistically significant reduction in rTL between baseline and 12 months 
in the combined sample of cases and controls (p < 0.001). The same statistical difference was 
observed when cases and controls were individually analyzed (p < 0.001). We found no 
significant difference in rTL between cases and controls at 12 months (p = 0.117). We found 
no significant influence of chronic stress on the association between IMDs and rTL at both 
baseline and 12 months.  
Conclusion: rTL is longer among cases of IMDs compared with age- and sex-matched 
controls. We observed a significant attrition in rTL over 12 months, which seems to be driven 
by the presence of any IMDs. There is a need for future longitudinal and experimental studies 
to understand the mechanisms driving our findings.  
Keywords: Internalizing mental disorders, relative telomere length, HIV+, perinatally 
HIV-infected youth, Uganda 
 
2.2 Background 
Human immunodeficiency virus/acquired immunodeficiency disease syndrome (HIV/AIDS) 
is a significant global health burden, with approximately 36.9 million people infected globally 
(UNAIDS, 2018). Both eastern and southern Africa remain the most affected regions, 
accounting for 45% of the world’s HIV infections (UNAIDS, 2018). Of the over 2 million 
HIV-positive (HIV+) children globally, 90% reside in sub-Saharan Africa (UNAIDS, 2010). 
In Uganda, the country with the fifth-highest HIV prevalence in the region, an HIV prevalence 
of 0.5% has been reported among children aged 0–14, which corresponds to approximately 
95,000 children living with HIV in the country (UPHIA, 2016–2017). The introduction of 
antiretroviral therapy (ART) has led to improved survival of HIV-infected youth (7–17 years); 
however, the mental health of these youth has received less attention (Mupambireyi et al., 
2014). Perinatally HIV-infected youth (PHIY) are faced with a burden of psychiatric morbidity 




2012; Van Rie et al., 2007). Studies undertaken in both the developed (Europe and the United 
States) and developing world (sub-Saharan Africa) have documented depression rates of 
between 12.7% and 40% (Musisi and Kinyanda, 2009; Gadow et al., 2012; Kamau et al., 2012; 
Mellins et al., 2012; Nachman et al., 2012; Lwidiko et al., 2018; Kim et al., 2014) among 
PHIY. For anxiety disorders, rates of 9% to 32.2% have been reported among PHIY (Kamau 
et al., 2012; Mellins et al., 2012; Nachman et al., 2012; Kinyanda et al., 2019).  
 
IMDs are associated with psychological distress (Musisi and Kinyanda, 2009), impaired quality 
of life, and non-adherence to ART (Walkup et al., 2009; Malee et al., 2011). In addition, 
patients with IMDs have higher mortality rates than have the general population (Cuijpers and 
Smit, 2002; Colton and Manderscheid, 2006; Ahmadi et al., 2011; Druss et al., 2011).  
 
IMDs are characterized by quiet, internal distress (Tandon, Si & Luby, 2011), in contrast to 
externalizing disorders, where overtly socially negative or disruptive behavior is displayed 
(Tandon, Si & Luby, 2011). IMDs with high levels of negative affectivity include depressive 
disorders (e.g., dysthymic disorder), anxiety disorders (e.g., generalized anxiety disorder and 
social anxiety disorder), and obsessive-compulsive disorder (Regier et al., 2013; Turygin et al., 
2013). Despite intensive research, the diagnosis of IMDs is still largely based on clinical 
symptoms, with an absence of biological markers to facilitate diagnosis. This is largely because 
the pathophysiological mechanisms underlying IMDs, such as depression and anxiety, are still 
largely unknown. Several studies have investigated the association between telomere length 
(TL) and IMDs, and shorter TL has been reported in adults with depression (Simon et al., 2006; 
Verhoeven et al., 2014; Cai et al., 2015b) and anxiety disorders (Kananen et al., 2010; 
Verhoeven et al., 2015).  
 
Telomeres are protein-bound deoxyribonucleic acid (DNA) repeat structures at the ends of 
chromosomes (Lindqvist et al., 2015), and are important in preventing chromosomes from 
fusing together during mitosis, thus preventing loss of genetic data (Allsopp et al., 1992; 
Blackburn, Greider, & Szostak, 2006). They also regulate cellular replicative capacity (Allsopp 
et al., 1992; Blackburn, Greider, & Szostak, 2006).  
During somatic cell replication, telomeres progressively shorten due to the inability of DNA 
polymerase enzyme to fully replicate the 3′ end of the DNA strand (Allsopp et al., 1992; 
Blackburn, Greider, & Szostak, 2006), a process termed as the “end replication problem” 




critically short TL is reached, the cell is triggered to enter replicative senescence and 
subsequently cell death (Allsopp et al., 1992; Blackburn, Greider, & Szostak, 2006). TL 
provides a metric of cellular age and accounts for roughly 15% of the variance of age (Epel 
and Prather, 2018). TL has been reported to shorten in a predictable way with chronological 
age by roughly 20–40 base pairs per year (Cesare and Reddel, 2010). TL is partially genetically 
determined, with heritability estimates ranging from 36% to 84% (Aviv, 2012) and is highly 
variable between individuals (Vasa-Nicotera et al., 2005; Njajou et al., 2007). The present 
study assessed TL as relative TL (rTL), with rTL being proportional to an individual’s TL 
(Cawthon, 2009). 
 
Several studies in youth have reported associations between adversity and telomere shortening 
(Shalev et al., 2013; Theall et al., 2013; Drury et al., 2014; Mitchell et al., 2014). Adversity 
experienced in youth ranges from exposure to traumatic stressors, such as sexual and physical 
abuse, to social adversities that relate to family structure, parental mental distress, and socio-
economic status (SES). Causal associations between stressful life events and early adversities, 
such as childhood sexual abuse and major depression, are well documented (Kendler et al., 
1999; Fergusson and Mullen, 1999; Kendler et al., 2000), with evidence suggesting molecular 
signatures of stress overlap with major depression (Cai et al., 2015b). Biological processes, 
such as inflammation and oxidative stress, which have been observed in several psychiatric 
disorders are also associated with telomere shortening (Wolkowitz et al., 2011a; Wolkowitz et 
al., 2011b), suggesting that telomere shortening may be related to certain psychiatric 
endophenotypes.  
 
Depression has been considered a syndrome of accelerated aging (Heuser, 2002). The first 
study to examine leucocyte TL (LTL) in a group of subjects with either major depression or 
bipolar disorder and aged-matched controls found shorter LTL among cases compared with 
healthy controls (Simon et al., 2006). A large longitudinal clinical cohort study found shorter 
LTL among groups who were currently depressed or had remitted depression compared with 
healthy controls (Verhoeven et al., 2014). However, there was no statistically significant 
difference in LTL between the currently depressed and remitted depression groups, suggesting 
that depression may leave an “indelible marker” on LTL. However, in the currently depressed 
group, a dose–response relationship was observed, with LTL inversely associated with both 
severity and duration of depression. This dose–response relationship was further supported by 




predicted reduced LTL at 38 years of age in a dose-dependent manner among male participants. 
It is, however, not possible to rule out that LTL was already reduced at the first episode of 
depression, indicating that shorter LTL could be a risk factor for depression. Indeed, Gotlib et 
al. (2015) described shorter LTL as a risk marker for depression, where shorter LTL was 
observed among girls (aged 10–14 years) at increased risk for depression. High risk for 
depression was assessed as having a mother with a history of recurrent episodes of depression, 
while low risk was assessed as having a mother with no current or past Axis I disorder during 
a girl’s lifetime. However, results across studies have been inconsistent. While several other 
studies have reported shorter LTL among currently depressed individuals compared with 
controls (Lung et al., 2007; Hoen et al., 2011; Wikgren et al., 2012; Garcia-Rizo et al., 2013), 
some studies have failed to find an association (Wolkowitz et al., 2011a; Teyssier et al., 2012; 
Needham et al., 2015; Schaakxs et al., 2015).  
 
Accelerated aging has also been described in anxiety disorders. Using the same study 
population as described in Verhoeven et al. (2014), the authors reported shorter LTL among 
subjects with a diagnosis of current anxiety disorder than among controls (Verhoeven et al., 
2015). There was, however, no statistically significant difference in LTL between the remitted 
anxiety disorder group and controls, suggesting that LTL shortening in anxiety disorders may 
be more reversible than that associated with depression. Needham et al. (2015) reported an 
association between shorter LTL and a diagnosis of generalized anxiety disorder and panic 
disorder among women. Kananen et al. (2010) reported shorter LTL among older anxiety 
disorder subjects (48– 87 years of age) compared with controls, and a study by Okereke et al. 
(2012) reported a dose–response relationship where severe phobia was associated with shorter 
LTL.  
 
PTSD has also been considered in the context of accelerated aging (Moreno-Villanueva et al., 
2013; Miller and Sadeh, 2014). Shorter LTL has been implicated in PTSD, though the effects 
were primarily explained by early life stress (O’Donovan et al., 2011). Shorter LTL was 
reported among combat-deployed soldiers with PTSD, compared with those without PTSD 
(Zhang et al., 2014). There is a need to understand whether telomere shortening is a direct 
effect of PTSD, whether the development of PTSD and shortening of telomeres are 
simultaneous effects of increased stress reactivity (Zhang et al., 2014), or whether telomere 





HIV infection has also been found to be associated with shortened telomeres (Oeseburg et al., 
2010; Auld et al., 2016). HIV/AIDS may be viewed as a chronic psychological stressor due to 
the illness and stigma that are associated with the disease (Varni et al., 2012). Since TL has 
been found to be a marker for chronic stress (Needham et al., 2015), shorter telomeres are 
expected in HIV/AIDS subjects as compared with the disease-free population.  
We hypothesized that in PHIY in Uganda, attrition in rTL over a 12-month period would be 
greater in cases of IMDs compared with age- and sex-matched controls without any psychiatric 
disorder. We further hypothesized that cases would have shorter rTL than controls. We thus 
aimed to determine the longitudinal association between IMDs and rTL and the influence of 
chronic stress in this relationship. 
 
2.3 Methods 
2.3.1 Study design  
This case–control study was nested within a Medical Research Council/Department for 
International Development (MRC/ DfID)-funded project that investigated mental health among 
children and adolescents living with HIV/AIDS in Kampala and Masaka districts of Uganda 
(CHAKA study), which enrolled 1,339 Ugandan PHIY (7–17 years) of black African ancestry 
(Kinyanda et al., 2019). All participants with any of the IMDs (368 cases) and an equal number 
of age- and sex-matched controls (n – 368) were selected from CHAKA (N = 736) and included 
in the present study. Both the baseline and 12-month archived blood sample for each of the 
included participants was retrieved from which genomic DNA was extracted. 
 
2.3.2 Study population  
Study participants were recruited from two HIV clinics in urban Kampala [Joint Clinical 
Research Centre (JCRC) and Nsambya Home Care] and three HIV clinics in rural Masaka [The 
AIDS Support Organization (TASO), Kitovu Mobile Clinic, and Uganda Cares]. All study 
participants were on ART. 
2.3.3 Procedures  
Consenting PHIY, as well as their caregivers, were interviewed using a structured 
questionnaire. The questionnaire included, among others, socio-demographic characteristics 
(sex, study site, age, caregiver level of education, and SES), and modules on depression, post-




Adolescent Symptom Inventory-5 (CASI-5) (Gadow & Sprafkin, 2013). The CASI-5 was 
locally adapted for use in Uganda (Mpango et al., 2017). Trained psychiatric nurses and 
psychiatric clinical officers administered the CASI-5 at two time points (baseline and 12 
months). The CASI-5 lists the symptoms of a wide range of psychiatric disorders including 
major depressive disorder, generalized anxiety disorder, PTSD, and attention-
deficit/hyperactivity disorder, among others. Individual CASI-5 items are rated on a 4-point 
frequency of occurrence scale ranging from never (0) to very often (3). There are several CASI-
5 scoring algorithms; however, in the present study we used symptom count cutoff scores that 
reflect the prerequisite number of symptoms for a clinical diagnosis. Disease severity was 
assessed by summing up the scores for the symptoms, where a higher score represented severe 
disease status. At each study visit, 4 ml of blood was withdrawn from each study participant 
through venipuncture into an EDTA vacutainer and was stored at −80 °C pending DNA 
extraction.  
 
2.3.4 Inclusion and exclusion criteria  
Inclusion criteria: i) HIV-infected outpatients, registered with any of the HIV clinics at any of 
the study sites; ii) aged between 7 and 17 years at the time of enrolment; iii) conversant in 
English or Luganda, the language into which the research assessment tools were translated; and 
iv) able to provide written informed consent(caregivers)/assent(adolescents). Cases were 
subjects who had any depressive disorder [depression or dysthymia (persistent depressive 
disorder)] or anxiety disorder. Controls were age-and sex-matched without any psychiatric 
disorder. Persistent IMDs were baseline cases that remained cases at 12 months, while remitted 
ones were baseline cases that lost disease status at 12 months Exclusion criteria: i) Seriously 
ill including being unable to understand study procedures and ii) any other psychiatric disorder 
other than the ones listed above.  
2.3.5 Ethical considerations  
Both CHAKA and the present study were conducted in compliance with the Code of Ethics of 
the World Medical Association (Declaration of Helsinki). The CHAKA study obtained ethical 
and scientific clearance from the Uganda Virus Research Institute (UVRI) Science and Ethical 
Committee (#GC/127/15/06/459) and the Uganda National Council of Science and Technology 
(#HS 1601). The present study obtained approval from the Higher Degrees Research & Ethics 




(#SBS 421) and the Health Research Ethics Committee of Stellenbosch University 
(#S17/09/179). Caregiver provided informed consent for their children/adolescents to 
participate in the study and for a blood specimen to be drawn for genetics analyses. Adolescents 
provided further assent to participate in the study. Study participants who were diagnosed with 
significant psychiatric problems were referred to mental health units at Entebbe and Masaka 
government hospitals. 
 
2.3.6 Measure of chronic stress  
Chronic stress was measured as social disadvantage and variables that were considered to 
confer social disadvantage were used to construct a composite index for chronic stress. A 
composite index of chronic stress was constructed from data collected on the following 
variables: orphanhood (double orphanhood carried a higher chronic stress score vs. single or 
not orphaned); food availability (not enough food carried a higher chronic stress score vs. 
enough food); study site (urban carried a higher chronic stress score than rural); and caregiver 
level of education (no formal education carried a higher chronic stress scores than primary and 
primary a higher stress score than secondary, etc.). Hierarchical cluster analysis using Statistica 
13.5 software (TIBCO, CA, USA), Euclidian distance, as distance measure and Ward’s method 
for clustering (Ward, 1963), was used to generate the different cut-off points for each chronic 
stress class. 
 
2.3.7 Chronic stress classes  
The chronic stress index ranged from 0 to 3.75, with a normal distribution. A total of three 
chronic stress classes were generated during HCA, i.e., mild, moderate, and severe. The mild 
class had a chronic stress score of 0 to 1.375, the moderate class had a score of greater than 
1.375 to 2.375, and the severe class had a score of greater than 2.375.  
2.3.8 Analysis of relative telomere length  
DNA was extracted from blood collected from each participant, using the QiAmp Mini DNA 
Extraction Kit (Qiagen GmbH, Germany). Extracted DNA was quantified by 260/280 and 
260/230 ultraviolet spectrophotometry on the NanoDrop 1000 spectrophotometer V3.7 
(Thermo Fisher Scientific, Wilmington, MA). The DNA was subsequently diluted to 5 ng/μl 
and amplified using the KAPA SYBR FAST quantitative polymerase chain reaction (qPCR) 




as a result of PCR optimizations for the primer and DNA concentrations that gave the best 
amplification plots for the telomere and human β-globin gene (HBG) assays respectively 
(please see Addendum A for the optimized amplification plots for the telomere and HBG 
assays). Primers specific for telomeric repeats (T) (Cawthon, 2002) and a stably expressed 
single copy reference gene (S), the human β-globin (HBG1, 5′-
GCTTCTGACACAACTGTGTTCACTAGC-3′; and HBG2, 5′-
CACCAACTTCATCCACGTTCACC-3′), were used to amplify telomeric repeats and HBG, 
respectively. For the telomere assay, each reaction included 5 μl of KAPA SYBR FAST qPCR 
Master Mix (Merck, Darmstadt, Germany); 1.35 and 4.50 μM of forward and reverse primers, 
respectively; 5 ng of genomic DNA; and water in a 10-μl reaction volume. The HBG assay 
was identical to the telomere assay except that 2.0 μM of each of the forward and reverse 
primers were used.  
 
In order to control for interplate variability for a given sample, both the telomeric repeats and 
the human β-globin gene for that sample were amplified on the same 384-well plate. All 
samples were randomized at DNA extraction and were plated across the 384-well plate, with 
the first row containing samples for the telomeric repeats assay and the next row containing the 
same samples for the human β-globin assay. In order to control for intraplate variability, each 
participant’s DNA sample was amplified in triplicate to reduce measurement variability within 
samples and this was ensured by checking that Ct values differed by no more than 0.5 across 
the three wells, and used the mean Ct value in the analysis. If the threshold cycle (Ct) values 
of the triplicates of particular samples differed by more than 0.5, those samples were excluded.  
Amplification was performed on the ABI 7900HT Fast Real-Time PCR system (Applied 
Biosystems, Foster City, CA) using the following thermal cycling profile: 95° C for 3 min, 
followed by 40 cycles of 95° C for 3 s and 60° C for 30 s, and a dissociation stage of 95° C for 
15 s, 64° C for 15 s, and 95° C for 15 s. A calibrator sample was prepared by pooling equal 
amounts of DNA from each participant for the construction of a standard curve.  
 
The calibrator DNA sample was serially diluted 1.68-fold per dilution, to produce a nine-point 
standard curve, with DNA amounts ranging from 50 to 0.79 ng/μl. After amplification of the 
standards dilutions, a linear plot of the Ct versus the log value of the input amount of DNA 
(standard curve) was constructed using ABI’s SDS v.2.3 software. The slope of the standard 




Standards were repeated across plates in order to control for interplate variability. Threshold 
and baseline values were used as determined by the SDS v.2.3 software. All Ct values were 
corrected for the PCR efficiency during the first step of GenEx processing using GenEx 
software (GenEx User Guide, 2012). GenEx software was also used to control for interplate 
calibrations.  
 
A validated qPCR method (Cawthon, 2002) was used to determine relative TLs (rTLs) in all 
samples. First, the mean telomere repeat copy number (tel, T) was normalized to a reference 
gene (single copy gene) (scg, S) copy number to control for differences in DNA quantity. The 
T/S ratio is proportional to the average TL. Thereafter, the factor by which the T/S ratio differs 
between the experimental sample and the calibrator sample is determined to provide an 
indication of relative average TL:  
 
T/S = 2-ΔCt 
Relative average TL (tel) = 2-ΔΔCt 
Where ΔCt = Ct(tel) – Ct(scg). 
A T/S > 1 indicates that the average rTL in the sample is greater than that of the reference 
sample, and a T/S < 1 indicates that the average rTL in the experimental sample is less than 
that in the reference sample.   
2.3.9 Power of the study  
We calculated the post hoc power for our study based on results from a study by Epel et al. 
(2004). We used the formula of sample size and power for difference in means in case–control 
studies (Kirkwood & Sterne, 2003). We worked on the assumption that cases (individuals with 
IMDs) would have higher levels of stress than controls (individuals without IMDs). Epel et al. 
(2004) found a 15% reduction in mean rTL among cases compared with controls. Given a 1:1 
ratio of cases to controls and using a 5% level of significance, with 368 cases and controls, our 
study was well powered (power greater than 80%) to detect any reduction above 4.75% in mean 
rTL between cases and controls. For instance, a reduction of 5% in mean rTL between cases 
and controls provided a power of 83.8%.  
2.3.10 Statistical methods  




Socio-demographic characteristics were described between cases and controls. Chi-square tests 
were used to assess the association between the socio-demographic characteristics and IMDs 
at baseline (cases vs. controls). SES was generated from a scale of nine household items (car, 
motorcycle, refrigerator, electricity, bicycle, radio, telephone, cupboard, and flask). Each item 
was weighted in the respective order, a car carrying a maximum weight of 9 and a flask a 
minimum weight of 1. A total score of items was generated, whose median cutoff of 13 was 
used to classify low and high SES. A score less than 13 was classified as low SES, while that 
greater than 13 was classified as high SES. Our study group (Kinyanda et al., 2011a) has 
previously used household items as a measure of SES in rural settings of Uganda. A t-test was 
used to compare CD4 counts between cases and controls to account for any disparity in HIV 
disease progression.  
 
Outliers were revealed by box and whisker plots and were all removed from the rTL data. The 
skewed rTL data became normally distributed after removal of outliers.  The distributions of 
rTL at baseline and at 12 months and the change in rTL were determined using a standardized 
normal probability plot (P-P plot) (See Supplementary Materials in section 2.14 below).  
 
The difference in rTL distribution at baseline and at 12 months was assessed using t-tests. The 
mean difference in rTL between cases and controls was also assessed using t-tests. The 
difference in rTL change between cases and controls was also assessed using t-tests. One-way 
analysis of variance was used to assess whether there were any statistically significant 
differences between change in rTL and each of the variables of age, sex, study site, caregiver 
education level, and child education level.  
 
Linear regression was used to i) assess the relationship between rTL and chronic stress, 
adjusting for sex and age; ii) model the effect of chronic stress on the association between 
IMDs and rTL, by comparing models without chronic stress to models with chronic stress; and 
iii) model the effect of age on the relationship between IMDs and rTL. These models 
(interactions) were performed on all the explanatory variables even without observing 
significant main effects in order to rule out the possibility of cross over interaction where 
significant interactions may be observed for non-significant main effects. 
There were missing data for rTL values at baseline or 12 months or both. For all analyses that 




significance was set at a p-value less or equal to 0.05, while a p-value greater than 0.05 but less 
than 0.07 was considered a trend towards marginal significance. 
2.4 Results 
Socio-demographic factors were evenly distributed between cases and controls as shown in 
Table 2.1.  
 
Table 2.1 Distribution of socio-demographic factors of study participants between cases 
and controls 
Variable (n) Case n (%) Control n (%) P-value 
Sex         
            Male (342) 









Study site         
              Urban (415) 









Age         
      7-11 years (389)   
     12-17 years (307) 
 
 
  202 (51.9) 





Education level (Caregiver) 
     No formal education (13) 
     Primary (648) 
     Secondary (35) 











               Low  (332) 
















CD4, cluster of differentiation 4; primary, 0 – 7 years of formal education; Secondary, 8 – 14 
years of formal education; Low SES, 0 – 13; High SES, > 13. All numbers that do not add up 
were due to missing data. 
 
The standard curves for both the Tel and HBG reactions, as well as the dissociation curve for 
each plate, are shown in addendum E. Tests of association between different socio-
demographic variables and rTL were run to determine potential confounders (Table 2.2). None 




SES were significantly associated with chronic stress (p < 0.001, p = 0.040, and p = 0.015, 
respectively) (Table 2.2b).  
 
Table 2.2a P-values for tests of association between socio-demographic variables and 
rTL change   
Variable Category Mean rTL P-value 
Sex Male 0.270 0.298 
 Female 0.266  
Study site Rural 0.221 0.235 
 Urban 0.271  
Age of child/adolescent 5 – 8 0.232 0.553 
 9 – 12 0.276  
 13 – 17 0.225  
Caregiver level of education None 0.161 0.912 
 Primary 0.143  
 Secondary 0.266  
 Tertiary 0.244  
 Other 0.295  
Socio-economic status Low 0.248 0.897 
 High 0.243  
Child/adolescent  education level  No formal 0.387 0.611 
 Pre-primary 0.243  
 Secondary 0.229  
 
Table 2.2b P-values for tests of association between socio-demographic variables and 
chronic stress 
Variable Category Number in each chronic 
stress class 
P-value 
Mild  Moderate Severe 
Sex Male 110 156 76 0.122 
 Female 153 169 71 
Study site Rural 235 75 11 <0.001 
 Urban 29 250 136 
Age of child/adolescent 5 – 8 114 107 125 0.040 
 9 – 12 83 125 51 
 13 – 17 67 93 50 
Caregiver education level  None 17 15 1 0.587 
 Primary 24 11 6 
 Secondary 60 124 58 
 Tertiary 146 139 55 
 Other 
tertiary 
11 29 25 
Socio-economic status Low 127 128 77 0.015 
 High 137 197 70 
Child/adolescent education 
level  




 Pre-primary 232 287 129 
 Secondary 23 34 15 
 
2.4.1 Difference in rTL between cases and controls  
RTL was normally distributed at both baseline and 12 months. Mean rTL (95%CI) of the 
combined sample of cases and controls was 1.148 (1.119–1.176) at baseline and 0.905 (0.879–
0.931) at 12 months. For cases, mean rTL (95%CI) was 1.198 (1.157–1.239) at baseline and 
0.925 (0.886–0.965) at 12 months; while for controls, mean rTL (95%CI) was 1.097 (1.057–
1.137) at baseline and 0.884 (0.851–0.917) at 12 months.  
At baseline, we found a statistically significant difference in rTL between cases and controls 
(p < 0.001). However, contrary to what we expected, rTL was longer in cases compared with 
controls. There was, however, no statistical difference in rTL between cases and controls at 12 
months (p = 0.117). In addition, the change between baseline and 12-month rTL (rTL change) 
did not differ statistically between cases and controls (p = 0.608) (Table 2.3). 
 
Table 2.3 Difference in rTL between cases and controls 
Time 




Cases 307 1.19807 0.36415 1.15717 - 1.23896 
<0.001 Controls 306 1.09668 0.35382 1.05688 - 1.13648 
12 month 
Cases  278 0.92517  0.33559 0.88555 - 0.96480  
 0.117 Controls  274 0.88419   0.27484 0.85150 -  0.91687 
 Cases 231 -0.25560  0.47261 0.19434 – 0.31688  
rTL 
change Controls 234 -0.23444 0.41546 0.18093 – 0.28795 
  0.608 
2.4.2 Differences between baseline and 12-month rTL (Change in rTL) 
In the combined analysis of baseline cases and controls, there was significant attrition in rTL 
between baseline and 12 months (p < 0.001). This attrition did not differ by IMD status (p = 
0.608). A further stratified analysis of cases only and controls only yielded similar p-values of 
<0.001 (Table 2.4).  
 
Table 2.4 Differences between baseline and 12 months rTL for baseline cases and 
controls 
Group Time point Obs Mean TL Std. Dev 95% Conf. Interval P-Value 




12 month 465 0.90331 0.31397 0.87470 - 0.93192 
Cases Baseline 231 1.19006 0.37096 1.14197 - 1.23815 
p<0.001   12 month 231 0.93445 0.34778 0.88937 - 0.97954 
Controls Baseline 234 1.10701 0.35618 1.06113 - 1.15288 
p<0.001   12 month 234 0.87257 0.27387 0.83730 - 0.90784 
 
2.4.3 Association between chronic stress and rTL  
We observed a trend towards statistical significance between chronic stress and baseline rTL 
(p = 0.067). Severe stress was significantly associated with longer rTL (p = 0.028) (Table 2.5). 
However, chronic stress was not significantly associated with either 12-month rTL or a change 
in rTL (p = 0.147 and p = 0.455, respectively) (Table 2.5).  
 
Table 2.5 Assessing association between chronic stress and rTL, adjusted for age and 
sex 
Time point Chronic stress class Coefficient P>|t| 95% Conf. Interval P-value 
 Mild  Reference    
Baseline 
Moderate 0.01251 0.717 -0.05514 - 0.08017 
0.067 Severe 0.09144 0.028 0.00991 - 0.17298 
 Mild  Reference    
12 month 
Moderate -0.03123 0.288 -0.08887 - 0.02640 
0.147 Severe 0.03416 0.334 -0.03520 - 0.10353 
 Mild Reference    
rTL change 
Moderate 0.05759 0.214 -0.03339 - 0.14858 
0.451 Severe 0.03707 0.507 -0.07254 - 0.14667 
 Reference, reference chronic stress class during regression analysis. 
2.4.4 Association between chronic stress and IMDs   
We found a trend toward statistical significance between chronic stress and IMDs (Table 2.6).  
 
Table 2.6 Association between chronic stress and Internalizing mental disorders 
Chronic stress 
class Cases (n) Controls (n)  Total p-value 
Mild 120 144 264 
0.065 
Moderate 178 147 325 
Severe 70 77 147 





2.4.5 The rTL and IMDs after 12 months  
We found no significant difference in baseline rTL between cases of IMDs that persisted 
compared to those that remitted after 12 months (p = 0.235). We also found no statistically 
significant association between 12-month rTL and 12-month IMD status (p = 0.090), as well 
as no association between disease severity and rTL at baseline (p = 0.238) and 12 months (p = 
0.264).  
 
2.4.6 Effect of chronic stress on the association between IMDs and rTL  
We found no significant influence of chronic stress on the association between IMDs and rTL 
both at baseline and at 12 months (Table 2.7). 
 
Table 2.7 Two-way analysis of variance for the interaction of chronic stress with IMDs 
on baseline and 12 months TL  
Outcome Observations Variable   F  P-value 
Baseline TL 613 IMDs 11.72 <0.001 
  Chronic stress 2.48 0.085 
  IMDs * chronic stress 0.14 0.870 
12 months TL 552 IMDs 2.31 0.130 
 rs2736100 1.71 0.182 
 IMDs * rs2736100 0.57 0.566 
* = interaction term. 
2.4.7 Effect of age on the relationship between IMDs and rTL  
On stratifying our analyses for age [children (7–11 years) and adolescents (12–17 years)], we 
observed no statistically significant differences by age group for IMDs and rTL compared with 
those that were observed with both age categories combined (Table 2.8).  
 
Table 2.8 Effect of age on the association between IMDs and rTL 
Baseline 
Category IMDs status Coefficient P>|t| 95% Conf. Interval P-value 
 Controls  Reference    
Total sample Cases 0.101 0.001 0.04443 - 0.15834 P<0.001 
 Controls  Reference    
Children  Cases 0.094 0.025 0.01203 - 0.17534 0.025 




Adolescents  Cases 0.110 0.007 0.03080 - 0.18999 0.007 
12 months 
Category IMDs status Coefficient P>|t| 95% Conf. Interval P-value 
 Controls  Reference    
Total sample Cases 0.041 0.117 -0.01034 - 0.09231 0.117 
 Controls  Reference    
Children  Cases 0.048 0.181 -0.02234 - 0.11776 0.181 
 Controls Reference    
Adolescents Cases 0.033 0.395 -0.04295 - 0.10858 0.395 
rTL change 
Category IMDs status Coefficient P>|t| 95% Conf. Interval P-value 
 Controls  Reference    
Total sample Cases 0.021 0.608 -0.05990 - 0.10223 0.601 
 Controls  Reference    
Children  Cases 0.017 0.768 -0.09841 - 0.13321 0.768 
 Controls Reference    
Adolescents  Cases 0.027 0.639 -0.08634 - 0.14043 0.639 
Children, 7-11 years; Adolescents, 12-17 years; reference, reference IMDs status during 
regression analysis. 
 
2.5 Discussion  
In this study, we investigated the association between chronic stress and rTL among PHIY 
cases with IMDs and age- and sex-matched controls in Uganda. To our knowledge, this is the 
first sub-Saharan African study to investigate the association between chronic stress with rTL 
and IMDs among PHIY.  
 
Several studies have determined the association between TL and different internalizing 
psychopathologies. Shorter TL have been reported among cases of depression compared with 
controls (Garcia-Rizo et al., 2013; Shalev et al., 2014; Verhoeven et al., 2014), while others 
have failed to find significant associations (Wolkowitz et al., 2011a; Teyssier et al., 2012; 
Simon et al., 2015). Shorter TL has also been implicated in both anxiety disorders (Kananen et 
al., 2010; Verhoeven et al., 2015) and PTSD (O’Donovan et al., 2011; Zhang et al., 2014) and 
has been reported to confer risk for PTSD (Malan et al., 2011). Due to these reported 
associations of shorter TL in the different internalizing psychopathologies, we hypothesized 
that rTL would be shorter among cases of IMDs than controls in our study participants. 
Contrary to our hypothesis, we observed longer rTL among cases of IMDs compared with their 
controls (p < 0.001). Longer rTL among IMDs could be due to elevated telomerase levels. TL 
is maintained by a telomerase enzyme component known as telomerase RNA component 




(TERT) (Wang and Meier, 2004; Blackburn, Geider & Szostak, 2006). Wolkowitz et al. (2012) 
indeed reported elevated telomerase levels among people with depression than among healthy 
matched controls at baseline. After 8 weeks of treatment with selective serotonin re-uptake 
inhibitors, they found that telomerase levels became even more elevated as depression remitted. 
It has been speculated that elevated telomerase levels are a compensatory effort towards 
excessive loss of telomeres (Damjanovic et al., 2007; Lin et al., 2012).  
 
We also observed a statistically significant reduction in rTL between baseline and 12 months 
in a combined sample of cases and controls (p < 0.001). A statistical difference was also 
observed when cases and controls were individually analyzed (p < 0.001). This difference was 
expected since TL generally decreases over the life span (Müezzinler, Zaineddin & Brenner, 
2013). We found no significant difference in rTL between cases and controls at 12 months (p 
= 0.117). Since cases had significantly longer rTL than controls at baseline (p < 0.001), the 
lack of a significant difference at 12 months indicates greater rTL attrition among cases 
compared with controls. This is an interesting observation that points to the notion that IMDs 
are possibly driving accelerated cellular aging (rTL attrition). Indeed, telomere shortening has 
been reported to be strongly influenced by chronic stress exposure (Ridout et al., 2015), and 
suffering from a chronic disease, such as heart disease (Haycock et al., 2014) and diabetes 
(Zhao et al., 2013), has been conceptualized as a prolonged stress exposure that could explain 
their association with TL. IMDs have been reported as chronic stressors (McEwen, 2003) with 
chronic biological adaptations that result in long-term biological damage that could potentially 
explain rTL attrition due to IMDs (Epel & Lithgow, 2014).  
IMDs could also be leading to rTL attrition through inflammatory pathways. Depression has 
been reported to prime larger cytokine responses to stressors (Kiecolt-Glaser, Derry & 
Fagundes, 2015). Increased systemic inflammation has been associated with decreased TL 
among a prospective cohort of workers exposed to high level of fine particulate matter (Wong 
et al., 2014), while interventions that attenuate inflammatory processes in fear- and anxiety-
based disorders have been thought to be effective in mitigating the symptoms of anxiety 
disorders (Michopoulos et al., 2017).  
 
If IMDs were driving rTL attrition, we would expect significant reduction in rTL among cases 
with no corresponding significant reduction among controls. Intriguingly, we observed 




in rTL that occurs over time. However, study subjects were only followed up for 12 months, 
and a longer follow-up period may be required to see a true difference in rTL attrition between 
cases and controls and thus more data is needed to justify our hypothesis. A number of factors 
affect TL, many of which may have been important to account for in the present study.  For 
example, participants were all on ART, with the type and duration of ART regimen not 
accounted for in the analysis, yet total time receiving ART and duration of treatment with 
nucleoside reverse transcriptase inhibitors have been associated with shorter telomere length 
(Montejano et al., 2017). In addition, factors known to affect rTL, such as diet (Shiels et al., 
2011) and frequency of physical exercise (Cherkas et al., 2008) were not accounted for. 
Moreover, studies have found that the effects on rTL may be determined even before birth from 
maternal stress, or through direct transmission of maternal rTL (Epel & Pranther, 2018). Also, 
since HIV infection has been associated with accelerated TL shortening (Alejos et al., 2019; 
Shiau et al., 2018; Auld et al., 2016), it is possible that effects of HIV and its associated co-
infections may have strongly confounded our findings. 
 
Although previous studies among children have found associations between TL and socio-
demographic variables, such as caregiver level of education (Needham et al., 2012), parental 
SES (Needham et al., 2012; Mitchell et al., 2014), sex (Drury et al., 2014), and living 
environments (Theall et al., 2013), we found no association between any baseline socio-
demographic variables and rTL change in the present study. This discrepancy could be due to 
cultural context, as previous studies were carried out in developed world settings that differ 
from the African low-income setting of this study. For example, stress due to orphanhood in 
the Ugandan context may be experienced differently, as there is a strong extended family 
system in Uganda where orphans tend to be taken care of by their uncles or aunts, unlike in the 
developed world where orphans are often institutionalized. The latter has been associated with 
shorter TL (Drury et al., 2012). More studies are needed to understand factors that affect TL in 
the sub- Saharan African context.  
 
We found no association between rTL change and persistence or remission of IMDs. This 
further suggests that rTL does not drive IMDs, but rather IMDs may be driving accelerated 
cellular aging. Higher mortality rates have been reported among patients with IMDs compared 
with the general population, and the mortality is mainly due to the same age-related diseases 
as the general population, such as cancer, and heart, and cerebrovascular disease. For example, 




mental illness died 1 to 10 years earlier than did clients with no major mental illness. Another 
study reported that persons with mental disorders died an average of 8.2 years younger than 
did the rest of the population and that presence of a mental illness was associated with a hazard 
ratio of 2 over a 17-year study period (Druss et al., 2011), supporting the mediating role of 
IMDs in accelerated cellular aging.  
 
Psychological stress (both perceived stress and chronicity of stress) has been significantly 
associated with lower telomerase activity and shorter TL (Epel et al., 2004). We investigated 
the association between chronic stress and rTL in our sample. We observed a marginally 
significant association between chronic stress and rTL (p = 0.067). However, contrary to 
expectation, severe chronic stress was associated with longer rTL (p = 0.028) (Table 2.5). 
Longer rTL was also associated with IMD caseness. Thus, if increased stress (chronic) is an 
acquired vulnerability factor for IMDs, then it stands to reason that severe chronic stress would 
be associated with longer rTL, an association that we indeed observed. Further, since IMDs are 
associated with impaired quality of life and negative clinical and behavioral outcomes among 
PHIY and poor adherence to ART (Malee et al., 2011; Walkup et al., 2009), we expected 
significantly lower CD4 counts among cases than controls. However, we found no significant 
difference in mean CD4 count between cases and controls (p = 0.939). We did not investigate 
other virologic markers of HIV disease severity, such as viral load. However, all study 
participants were on ART, and thus no difference would be expected if adherence to treatment 
was similar between cases and controls.  
 
We observed an association between chronic stress and study site and SES respectively. Living 
in urban areas and having a high SES were associated with more chronic stress than living in 
rural areas and having a low SES. The association of both urban location and high SES with 
increased chronic stress may be due to a correlation between the two variables, as participants 
in urban areas are often of higher SES as compared with their rural counterparts. The 
association of urban location with increased chronic stress could be due to ecological factors 
and pressures that are associated with urban life as compared with rural life.  
We also observed an association between age and chronic stress. Adolescents (12–17 years) 
were more stressed than children (7–11 years) and this could be due to the fact that adolescents 
were aware of their HIV status and the stress could be associated with the burden of being 





Lastly, since severe chronic stress is associated with longer rTL, we expected severe chronic 
stress to lower the p-value of the regression for the association between IMDs and rTL, an 
interaction we did not observe. We think that this could due to duration of chronic stress. 
Although the chronic stress variables used in the present study are known stressors in this 
population, the duration of the stressor was not assessed for. 
 
2.6 Limitations and recommendations  
We defined IMDs as having any depressive disorder or anxiety disorder or PTSD. The 
inclusion of PTSD as an IMD is contentious as the disorder has recently been delineated from 
IMDs in the DSM-5. PTSD has been associated with the most robust TL attrition (Darrow et 
al., 2016), it is possible that the TL differences observed between baseline and 12 months may 
have been strongly influenced by inclusion of PTSD. We recommend that future studies 
undertake a comparative analysis of the different disorders that make up the IMD spectrum to 
elucidate the independent contribution of each particular disorder.  
 
Due to lack of data, we did not investigate factors that are known to affect rTL, such as 
frequency of physical activity, medication, diet, and presence of other comorbid diseases. Also, 
much as CD4 counts did not significantly differ between cases and controls, the ART regimen 
for each study participant was not accounted for in the analysis. Future studies should endeavor 
to consider these factors.  
 
Both the duration and severity of IMDs have been shown to affect rTL. We did not assess the 
duration of IMDs. However, we think that this may not have greatly affected our findings 
because disease severity was not significantly associated with rTL in the present study. Future 
studies should, however, account for the duration of IMDs.  
 
We suggest that the significantly longer rTL observed among cases at baseline is due to 
elevated telomerase activity/levels. However, we did not investigate telomerase activity/levels 
between cases and controls. Future studies should investigate this possibility. Also, certain 
genes, such as the telomerase reverse transcriptase and telomerase RNA component, have been 
reported to influence TL biology. The role of polymorphisms in these genes influencing rTL 





The qPCR efficiencies were outside the optimal range of 90 – 110% (Čepin, 2017) (please see 
addendum E for the standard curves and the dissociation graphs). The possible reasons for this 
observation have been discussed under section 5.7 of this PhD thesis. 
 
Chronic stress was measured using a number of context-specific indicators because there is no 
locally adapted tool for assessing chronic stress in this setting. While this may be a limitation 
and may limit generalizability to other settings, the variables used to generate the chronic stress 
index are known stressors in this population. Validation of the chronic stress index tool will be 
required in future studies in Uganda. 
 
2.7 Conclusions  
RTL was longer in cases with IMDs compared with age- and sex-matched controls.  
We observed significant attrition in rTL over 12 months. This rTL attrition seems to be driven 
by the presence of any IMDs, indicating that IMDs could be driving accelerated rTL attrition. 
Mechanisms that either directly influence rTL or alleviate the effects of IMDs on rTL attrition 
could explain our study findings, and longitudinal and experimental studies are needed to fully 
elucidate underlying mechanisms. 
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Probability-probability (p-p) plots showing the distribution of rTL at baseline and 12 months, 
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Baseline (Figure 2.1) and 12 month rTL (Figure 2.2), as well as the rTL change (Figure 2.3), 
were normally distributed as revealed by the plots below. 
 
 Figure 2.1: p-p plot for distribution of TL at baseline 
 
 
Figure 2.2: p-p plot for distribution of TL at 12 months 
 












This chapter represents a manuscript that highlights the moderating role of genetic variants in 
TERT and TERC on the association between IMDs and accelerated TL attrition among the 
study participants. This manuscript has been submitted to BMC Medical Genetics (Impact 
factor 1.913) for publication and is currently under editorial assessment. 
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Internalizing mental disorders (IMDs) (depression, anxiety and post-traumatic stress disorder) 
have been associated with accelerated telomere length (TL) attrition; however, this association 
has not been investigated in the context of genetic variation that has been found to influence 
TL. We have previously reported an association between IMDs and accelerated TL attrition 
among Ugandan HIV+ children and adolescents. This study investigated the moderating effects 
of selected single nucleotide polymorphisms in the telomerase reverse transcriptase gene 
(TERT) (rs2736100, rs7726159, rs10069690 and rs2853669) and the telomerase RNA 
component gene (TERC) (rs12696304, rs16847897 and rs10936599) on the association 
between IMDs and TL, among Ugandan HIV+ children (aged 5–11 years) and adolescents 
(aged 12–17 years). 
 
Results 
We found no significant interaction between IMDs and any of the selected single nucleotide 
polymorphisms (SNPs) on TL at baseline. We observed significant interactions of IMDs with 




TERT rs2736100 and TERC rs16847897 moderate the association between IMDs and TL 
among Ugandan HIV+ children and adolescents at 12 months.  Understanding the nature of 
this association may shed light on the pathophysiological mechanisms underlying advanced 
cellular aging in IMDs.  
 
Key words: Internalizing mental disorders, telomere length attrition, TERT rs2736100, TERC 
rs16847897, HIV+ children and adolescents, Uganda 
 
3.2 Background 
Human immunodeficiency virus-positive (HIV+) children and adolescents suffer a 
considerable burden of internalizing mental disorders (IMDs) (namely, depression, anxiety and 
posttraumatic stress disorder) (Kinyanda et al., 2019; Mellins et al., 2012; Nachman et al., 




developing world (sub-Saharan Africa) among HIV+ children and adolescents have 
documented rates of major depressive disorder of between 12.7% and 40% (Mellins et al., 
2012; Nachman et al., 2012; Lwidiko et al., 2018; Kim et al., 2014; Kamau et al., 2012; Gadow 
et al., 2012; Musisi & Kinyanda, 2009) and rates of anxiety disorders of between 9% and 32.2% 
(Kinyanda et al., 2019; Mellins et al., 2012; Nachman et al., 2012; Kamau et al., 2012). For 
IMDs combined, rates of between 12% and 27% have been documented in Uganda and South 
Africa, respectively (Kinyanda et al., 2019; Woollet, Cluver, Bandeira & Brahmbhatt, 2017). 
Among people living with HIV/AIDS, IMDs have been associated with a number of other 
negative outcomes, including accelerated cellular aging (Kalungi et al., 2019), faster HIV 
disease progression (Chida & Vedhara, 2009; Ironson et al., 2005), poor adherence to 
medication (Ironson et al., 2005; Kinyanda et al., 2018), risky sexual behavior (Kinyanda et 
al., 2018; Springer, Dushaj & Azar, 2012), poor linkage to care for newly diagnosed HIV+ 
persons (Bhatia et al., 2011), increased HIV transmission (through the promotion of HIV drug 
resistance) (Remien & Mellins, 2007) and impaired academic and social functioning (Kinyanda 
et al., 2018).  
 
While considerable research has investigated the psychosocial risk factors for IMDs among 
HIV+ children and adolescents, there is a paucity of research on biological risk factors, 
including genetic factors. Recent GWASes have identified loci for depression (Wray et al., 
2018), anxiety disorders (Meier et al., 2019) and PTSD (Nievergelt et al., 2019; Gelernter et 
al., 2019), providing evidence for the role of genetic variation in the etiology of IMDs. 
Nevertheless, the underlying etiology, and biochemical and molecular events in particular, of 
IMDs are largely unknown.  
 
IMDs are associated with increased mortality and age-related disease such as cancer, heart and 
cardio-vascular disease (Pratt, Druss, Manderscheid & Walker, 2016; Druss et al., 2011; Colton 
& Manderscheid, 2006; Cuijpers & Smit, 2002). IMDs are also highly comorbid with both 
psychiatric and somatic disorders, including those associated with advanced aging (Lotfaliany 
et al., 2019). Depression has, for example, been reported to be associated with chronic diseases 
(e.g., type 2 diabetes mellitus and cardiovascular disease) (Lotfaliany et al., 2019; Mason, Beck 
& Muruwe, 2012), as well chronic inflammation (Leonard, 2007). In addition, higher mortality 
rates have been reported among patients with mental disorders (e.g., depression and other 
affective disorders) compared to the general population, with this mortality mainly due to the 




Manderscheid, 2006; Cuijpers & Smit, 2002; Druss et al., 2011). Evidence for the role of TL 
among patients with IMDs and comorbid age-related diseases may offer a novel potential 
mechanism for the excess morbidity and mortality associated with IMDs (Ramunas et al., 
2015).  
 
Several studies have investigated the association between telomeres, the protein-bound 
deoxyribonucleic acid (DNA) repeat structures at the ends of chromosomes, and IMDs 
(Lindqvist et al., 2015). Telomeres are important in protecting chromosomes from fusing 
together during mitosis, thus preventing loss of genetic data (Allsopp et al., 1992; Blackburn, 
Geider & Szostak, 2006). They shorten progressively with each cell division, eventually 
leading to DNA damage responses, replicative senescence, or programmed cell death 
(Zlotorynski, 2019). Since telomeres shorten with each cycle of cell division, TL provides a 
marker of biological aging (Shay, 2016).  
 
Shorter TL has been reported among patients with depression (Verhoeven et al., 2017; Lin, 
Huang & Hung, 2016; Schutte & Maouff, 2015; Garcia-Rizo et al., 2013; Verhoeven et al., 
2014; Shalev et al., 2014; Douillard-Guilloux, Guiolloux, Lewis & Sibille, 2013; Kinser & 
Lyon, 2013), anxiety disorders (Verhoeven et al., 2017; Verhoeven et al., 2015; Kananen et 
al., 2010) and PTSD (Avetyan, Zakharyan, Petrek & Arakelyan, 2019; Roberts et al., 2017; 
O’Donovan et al., 2011; Zhang et al., 2014).  
 
We previously found evidence to suggest accelerated TL attrition that was driven by IMDs 
among Ugandan HIV+ children and adolescents (Kalungi et al., 2019). There is, however, a 
dearth of data on the mechanisms by which IMDs lead to TL attrition. IMDs act as chronic 
stressors (Dieleman et al., 2015; McEwen, 2003), producing long-lasting biological 
adaptations that could potentially explain TL attrition due to IMDs (Epel & Lithgow, 2014). 
Specifically, chronic stress can exert long-lasting effects on the hypothalamic-pituitary-adrenal 
axis, such that previous experience of stress may prime heightened response on subsequent 
stressor exposure (Aristizabal et al., 2019). Chronic stress also increases inflammatory 
signaling, which may in turn produce a pro-oxidative environment. Both inflammation and 






TL is heritable, with heritability estimates ranging between 44–80 % (Njajou et al., 2007; Broer 
et al., 2013).  Therefore, genetic variation may contribute to telomere maintenance (Codd et 
al., 2013) and this genetic variation may confer risk for accelerated TL attrition. TL is 
maintained by telomerase, a catalytic enzyme with a protein component encoded by telomerase 
reverse transcriptase gene (TERT) and an RNA template component encoded by telomerase 
RNA component gene (TERC). Together, these act to add small DNA repeat segments to the 
end of chromosomes, thus counteracting TL attrition (Blackburn, Geider & Szostak, 2006; 
Wang & Meier., 2004). A large genome-wide meta-analysis of 37,684 individuals found that 
TERT and TERC were amongst several loci found to influence mean TL (Codd et al., 2013), 
suggesting that genetic variation in these telomerase components has functional implications 
on TL.   
 
The TERC rs12696304 G-allele and rs16847897 C-allele have been found to be associated with 
shorter TL by a candidate gene study on  Swedish samples and a GWAS on British samples 
(Codd et al., 2010; Melin, Nordfjäll, Andersson & Roos, 2012). In addition, TERT rs2736100 
C-allele has been associated with shorter TL (Codd et al., 2013), while TERT rs7726159 AA 
genotype was associated with longer TL by a candidate gene study using White European 
samples (Rode, Nordestgaard & Bojesen, 2016). 
 
We have previously determined an association between IMDs and TL in a sample of Ugandan 
HIV+ children and adolescents (Kalungi et al., 2019). Specifically, TL was significantly longer 
in IMD cases at baseline but did not differ from control TL at 12-month follow-up, suggesting 
that TL shortening over the one-year period was greater in participants with IMDs. Given that 
TERT and TERC are involved in TL maintenance (Blackburn, Geider & Szostak, 2006), the 
present study investigated whether genetic variation in TERT (rs2736100, rs7726159, 
rs10069690 and rs2853669) and TERC (rs12696304, rs16847897 and rs10936599) moderated 
the association between IMDs and each of baseline and 12-month TL. Having observed that 
IMDs were driving accelerated TL attrition in the previous study (Kalungi et al., 2019), we 
modelled IMDs as the independent variable and TL as the dependent variable. We thus assessed 





No significant differences were observed when socio-demographic variables were compared 
between case and control participants (Table 3.1). 
 
Table 3.1: Distribution of socio-demographic factors in cases and controls 
Variable (n) Case n (%) Control n (%) P-value 
Sex         
            Male (342) 








p = 0.111 
Site         
              Urban (415) 








p = 0.941 
Age         
      5–11 years (389)   
     12–17 years (307) 
 
 
  202 (57.6) 




p = 0.374 
Education level 
     No formal education (13) 
      Primary (648) 
     Secondary (72) 









p = 0.371 
Socioeconomic status 
               Low  (332) 







p = 0.459 







p = 0.939 
CD4 = cluster of differentiation 4; primary = 0 – 7 years of formal education; Secondary = 8 – 
14 years of formal education; Low socioeconomic status = 0 – 13; High socioeconomic status 
= > 13 (see statistical methods section). All numbers that do not add up were due to missing 
data 
 
The genotypes for all the selected SNPs were in Hardy-Weinberg equilibrium (HWE) (Table 
3.2). TERT rs7726159 and rs2736100 were in linkage disequilibrium (LD), resulting in CT, CG 
and AG haplotypes while none of TERC SNPs were in LD (see Supplementary materials S3.1 
and S3.2). The association between each investigated SNP and TL are shown in Table 3.2 




baseline TL or TL change; however, TERC rs16847897 significantly associated with 12-month 
TL (Table 3.2).  
Table 3.2: P-values for Hardy-Weinberg equilibrium and association of each selected 
single nucleotide polymorphism with TL 
Single nucleotide 
polymorphism 
P-value of association with HWE p-value 
Baseline TL 12 months TL TL change 
TERC rs16847897 0.650 0.014 0.393 0.461 
TERC rs12696304 0.861 0.991 0.981 0.443 
TERC rs10936599 0.406 0.142 0.510 1 
TERT rs2736100 0.300 0.366 0.581 0.091 
TERT rs2853669 0.438 0.507 0.591 0.798 
TERT rs7726159 0.590 0.855 0.802 0.882 
TERT rs10069690 0.567 0.831 0.802 0.274 
TERT rs7726159-
rs2736100 
0.331 0.724 0.725 N/A 
HWE = Hardy-Weinberg equilibrium, TERC = telomerase RNA component gene, TERT = 
telomerase reverse transcriptase gene, TERT rs7726159-rs2736100 = TERT rs7726159 and 
rs2736100 haplotype, N/A = not applicable. 
 
Moderating effects of single nucleotide polymorphisms in telomerase reverse 
transcriptase gene and telomerase RNA component gene on the association between 
internalizing mental disorders and telomere length 
None of the selected SNPs were found to moderate the association between IMDs and TL at 
baseline (Table 3.3). We however found that TERT rs2736100 and TERC rs16847897 
significantly moderated the association between IMDs and TL at 12 months (p = 0.007 and p 
= 0.012 respectively) (Table 3.3). For TERT rs2736100, mean TL was longer in cases compared 
to controls, but only in those individuals with the GG genotype (n = 139; 82 cases, 57 controls) 
(Figure 3.1). No significant difference in TL was observed between cases and controls who 
possessed either the TG (n = 330) or TT (n = 201) genotypes (Figure 3.1). For TERC 
rs16847897, mean TL was longer in cases compared to controls, but only in individuals with 
the CC genotype (n = 44; 27 cases, 17 controls) (Figure 3.1). No significant difference in TL 
was observed between cases and controls who possessed either the GC (n = 265) or GG (n = 




participants with at least one T-allele for TERT rs2736100 and at least one G-allele for TERC 
rs16847897. P-values for the interaction between the rest of the SNPs and IMDs on baseline 
TL, 12 months TL and TL change are shown in Table S3.1 (see supplementary materials). 
 
Table 3.3: Two-way analysis of variance for the interaction of IMDs with rs2736100 and 
with rs16847897 on TL at 12 months 
SNP Obs Variable   F  Bonferroni 
corrected P-value 
(α = 0.025) 
Baseline     
rs2736100 596 IMDs 15.52 <0.001 
  rs2736100 0.98 0.375 
  IMDs * rs2736100 1.15 0.318 
rs16847897 597 IMDs 2.53 0.112 
  rs16847897 0.37 0.692 
  IMDs * rs16847897 1.79 0.168 
12 months     
rs2736100 511 IMDs 6.03 0.014 
 rs2736100 0.44 0.645 
 IMDs * rs2736100 4.95 0.007 
rs16847897 515 IMDs 7.25 0.007 
 rs16847897 3.00 0.050 
 IMDs * rs16847897 4.44 0.012 
SNP: single nucleotide polymorphism; Obs: number of observations; IMDs*rs2736100: 
interaction of internalizing mental disorders with TERT rs2736100 on relative telomere length; 
IMDs *TERC rs16847897, interaction of internalizing mental disorders with rs16847897 on 






Figure 3.1: Mean TL between cases and controls by genotype for TERT rs2736100 and 
TERC rs16847897 at 12 months. 
For TERT rs2736100 mean TL was significantly different between cases and controls, but only 
in individuals with the GG genotype while for TERC rs16847897, mean TL was significantly 
different between cases and controls but only in individuals with CC genotype.  
 
3.4 Discussion 
We previously found that TL was longer at baseline in cases with IMDs, but that this difference 
did not remain 12 months later (Kalungi et al., 2019). The present study built on these results 
and investigated whether selected polymorphisms within TERT and TERC interacted with 
IMDs to influence TL, where TERT rs2736100 and TERC rs16847897 significantly moderated 
the association between IMDs and TL at 12 months. To our knowledge, this is the first sub-
Saharan African study to investigate these interactions among HIV+ children and adolescents. 
 
Telomeres are maintained by the telomerase enzyme, an enzyme whose catalytic protein 
component and RNA template is encoded by TERT and TERC, respectively (Blackburn, 
Greider, & Szostak, 2006; Wang & Meier., 2004). Given the role that TERT and TERC play 
in the structure of telomerase (Chen & Greider, 2003; Lee & Blackburn, 1993), variations in 
genes encoding these components could influence TL. However, none of the investigated 
polymorphisms significantly influenced the association between IMDs and TL at baseline. We 
found a significant interaction between IMDs and TERT rs2736100 and TERC rs16847897 on 
TL at 12 months. This interaction points to a possible direct influence of IMDs on TL 
shortening. It is possible that chronic pathophysiological processes characteristic of IMDs, 
including inflammation, oxidative stress and HPA axis dysregulation (Yu & Woo, 2016),  
produced a cumulative burden over the one-year study period, with the resultant increase in 




there is no difference in 12 months TL between cases and controls for participants carrying 
TERT rs2736100 GT or TT genotype. Similarly, for TERC rs16847897, the GC or GG 
genotypes appear to be associated with reduced TL at 12 months. Although we found no 
significant interaction between IMDs and the selected SNPs on TL change, TERT rs2736100 
and TERC rs16847897 interacted with IMDs to influence 12 months TL, results of which depict 
these genotypes as accelerators of TL attrition among cases of IMDs. However, it is hard to 
tease out the true effects of the genotypes on TL attrition in the present study, since the 
reduction in TL after 12 months was strongly significant in both cases and controls (p < 0.001 
respectively), possibly due to the short one year study period that is not long enough to clearly 
show the difference in TL attrition between cases and controls. Future studies with a longer 
study period are required to confirm our findings.  
 
Although the functionality of TERT rs2736100 and TERC rs16847897 SNPs is not well known, 
data from previous studies strongly suggest their involvement in disease-associated TL attrition 
(sporadic idiopathic pulmonary fibrosis), as well as pathophysiological mechanisms, such as 
inflammation, that are relevant to IMDs (Ding et al., 2013; Mushiroda et al., 2008; Armanios 
et al., 2007). The rs2736100 SNP is located within intron 2 of TERT, a position that has been 
described to be a putative regulatory region (Taylor et al., 2006).  The SNP has been reported 
as a critical factor in TERT synthesis and activation (Melin, Nordfjäll, Andersson & Roos, 
2012) and has previously been associated with diseases characterized by TL attrition, including 
lung cancer (McKay et al., 2008) and sporadic idiopathic pulmonary fibrosis (Armanios et al., 
2007; Mushiroda et al., 2008; Tsakiri et al., 2007). TERT has also been reported to interact 
with natural factor kappa B (NF-κb) p65, where it activates NF-κb and increase 
metalloproteinases in cancer cells (Ding et al., 2013). On the other hand, TERC rs16847897 
has also been reported as locus that probably regulates TL. The TERC rs16847897 CC genotype 
has been associated with both shorter TL and lower TERT levels (Al Khaldi, Mojiminiyi, 
AlMulla, & Abdella, 2015) while each copy of TERC rs16847897 major G-allele (CG or GG) 
was also associated with shorter mean TL in a Han Chinese population (Shen et al., 2011). 
 
TERT rs2736100 and TERC rs18647897 appear to have regulatory functions or may be in LD 
with variants that have regulatory functions and thus require further study. Although the nature 
of the interaction between IMDs and TERT and TERC on TL is not known, IMDs have been 
associated with increased oxidative stress (Ng, Berk, Dean & Bush, 2008; Sarandol et al., 2007) 




interleukin-6 and tumor necrosis factor alpha (Musinguzi et al, 2018; Miller, Maletic & Raison, 
2009). Oxidative stress leads to TL shortening through the inhibition of telomerase activity (Yu 
& Woo, 2016; Kurz et al., 2004; von Zglinicki, 2002). We hypothesize that IMD-related 
increases in oxidative stress and inflammatory responses produce a cumulative 
pathophysiological burden. The effect of this on TL may potentially be influenced by genetic 
variation in TERT and TERC. 
 
As per the interaction plots, we observed an association between TERC rs16847897 C-allele 
and longer TL among the study participants (cases and controls), an observation that is contrary 
to a large genome-wide meta-analysis that reported an association between TERC rs16847897 
G-allele with longer TL (Codd et al., 2013). We have no direct explanation for this observation. 
However it is important to note that the association of the C-allele with longer TL is an outcome 
of a longitudinal interaction of the SNP with IMDs. The nature of this interaction needs to be 
elucidated in order to draw conclusions. It is also noteworthy that HIV infection has been 
associated with TL shortening (Alejos et al., 2019; Shiau et al., 2018; Auld et al., 2016) and 
thus HIV infection and its associated co-infections may have strongly confounded our findings. 
Future studies that control for these studies or studies among general populations are required 
for better comparison of findings.  
 
Our study presents with limitations which deserve mention, and results should be interpreted 
keeping these in mind. We defined our cases as those individuals diagnosed with depressive 
disorder, any anxiety disorder or PTSD. The inclusion of PTSD (n = 60) in this sample is 
contentious, as the disorder has recently been excluded from the IMD categorization in the 
DSM-5 (American Psychiatric Association, 2013). This may have affected our findings. In 
order to elucidate the independent contribution of each particular disorder, future studies should 
analyze each IMD separately. Also, the qPCR efficiencies were outside the optimal range of 
90 – 110% (please see addendum E for the standard curves and the dissociation graphs) (Čepin, 
2017). The possible reasons for this observation have been discussed under section 5.7 of this 
PhD thesis. In addition, we did not control for population stratification at analysis since the 
study participants belonged to the Bagandan population group for which principal components 
analysis on GWAS data of a sample of over 4,000 individuals has shown that they are 
genetically similar, as principal components 1 and 2 have been reported to have explained 0.3% 
and 0.1% of the genetic variation in a Bagandan general population cohort (Gurdasani et al., 




although they identified as Baganda and their inclusion could have caused population 
admixture that could have led to spurious results. Future studies should endeavor to control for 
population stratification.  
 
Despite the limitations, our study has strengths that are worth mentioning. First, the study 
sample size was large enough (368 cases and 368 controls) to allow a sufficient power of 
greater than 80% for the association between IMDs and TL. Second, we measure TL at baseline 
and 12 months, a longitudinal aspect that allowed us to assess for causation. 
 
3.5 Conclusions 
We observed TERT rs2736100 and TERC rs16847897 produce effects on 12-month TL in 
Ugandan HIV+ children and adolescents diagnosed with IMDs. Functional studies on 
telomerase, TERT and TERC are needed to provide insights on the mechanisms underlying the 
SNP x IMD interactions on TL in our study group. Understanding how IMDs interact with 
genetic polymorphisms to influence TL may explain the accelerated aging due to IMDs and 
may elucidate the nature of comorbidity observed between IMDs and age-related diseases such 
as diabetes and cardiovascular disease.  
 
3.6 Methods 
3.6.1 Study design  
This case-control study was carried out in children (aged 5-11 years) and adolescents (12-17 
years). A total of 368 cases with any IMD and 368 age- and sex-matched controls were 
included. Both cases and controls were Ugandans. This study was nested within the previously 
described CHAKA study (Kinyanda et al., 2019; Mpango et al., 2017), which enrolled 1339 
HIV+ children and adolescents (855 children and 484 adolescents) in Uganda. 
 
3.6.2 Study population 
Study subjects were recruited from two HIV clinics in urban Kampala (Joint Clinic Research 
Centre (JCRC) and Nsambya Home Care) and three HIV clinics in rural Masaka (The AIDS 
Support Organization (TASO), Kitovu Mobile Clinic and Uganda Cares). All study subjects 





As part of CHAKA study, children and assenting adolescents, as well as their caregivers, were 
interviewed using a structured questionnaire and provided a blood specimen (4 ml) for genetic 
analyses. The questionnaire included, amongst others, socio-demographic characteristics and 
depression, PTSD and anxiety modules of the DSM-5 referenced Child and Adolescent 
Symptoms Inventory-5 (CASI-5) (Gadow & Sprafkin, 2013). The CASI-5 was administered 
by trained psychiatric nurses and psychiatric clinical officers at two time points (baseline and 
12 months). The CASI-5 lists the symptoms of a wide range of psychiatric disorders including 
MDD, generalized anxiety disorder, PTSD and attention-deficit/hyperactivity disorder among 
others. Individual CASI-5 items are rated on a four-point frequency of occurrence scale ranging 
from never (0) to very often (3). Though there are several CASI-5 scoring algorithms, in the 
present study we used symptom count cut-off scores, which reflect the prerequisite number of 
symptoms for a clinical diagnosis. At each study visit, 4 ml of blood from each study participant 
was collected via venipuncture into an EDTA vacutainer and subsequently stored at −80°C 
pending DNA extraction. 
 
3.6.4 Inclusion and exclusion criteria  
Inclusion criteria: i) HIV-infected outpatients, registered with the HIV Clinics at JCRC or 
Nsambya Home Care at the Kampala study site and TASO, Kitovu mobile or Uganda Cares 
clinic at the Masaka site; ii) aged between 5 and 17 years at the time of enrolment; iii) 
conversant in English or Luganda, the language into which the assessment tools were 
translated; and iv) able to provide written informed consent/assent.  Cases were HIV+ children 
and adolescents who had any depressive disorder (depression or dysthymia [persistent 
depressive disorder]), anxiety disorder or PTSD. Controls were age- and sex- matched HIV+ 
children and adolescents without any psychiatric disorder. Persistent IMDs were baseline cases 
that remained cases at 12 months while remitted ones were baseline cases  
that no longer qualified for a diagnosis at 12 months. Exclusion criteria: i) seriously ill and 
unable to understand study procedures; and ii) any other psychiatric disorder other than the 
IMDs listed above. 
 
3.6.5 Ethical considerations 
The study complied with the Code of Ethics of the World Medical Association (Declaration of 
Helsinki). The CHAKA study obtained ethical and scientific clearance from the Uganda Virus 




Uganda National Council of Science and Technology (# HS 1601). The present study obtained 
approval from the Higher Degrees Research & Ethics Committee, School of Biomedical 
Sciences, College of Health Sciences, Makerere University (# SBS 421) and the Health 
Research Ethics Committee of Stellenbosch University (#S17/09/179). Study subjects who 
were diagnosed with significant psychiatric problems were referred to mental health units at 
Entebbe and Masaka government hospitals. 
 
3.6.6 Selection of cases and controls 
All baseline cases of IMDs (n = 368) in the parent study, CHAKA were considered and thus 
cases were HIV+ children and adolescents who had any Internalizing mental disorder (IMD). 
All cases at baseline were ascertained, and the cases were then stratified by site (one of two 
sites), sex, age category (one of three categories) and Socio-economic status (SES) (one of 
three SES categories). This resulted in a total of 36 strata (2X2X3X3). In each stratum the 
number of cases was ascertained (e.g. for males in site 1 in the youngest age category and the 
lowest SES group there were 9 cases). An equal number of controls (HIV+ children and 
adolescents without any psychiatric disorder) were then randomly sampled from the stratum 
concerned (so for males in site 1 in the youngest age category and the lowest SES group we 
sampled 9 controls), thus the controls were frequency matched to the cases on site, sex, age 
and SES. 
 
3.6.7 Determination of genotypes for selected polymorphisms in telomerase reverse 
transcriptase gene and telomerase RNA component gene and analysis for linkage 
disequilibrium 
DNA samples were genotyped for each selected SNP in each of TERT (rs2736100, rs7726159, 
rs10069690 and rs2853669) and TERC (rs12696304, rs16847897 and rs10936599), using a 
kompetitive allele-specific PCR (KASP) assay (LGC, Middelsex, United Kingdom). This 
genotyping chemistry allowed for bi-allelic discrimination of SNPs although none of the SNPs 
was validated. The genotyped SNPs in each of TERT and TERC were analyzed for LD using 
Haploview software, version 4.2 (Barrett, 2009).’ 
 
3.6.8 Power of the study 
We calculated the post hoc power for our study based on results from a study by Epel et al. 
(2004). We used the formula of sample size and power for difference in means in case–control 




levels of stress than controls (individuals without IMDs). Epel et al. (2004) found a 15% 
reduction in mean TL among cases compared with controls. Given a 1:1 ratio of cases to 
controls and using a 5% level of significance, with 368 cases and 368 controls, our study was 
well powered (power greater than 80%) to detect any reduction above 4.75% in mean TL 
between cases and controls. For instance, a reduction of 5% in mean TL between cases and 
controls provided a power of 83.8%. 
 
3.6.9 Statistical methods 
Statistical analyses were conducted using Stata 15 (StataCorp, TX, USA). Socio-demographic 
characteristics (including socio-economic status) were described between cases and controls. 
Socio-economic status (SES) was generated from a scale of 9 household items owned (car, 
motorcycle, refrigerator, electricity, bicycle, radio, telephone, cupboard and flask). Each item 
was weighted in the respective order, a car carrying a maximum weight of 9 and a flask a 
minimum weight of 1. A total score of items was generated, whose median cut-off of 13 was 
used to classify low and high SES. A score less than 13 was classified as low SES, while that 
greater than 13 was classified as high SES. Our study group (Kinyanda et al., 2011a) has 
previously used household items as a measure of SES in rural settings of Uganda. A t-test was 
used to compare CD4 counts between cases and controls to account for any disparity in HIV 
disease progression. 
 
Associations between the different socio-demographic factors and TL were tested using one-
way analysis of variance (ANOVA) to determine potential confounders.  Independent sample 
t-tests were used to assess the association between IMDs and TL both at baseline and 12 
months. TERT and TERC genotypes were assessed for HWE using a likelihood ratio test. The 
genotypes were not validated as genotyping was done by a service provider using an automated 
SNP genotyping array. A two-way ANOVA was used to assess for interaction between each 
of the polymorphisms and IMDs on TL both at baseline and 12 months, with Bonferroni 
corrections for multiple testing. To perform a Bonferroni correction, the p-value threshold of 
0.05 was divided by 2 (number of separate tests) to yield a corrected threshold p-value of 0.025. 
These interactions were performed on all the explanatory variables even without observing 
significant main effects in order to rule out the possibility of cross over interaction where 
significant interactions may be observed for non-significant main effects. For significant 
interactions, mean TL at 12 months was plotted against genotypes to elucidate the nature of the 




from each 12 month TL value for each study participant. Where required, 95% confidence 
intervals were calculated. 
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3.15 Supplementary materials 
Figure S3.1 
LD plot showing linkage disequilibrium (LD) for TERT rs10069690, rs7726159, rs2736100 and 
rs2853669. 
 
The linkage disequilibrium map of TERT. D’ values are depicted in the diamonds with darker 
colours depicting stronger LD. The LD map was created using the default Gabriel LD (Gabriel et 
al., 2002), implemented in Haploview, version 4.2 (Barrett, 2009). TERT rs7726159 and rs2736100 
were in LD resulting in CT, CG and AG. Location = 5’ to 3’ on chromosome 5. 
Figure S3.2 
 
The linkage disequilibrium map of TERC. D’ values are depicted in the diamonds with darker 
colours depicting stronger LD. The LD map was created using the default Gabriel LD (Gabriel et 
al., 2002), implemented in Haploview, version 4.2 (Barrett, 2009). None of the SNPs were in LD. 





Table S3.1: Two-way analysis of variance for the interaction of IMDs with selected SNPs in telomerase reverse transcriptase gene and telomerase 
RNA component genes on baseline telomere length, 12 months telomere length and telomere length change 
 
SNP 
Baseline telomere length 12 months telomere length Telomere length change 
Obs Variable F P>F Obs Variable F P>F Obs Variable F P>F 
TERT rs2853669 585 IMDs 4.64 0.032 495 IMDs 0.02 0.887 444 IMDs 2.47 0.117 
  rs2853669 0.86 0.424  rs2853669 0.75 0.475  rs2853669 0.68 0.506 
  IMDs*rs2853669 1.10 0.333  IMDs*rs2853669 0.26 0.770  IMDs*rs2853669 1.22 0.297 
TERT rs7726159 606 IMDs 10.8 0.001 526 IMDs 4.32 0.038 459 IMDs 0.26 0.609 
  rs7726159 0.21 0.809  rs7726159 0.01 0.986  rs7726159 0.19 0.830 
  IMDs*rs7726159 1.16 0.316  IMDs*rs7726159 1.32 0.267  IMDs*rs7726159 0.01 0.986 
TERT rs10069690 600 IMDs 12.03 <0.001 513 IMDs 1.85 0.175 454 IMDs 0.76 0.384 
  rs10069690 0.32 0.729  rs10069690 0.27 0.760  rs10069690 0.44 0.644 
  IMDs*rs10069690 0.53 0.589  IMDs*rs10069690 1.96 0.142  IMDs*rs10069690 1.57 0.210 
TERC rs12696304 597 IMDs 8.63 0.003 512 IMDs 2.43 0.120 451 IMDs 0.18 0.668 
  rs12696304 0.23 0.979  rs12696304 0.02 0.978  rs12696304 0.03 0.972 
  IMDs*rs12696304 0.33 0.720  IMDs*rs12696304 1.79 0.167  IMDs*rs12696304 1.37 0.255 
TERC rs10936599 597 IMDs 2.90 0.089 516 IMDs 0.72 0.397 454 IMDs 0.00 0.958 
  rs10936599 1.01 0.314  rs10936599 2.40 0.122  rs10936599 0.45 0.503 
  IMDs*rs10936599 0.01 0.921  IMDs*rs10936599 0.02 0.878  IMDs*rs10936599 0.09 0.767 








This chapter highlights the role of chronic stress and genetic variants in SLC6A4 and TPH2 
on the association between acute stress and IMDs among the study participants. It is based on 
a manuscript that is scheduled for submission to Frontiers in Genetics (Impact factor, 3.517).  
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Internalizing mental disorders (IMDs) among HIV+ children and adolescents are associated 
with poor disease outcomes, such as faster HIV disease progression. Although it has been 
suggested that the development of IMDs is moderated by interaction of stressful life events and 
vulnerability (genetic and or acquired) factors, which are, in turn, modulated by resilience 
factors, the underlying etiology, including biochemical or molecular events, are largely 
unknown. This study investigated the association between acute stress and IMDs, and 
moderation by chronic stress and genetic variants in the serotonin transporter (SLC6A4) and 
tryptophan hydroxylase 2 (TPH2) genes. 
 
Hypothesis 
We hypothesized that acute stress acts through genetic and environmental vulnerability factors 
to increase the risk of developing IMDs. 
 
Methods 
Polymorphisms in SLC6A4 (5-HTTLPR, rs25531, 5-HTTLPR-rs25531 and STin2 VNTR) and 
TPH2 (rs1843809, rs1386494, rs4570625 and rs34517220) were genotyped in 368 HIV+ 
children and adolescents (aged 5-17 years) with any IMD (depression, anxiety disorders or 
post-traumatic stress disorder), and 368 age- and sex-matched controls.  Chronic and acute 
stress categories were derived by hierarchical cluster analysis, using a composite index that 
assessed social disadvantage variables. Logistic regression analysis was used to assess the 
independent moderating effect of chronic stress and each selected polymorphism on the 
association between acute stress and IMDs.   
 
Results 
We observed a statistically significant association between severe acute stress and IMDs (p = 
0.001). The likelihood of having an IMD increased with increasing acute stress, where HIV+ 
children and adolescents who experienced severe acute stress were twice as likely to develop 
IMDs compared to HIV+ children and adolescents who experienced mild acute stress (p = 
0.001). Chronic stress was found to interact with severe acute stress to increase the risk of 
IMDs (p = 0.033). Acute stress was found to interact with 5-HTTLPR-rs25531 S-A-S-A 




0.049). We found no evidence for a combined interaction of acute stress, chronic stress and 5-
HTTLPR-rs25531 on IMDs. 
 
Conclusions 
The odds of having an IMD were higher among HIV+ children and adolescents who 
experienced severe acute stress compared to HIV+ children and adolescents who experienced 
mild acute stress. Chronic stress and 5-HTTLPR-rs25531 independently moderated the 
association between acute stress and IMDs. 
 
4.2 Background 
HIV-positive (HIV+) children and adolescents suffer a considerable burden of internalizing 
mental disorders (IMDs) (Kinyanda et al., 2019; Mellins et al., 2012; Nachman et al., 2012). 
IMDs are characterized by quiet, internal distress (Tandon, Si, & Luby, 2011) and include 
depressive and anxiety disorders, as well as posttraumatic stress disorder (PTSD) (American 
Psychiatric Association, 2013). IMDs among people living with HIV/AIDS have generally 
been associated with a number of negative outcomes, including more rapid HIV disease 
progression (Chida & Vedhara, 2009; Ironson et al., 2005), poor adherence to medication 
(Kinyanda et al., 2018; Springer, Dushaj & Azar, 2012), risky sexual behavior (Kinyanda et 
al., 2018; Springer, Dushaj & Azar, 2012) and poor linkages to care for newly diagnosed 
persons with HIV (Bhatia et al., 2011). 
 
IMDs are complex disorders with gene-environment interactions contributing to their etiology 
(Musci, Augustinavicius & Volk, 2019). The behavioral disturbances characteristics of these 
disorders are likely due to a large number of genes, with each having only a small effect size 
on phenotype (Assary, Vincent, Keers & Pluess, 2018; Plomin & Davis, 2009). The role of 
psychosocial factors and their interaction with biological mechanisms in the etiology of IMDs 
is still poorly understood. HIV+ children and adolescents experience various chronic life 
stressors such as awareness of their HIV-status, increased levels of stigma and poorer parental 
mental health (Betancourt et al., 2014). As chronic stressors are reported to be risk factors for 
IMDs (Revenson et al., 2016; Adelman et al., 2014; Robles, Slatcher, Trombello, & McGinn, 
2014), chronic stressors likely contribute to the etiology of IMDs among HIV+ children and 





IMDs are highly heritable (Smoller et al., 2016): twin studies have estimated a genetic 
heritability of 35% for depression (Otte et al., 2016) and 30-50% for post-traumatic stress 
disorder (PTSD) (Smoller et al., 2016). A meta-analysis of family and twin studies estimated 
a genetic heritability of 31.6% for generalized anxiety disorder (GAD) (Hettema, Neale & 
Kendler, 2001). A more recent GWAS of monozygotic and dizygotic female twins has 
estimated a genetic heritability of 42% for GAD (Davies et al., 2015). Despite being highly 
heritable, the underlying etiology of IMDs is largely unknown although dysregulation in 
serotonergic transmission has been implicated in IMDs like depression among adults living 
with HIV (Hammoud et al., 2010).  
 
The serotonergic system in the central nervous system is extremely important in regulating 
mood and anxiety (Olivier et al., 2015). After an impulse is fired and serotonin (5-HT) is 
released into the synaptic cleft, 5-HT re-uptake reduces the activity of the serotonergic neurons, 
preparing the neuron for a new discharge (Olivier et al., 2015; Artigas, 2013a, b). Encoded by 
the serotonin transporter gene (solute carrier family 6 member 4, SLC6A4), the serotonin 
transporter (5-HTT) influences serotonergic transmission by regulating the duration of 
serotonin in the synaptic cleft (Kristensen et al., 2011; Rudnick, 2006). 5-HTT is a target for 
selective serotonin re-uptake inhibitors (SSRIs) that competitively block substrate binding and 
thereby prolong neurotransmitter action at the synapse (Cipriani et al., 2018; Kristensen et al., 
2011). Tryptophan hydroxylase 2 (TPH2), encoded by TPH2, catalyzes the rate-limiting step 
in 5-HT biosynthesis (Carkaci-Salli et al., 2006; Walther et al., 2003) and is expressed 
exclusively in the brainstem (Kennedy et al., 2012), an area which is the major locus of 
serotonin-producing neurons (Kennedy et al., 2012). Long-term treatment with the SSRI 
fluoxetine has been found to be associated with concurrent upregulation of TPH2 messenger 
ribonucleic acid (RNA) expression and alleviation of depressive symptoms (Shishkina et al., 
2007), indicating that low TPH2 messenger RNA expression could represent a dysregulation 
corrected by fluoxetine. The 5-HTT and TPH2 are thus important proteins in the availability 






SLC6A4 is located on chromosome 17 (US National Library of Medicine, 2019). Within the 
promoter region of the SLC6A4 is the serotonin transporter-linked polymorphic region (5-
HTTLPR), which has been implicated in depression (Wang et al., 2016; Clarke et al., 2010), 
anxiety-related traits (Munafò et al., 2009b) and PTSD (Xie et al. 2009). 5-HTTLPR variants 
comprise either 14 (short, S-allele) or 16 (long, L-allele) copies of a 22-23 base pair (bp) 
imperfect repeat (Heils et al., 1996). In vitro studies show that the L-allele has two-to-three 
times higher basal transcriptional activity compared to the S-allele (Lesch et al., 1996; Philibert 
et al., 2008). In proximity to 5-HTTLPR is an A to G single nucleotide polymorphism (SNP), 
which has been reported to alter expression of the SLC6A4 by creating a functional AP2 
transcription-factor binding site (Ehli et al., 2012; Hu et al., 2006). The G-allele has been 
associated with reduced reporter gene expression.  This SNP, when analyzed in combination 
with 5-HTTLPR, results in L-A and L-G haplotypes. The L-G haplotype has been shown to have 
lower expression levels compared to the L-A haplotype (Hu et al., 2006; Lipsky, Hu & 
Goldman, 2009). However, some studies found no effect of the L-G haplotype on SLC6A4 
expression (Philibert et al., 2008; Martin et al., 2007).  
 
Also contained within SLC6A4 is a variable number of tandem repeats (VNTR) polymorphism. 
Located in the second intron (STin2), it consists of multiple repeated copies of a 16-17 bp 
element (Furlong et al., 1998; Battersby et al., 1996). Three alleles have been reported 
(National Center for Biotechnology Information, 2019), containing 9 (STin2.9), 10 (STin2.10) 
and 12 (STin2.12) copies of the repeat.  The alleles have been associated with differential 
expression, with STin2.9 associated with increased SLC6A4 expression, with increasing 
number of repeats associated with reduced reporter gene expression in rat neonate prefrontal 
cortical cultures (Ali et al., 2010). The STin2 VNTR polymorphism has also been found to 
interact with the 5-HTTLPR polymorphism to regulate expression of SLC6A4 with the 
combination of the 5-HTTLPR S-allele and either STin2.10 or STin2.12 associated with 
increased expression (Ali et al., 2010; Haddley et al., 2011).   The STin2.9 allele has been 
found to be associated with anxiety in patients with self-harming behaviors (Evans, Li, & 
Whipple, 2013), STin2.10 has been found to associated with both anxiety and PTSD (Xiao et 
al., 2019; Evans, Li & Whipple, 2013) and the STin2.12 allele has been found to be associated 






The tryptophan hydroxylase 2 gene is located on chromosome 12 at position 12q21.1.  Intronic 
TPH2 rs1843809 and rs1386494, and the intergenic rs4570625 SNP have been found to be 
associated with depression (Gao et al., 2012; Zill et al., 2004; Anttila et al., 2009). The 
rs34517220 SNP has been reported to modulate TPH2 expression through altering the binding 
sites for foxa1 and foxa2 transcription factors (Pristerà et al., 2015). Foxa2 plays a role in 
establishing progenitor domains for serotonergic neuron precursors in the ventral hindbrain and 
in activating transcription factors required for the terminal differentiation of serotonergic 
neurons (Jacob et al., 2007). Therefore, rs34517220-driven variation in Foxa2 binding could 
have important effects on the development of neural serotonergic systems. 
 
The diathesis-stress hypothesis of neuropsychiatric disorders postulates that a lower stress 
threshold is required for psychiatric disease to occur in individuals who harbor certain 
vulnerability factors, which may be genetic and/or acquired (Caspi et al., 2003; Silberg et al., 
2001; Monroe & Simons, 1991) (Figure 4.1). Stress represents a prevalent environmental risk 
factor for a number of mental disorders, including depression, anxiety and PTSD (Popoli et al., 
2012; de Kloet et al., 2005) and it is currently accepted that gene-environment interactions 
underlie the etiology of many, if not all, of the IMDs (Jawahar, Toben, & Baune, 2019; Willis 
& Brock, 2019; Caspi & Moffitt, 2006).  
 
In the context of the diathesis-stress hypothesis, with acute stress representing the exposure 
variable, we investigated polymorphisms in SLC6A4 (5-HTTLPR, rs25531, and STin2 VNTR) 
and TPH2 (rs1843809, rs1386494, rs4570625 and rs34517220) as the genetic vulnerability 
factors and chronic stress as the acquired vulnerability factor for IMDs in a sample of HIV+ 
children and adolescents. Our a priori selection of these polymorphisms was based on their 
association with IMDs (5-HTTLPR, STin2 VNTR, TPH2 rs1843809, rs1386494, rs4570625 





Figure 4.1: The conceptual framework for the present investigation, based on the 
diathesis-stress model.  
  
The conceptual framework is adapted from the diathesis-stress model for depression (Monroe 
& Simons, 1991). The aim of the present study was to investigate the association between acute 
stress and IMDs (A). We postulated that acute stress would interact with vulnerability factors 




4.3.1 Study design   
This was a case-control study nested within a Medical Research Council/Department for 
International Development (MRC/DfID)-funded project that investigated mental health among 
HIV+ children and adolescents in Kampala and Masaka districts of Uganda (CHAKA study). 
The present study selected from the 1339 Ugandan HIV+ children and adolescents (aged 5 – 
17 years) of black African ancestry enrolled in the CHAKA study (Kinyanda et al., 2019).  Of 
the 1339, all participants with any internalizing mental disorder (IMD) (368 cases) who met 
inclusion criteria (see below) and an equal number of age-, site-, socio-economic status (SES)- 
and sex- matched controls were selected. Cases were defined as subjects who had any 
depressive disorder (depression or dysthymia [persistent depressive disorder]) or any anxiety 
disorder (generalized anxiety disorder, separation anxiety disorder, social anxiety disorder, 
panic disorder and agoraphobia) or PTSD. Controls were age-, site-, SES- and sex-matched 
participants, without any psychiatric disorder. Genomic DNA was extracted from an archived 




4.3.2 Study population  
Study participants for the CHAKA study were recruited from two HIV clinics in urban 
Kampala (Joint Clinic Research Centre and Nsambya Home Care) and three HIV clinics in 
rural Masaka (The AIDS Support Organization, Kitovu mobile clinic and Uganda Cares clinic). 
Study staff visited the patient waiting areas of each clinic, introduced the study and requested 
participants enroll in the study. At each of the study sites, HIV+ children and 
adolescents/caregiver dyads who agreed to participate in the study were then screened for 
suitability according to the eligibility criteria (Kinyanda et al., 2019). All study participants 
were on antiretroviral therapy.  The study participants were of Bagandan ethnicity, the largest 
ethnic group in Uganda. The study participants were thus expected to be genetically similar 
since relatively modest genetic differentiation has been observed among populations 
representing the major sub-populations in sub-Saharan Africa (Gurdasani et al., 2015). 
 
4.3.3 Procedures  
Children and assented adolescents, as well as their caregivers, were interviewed using a 
structured questionnaire. The questionnaire included, among others, socio-demographic 
characteristics (sex, study site, age, caregiver level of education and SES) and modules on 
depression, anxiety and PTSD from the DSM-5 referenced Children and Adolescent Symptom 
Inventory 5 (CASI-5; caregiver reported) (Gadow & Sprafkin, 2013) and the Youth Inventory-
4R (YI-4R; youth reported) (Gadow & Sprafkin, 1999).  
 
Both the CASI-5 and the YI-4R were locally adapted for use in Uganda by the CHAKA study 
team (Mpango et al., 2017). The assessment tools were administered by trained psychiatric 
nurses and psychiatric clinical officers at two time points (baseline and 12 months). The CASI-
5 and YI-4R list the symptoms of a wide range of psychiatric disorders including major 
depressive disorder, generalized anxiety disorder, PTSD and attention-deficit/hyperactivity 
disorder, among others. Individual CASI-5 items are rated on a 4-point frequency of occurrence 
scale ranging from never (0) to very often (3). Though there are several CASI-5 scoring 
algorithms, in the present study we used symptom count cut-off scores that reflect the 
prerequisite number of symptoms for a clinical diagnosis.  
 
At each study visit, 4 ml of blood was withdrawn from each study participant by venipuncture 





4.3.4 Inclusion and exclusion criteria  
The following were the inclusion and exclusion criteria for the CHAKA study: 
Inclusion criteria: i) HIV-infected outpatients, registered with an HIV clinic at any of the study 
sites; ii) aged between 5 and 17 years at the time of enrolment; iii) conversant in English or 
Luganda, the language into which research assessment tools were translated; and iv) able to 
provide written informed consent (caregiver) and assent (adolescents).  Exclusion criteria: i) 
seriously ill ii) being unable to understand study procedures.  
 
4.3.5 Ethical considerations  
Both CHAKA and the present study were conducted in compliance with the Code of Ethics of 
the World Medical Association (Declaration of Helsinki). The CHAKA study obtained ethical 
and scientific clearance from the Uganda Virus Research Institute’s Science and Ethical 
Committee (# GC/127/15/06/459) and the Uganda National Council of Science and 
Technology (# HS 1601). The present study obtained approval from the Higher Degrees 
Research & Ethics Committee of the School of Biomedical Sciences, Makerere University (# 
SBS 421) and the Health Research Ethics Committee of Stellenbosch University (# 
S17/09/179). All caregivers provided informed consent for their children / adolescents to 
participate in the study and for a blood specimen to be drawn from them (child/adolescent) for 
genetics analyses. Adolescents further provided informed assent to participate in the study. 
Study participants who were diagnosed with significant psychiatric problems were referred to 
mental health units at Entebbe and Masaka government hospitals. 
 
4.3.6 Selection of cases and controls 
All baseline cases of IMDs (n = 368) in the CHAKA study were considered and thus cases 
were HIV+ children and adolescents who had any IMD. All cases at baseline were ascertained, 
and the cases were then stratified by site (one of two sites), sex, age category (one of three 
categories) and SES (one of three SES categories). This resulted in a total of 36 strata (2 x 2 x 
3 x 3). In each stratum the number of cases was ascertained (e.g. for males in site 1 in the 
youngest age category and the lowest SES group there were 9 cases). An equal number of 
controls (HIV+ children and adolescents without any psychiatric disorder) were then randomly 
sampled from the stratum concerned (so for males in site 1 in the youngest age category and 
the lowest SES group we sampled 9 controls), thus the controls were frequency matched to the 




4.3.7 DNA extraction 
Archived whole blood samples were retrieved and DNA was extracted from each retrieved 
sample using the QiAmp Mini DNA Extraction Kit according to manufacturer’s instructions 
(Qiagen GmbH, Germany).    
 
4.3.8 Determining SLC6A4 genotypes 
All polymerase chain reactions (PCR) for SLC6A4 polymorphisms were performed in a 
GeneAmp PCR System 9700 (Perkin Elmer Biosystems, Foster City, CA, USA). PCR was 
carried out in 25 μl reaction volumes containing: DNA template, 200 μM dNTP (Kapa 
Biosystems, Cape Town, South Africa), 5 μl of 10X Taq DNA polymerase buffer (Kapa 
Biosystems), 1.0 mM magnesium chloride (Kapa Biosystems), 0.625 units (U) Taq DNA 
polymerase (Kapa Biosystems), and 0.5 μM of each primer (Integrated DNA Technologies, 
Coralville, Iowa, United States), with bi-distilled water.  
 
The 5-HTTLPR, 5-HTTLPR-rs25531 and STin2 VNTR polymorphisms were genotyped 
following a procedure described by Kalungi et al. (2017). Fragment sizes revealed by PCR 
were confirmed by restriction fragment length analysis on the ABI prism. Expected fragment 
sizes of the alleles at the 5-HTTLPR-rs25531 locus were as follows: S-A = 281 bp, L-A = 325 
bp and S-G-L-G = 151 bp, resulting into the following genotypes: S-A-S-A = 281 bp; L-A-L-A 
= 325 bp; S-G-S-G, L-G-L-G, L-G-S-G = 151 bp; L-G-S-A = 151 bp + 281 bp and L-A-S-G, L-
A-L-G = 325 bp + 151 bp. Expected fragment sizes of the alleles at the STin2 VNTR locus 
were as follows: 9-repeat (STin2.9) = 250 bp, 10-repeat (STin2.10) = 265 bp and 12-repeat 
(STin2.12) = 300 bp, resulting in the following genotypes: 9/9 = 250 bp, 9/10 = 250bp + 265bp, 
9/12 = 250 bp + 300 bp, 10/10 = 265 bp, 10/12 = 265 bp + 300bp, and 12/12 = 300 bp. 
 
4.3.9 Determining genotypes for selected SNPs in tryptophan hydroxylase 2 gene 
DNA samples were quantified and sent to LGC laboratory (LGC, Middlesex, United Kingdom) 
for automated SNP genotyping using the kompetitive allele-specific PCR (KASP) assay. 
Genotypes were determined for TPH2 rs1843809, rs1386494, rs4570625 and rs34517220. 
However none of these genotypes were validated. 
 
Because the Bantu group of people in East Africa have been reported to genetically cluster 
together as per principal components analysis (Unpublished results on NeuroGAP data, 




0.1 was set for each selected SNP based on the Luhya, a population that belongs to same Bantu 
group as the population of the present study. The minor allele frequency data were obtained 
from an online genomic project (Clarke et al., 2017). 
 
4.3.10 Haplotype analyses 
We used Haploview version 4.2 (Barrett, 2009) to analyze for linkage disequillibrium (LD).  
SLC6A4 analyses included 5-HTTLPR, rs25531 and STin2 VNTR polymorphisms. As 
Haploview relies on allelic discrimination, the 5-HTTLPR and STin2 VNTR were coded as 
dummy variables i.e. S = 1, L = 2 and STin2.10 = 1 and STin2.12 = 2. As very few participants 
carry the STin2.9 allele (n = 6), these participants were coded as missing STin2 VNTR data. 
TPH2 analyses included the three alleles genotyped. Participants with more than 50% missing 
genotypes were excluded from the analysis, yielding data from 692 participants for each of the 
SLC6A4 and TPH2 analyses. None of the investigated TPH2 polymorphisms were in LD while 
SLC6A4 5-HTTLPR and rs25531 were in LD (Supplementary materials, Figures S4.1 and 
S4.2). 
 
4.3.11 Generation of acute and chronic stress class categories 
Social disadvantage variables were grouped into an index of acute and chronic stress. Caregiver 
mental state (assessed as psychological distress using the Self-report Questionnaire-20 
(Beusenberg, Orley & World Health Organization, 1994)), child–caregiver relationship 
(assessed as child-caregiver interactions, using data on how often the caregiver i) beats, ii) 
insults, iii) spanks or iv) yells at the child/adolescent) and HIV symptoms were grouped 
together to constitute ‘acute stress’ and orphanhood, study site (urban vs rural) and caregiver 
level of education as variables constituting ‘chronic stress’. Variables were scored on a 
disadvantage scale where, for example, double orphanhood carried a higher chronic stress score 
vs. single orphanhood or not orphaned; food availability: not enough food carried a higher 
chronic stress score vs. enough food; study site: urban carried a higher chronic stress score than 
rural; and caregiver level of education: no formal education carried a higher chronic stress 
scores than primary and primary a higher stress score than secondary etc. Hierarchical cluster 
analysis using Statistica 13.5 software (TIBCO, CA, USA), Euclidian distance, as distance 
measure and Ward’s method for clustering (Ward, 1963), was used to generate the different 





The acute stress index ranged from 0 to 2.46, with a normal distribution, while the chronic 
stress index ranged from 0 to 3.75, with a normal distribution as well. A total of 3 classes were 
generated for each type of stress by the hierarchical cluster analysis i.e. mild, moderate and 
severe. For acute stress, the mild class had an acute stress score of less than 0.362, the moderate 
class a score of 0.362 to 0.622, while the severe class a score of greater than 0.622. For chronic 
stress, the mild class had a chronic stress score of less than 1.375, the moderate class a score 
of 1.375 to 2.375, while the severe class a score of greater than 2.375. 
 
4.3.12 Power of the study 
Using Stata 15 (StataCorp, TX, USA) software, we did a post hoc power calculation. Given a 
case-control ratio of 1:1, and assuming a zero correlation of exposure between cases and 
controls, a probability of 0.5 of exposure among controls at a 0.05 significance level, and an 
expected odds ratio at least 1.8 for IMDs under severe acute stress, we needed 188 cases to 
achieve a power of 80% (Lachin, 1992). Our sample of 368 cases was therefore adequately 
powered. 
 
4.3.13 Statistical methods 
Statistical analyses were conducted using Stata 15 (StataCorp, TX, USA). Socio-demographic 
characteristics were compared between cases and controls. SES was generated from a scale of 
9 household items owned (car, motorcycle, refrigerator, electricity, bicycle, radio, telephone, 
cupboard and flask). Each item was weighted in the respective order, a car carrying a maximum 
weight of 9 and a flask a minimum weight of 1. A total score of items was generated; with a 
median value of 13. A score less than 13 was classified as low SES while that greater than 13 
was classified as high SES. A T-test was used to compare the distribution of cluster of 
differentiation 4 (CD4) counts between cases and controls. We computed 95% confidence 
intervals and statistical significance was set at a p-value less than or equal to 0.05.  
 
Genotype distributions were compared between cases and controls. Likelihood-ratio tests were 
used to test genotypes for the Hardy-Weinberg equilibrium (HWE) in both cases and controls. 
Logistic regression was used to assess the relationship between TPH2 rs1843809 and IMDs 
(Equation for the model was Y = β0 + β1X1, where, Y = IMDs, β0 = constant, X1 = rs1843809, 
and β1 = coefficient for rs1843809). Logistic regression models were used to assess the 
relationship between acute stress and IMDs (Equation for the model was Y = β0 + β1X1, where, 





The moderating effect of chronic stress on the association between acute stress and IMDs was 
assessed by comparing logistic regression models of the association between acute stress and 
IMDs with and without chronic stress. Interactions between acute stress and chronic stress were 
tested using a likelihood-ratio test (equation for the model was Y = β0 + β1X1 + β2X2 + β3X1X2, 
where Y = IMDs, β0 = constant, X1 = acute stress, X2 = chronic stress and β1 to β3 are the 
coefficients for acute stress, chronic stress and the interaction term respectively). 
 
The moderating effect of each genotype for each of the selected polymorphisms on the 
association between acute stress and IMDs was also assessed by comparing logistic regression 
models of the association between acute stress and IMDs with and without the polymorphism 
controlling for chronic stress.  Interactions between acute stress and each of the polymorphism 
were tested using a likelihood-ratio test, controlling for chronic stress (equation for the model 
was Y = β0 + β1X1 + β2X2 + β3X3 + β4X1X2, where, Y = IMDs, β0 = constant, X1 = acute stress, 
X2 = polymorphism/SNP, X3 = chronic stress and β1-β4 are the coefficients for acute stress, the 
polymorphism/SNP, chronic stress and the interaction respectively). These interaction models 
were performed on all the explanatory variables even without observing significant main 
effects in order to rule out the possibility of cross over interaction where significant interactions 
may be observed for non-significant main effects. Three-way interactions of acute stress, 
chronic stress and any selected polymorphism on IMDs were not assessed as the two-way 
models were better than the three-way models. The 95% confidence intervals were calculated 
for all analyses.  
 
4.4 Results 









Table 4.1: Distribution of socio-demographic factors in cases and controls 
Variable (n) Case n (%) Control n (%) p-value 
Sex         
            Male (342) 









Site         
              Urban (415) 









Age         
      7-11 years (389)   
     12-17 years (307) 
 
 
  202 (57.6) 






     No formal education (13) 
      Primary (648) 
     Secondary (72) 











               Low  (332) 
















CD4, cluster of differentiation 4; primary, 0 – 7 years of formal education; Secondary, 8 – 14 
years of formal education; Low socioeconomic status, 0 – 13; High socioeconomic status, > 
13. All numbers that do not add up to the total of 736 participants were due to missing data. 
 
The HWE p-values among cases and controls for each polymorphism are shown in Table 4.2. 
None of the genotype distributions deviated significantly from HWE among controls except 
for rs1386494, which was thus removed from further analysis. For investigated SLC6A4 
polymorphisms, 5-HTTLPR was in LD with rs25531 (see Supplementary Material Figure 
S4.1), while for TPH2 SNPs, none of the polymorphisms were in LD (see Supplementary 
Material Figure S4.2). The association between each investigated polymorphism and IMDs is 
shown in Table 4.2. Participants with TPH2 rs1843809 TG and TT genotypes were protective 





Table 4.2: Distribution and Hardy-Weinberg analysis of genotypes between cases and 
controls for selected polymorphisms in SLC6A4 and TPH2 






5-HTTLPR (n =698)                                                                       0.286 0.323 0.1916 
LL 223 (62.3) 231 (67.9)    
LS 115 (32.1) 94 (27.7)    
SS 20 (5.6) 15 (4.4)    
rs25531 (n =685)                                                                            0.988 0.795 0.641 
AA 227 (65.4) 221 (65.4)    
AG 108 (31.1) 106 (31.4)    
GG 12 (3.5) 11 (3.2)    
5-HTTLPR-rs25531 haplotype (n = 685)                                   0.688 N/A N/A 
L-A-L-A 130 (37.4) 136 (40.2)    
L-A-L-G 76 (21.9) 82 (24.3)    
L-A-S-A 79 (22.8) 71 (21.0)    
L-A-S-G 2 (0.6) Absent    
L-G-L-G 12 (3.5) 11 (3.3)    
S-A-S-A 18 (5.2) 15 (4.4)    
S-A-L-G 30 (8.6) 23 (6.8)    
STin2 VNTR (n = 687)                                                                   0.203 0.090 0.440 
10/10 26 (7.5) 28 (8.8)    
10/12 126 (36.3) 112 (35.3)    
12/12 189 (54.5) 177 (55.9)    
9/9 5 (1.4) Absent    
9/12 1 (0.3) Absent    
rs1843809 (n = 686)   0.003 0.009 0.537 
TT 105 (30.1) 113 (33.5)    
TG 150 (43.0) 169 (50.2)    
GG 94 (26.9) 55 (16.3)    
rs1386494 (n = 685)   0.06 0.956 0.007 
GG 210 (59.7) 202 (60.7)    
GA 124 (35.2) 125 (37.5)    
AA 18 (5.1) 6 (1.8)    
rs34517220 (n = 
685) 
  0.945 0.557 0.913 




AG  170 (48.4) 166 (49.7)    
GG  91 (25.9) 84 (25.2)    
rs4570625 (n = 683)   0.574 0.787 0.229 
GG  88 (25.2) 90 (26.9)    
GT  177 (50.7) 156 (46.7)    
TT  84 (24.1) 88 (26.4)    
5-HTTLPR = serotonin transporter linked polymorphic region, STin2 VNTR = Serotonin 
transporter intron 2 variable number of tandem repeats, HWE = Hardy-Weinberg 
equilibrium, N/A = not applicable. P-value* = p-value for association of each investigated 
polymorphism with IMDs. 
Table 4.3: Association between tryptophan hydroxylase 2 gene rs1843809 and 
internalizing mental disorders 
IMDs Odds ratio P>|Z| 95% confidence interval 
rs1843809 GG Reference 
rs1843809 TG 0.52 0.001 0.349 – 0.774 
rs1843809 TT 0.54 0.005 0.355 – 0.832 
IMDs = internalizing mental disorders. 
 
Table 4.4 determines the association between acute stress and IMDs while table 4.5 determines 
the independent effect of chronic stress and SLC6A4 polymorphisms on the association seen 
in Table 4.4 (between acute stress and IMDs). A significant association was observed between 
acute stress and IMDs (Table 4.4). 
Table 4.4: Association between acute stress and IMDs 
Acute stress class OR (IMDs) P > |Z| 95% CI P-value 
Mild Reference    
Moderate 1.1 0.687 0.758 – 1.523 0.001 
Severe 1.9 0.001 1.298 – 2.651  
OR = odds ratio; IMDs = internalizing mental disorders, CI = confidence interval 
 
Apart from the 5-HTTLPR-rs25531 haplotype (Table 4.5), we found no significant interactions 
between acute stress and any of the investigated polymorphisms on IMDs (supplementary 
materials, Table S4.1). Significant interactions between acute and chronic stress (p = 0.033) 




IMDs (Table 4.5). The odds of an IMD were 4.3 times higher among participants under both 
severe acute stress and severe chronic stress as compared to those under mild acute stress and 
mild chronic stress (Table 4.5). The odds for being a case of an IMD were 14.8 times higher in 
participants with the S-A-S-A haplotype with moderate acute stress compared to participants 
with the L-A-L-A haplotype and mild acute stress. Similarly, the odds of having an IMD were 
11.95 times higher in S-A-S-A participants with severe acute stress compared to L-A-L-A 
participants with mild stress (Table 4.5). 
 
Table 4.5: Logistic regression analyses for the interaction of acute stress with 5-
HTTLPR-rs25531 and chronic stress respectively on IMDs 
Model Variable Odds 
ratio 





Mild acute stress Reference   0.046a 
Moderate acute stress 1.22 0.282 0.848 - 1.761 










Mild AS*L-A-S-G 1    0.049b 
Moderate AS*L-A-L-G 2.52 0.022 1.142 – 5.540 
Moderate AS*L-A-S-A 1.60 0.235 0.736 – 3.497 
Moderate AS*L-A-S-G 0.63 0.124 0.351 – 1.135 
Moderate AS*L-G-L-G 0.83 0.870 0.092 – 7.535 
Moderate AS*S-A-L-G 1.48 0.563 0.395 – 5.500 
Moderate AS*S-A-S-A 14.83 0.030 1.294 -170.010 
    
Severe AS*L-A-L-G 3.72 0.002 1.630 – 8.474 
Severe AS*L-A-S-A 2.82 0.013 1.248 – 6.350 
Severe AS*L-A-S-G 1.16 0.629 0.641 – 2.091 
Severe AS*L-G-L-G 0.85 0.872 0.121 – 6.010 
Severe AS*S-A-L-G 1.58 0.493 0.426 – 5.881 
Severe AS*S-A-S-A 11.95 0.011 1.755 –81.331 
Including 
chronic stress 
Acute stress*Chronic stress 
 Moderate AS*moderate CS 1.04 0.896 0.607- 1.768 0.033c 
 Moderate AS*severe CS 1.80 0.035 1.041 – 3.106 
     
 Severe AS*moderate CS 0.95 0.904 0.406 – 2.217 
 Severe AS*severe CS 4.28 0.001 1.832 – 
10.012 
AS = acute stress, CS = chronic stress, Acute stress*5-HTTLPR-rs25531 = interaction between 
acute stress and 5-HTTLPR-rs25531 genotypes on IMDs, a = the model without chronic 




5-HTTLPR-rs25531 on IMDs, c = p-value for the likelihood-ratio test of interaction between 
acute stress and chronic stress on IMDs. 
 
4.5 Discussion 
This study investigated the association between acute stress and IMDs, and whether this 
association is moderated by chronic stress, or genetic variants in SLC6A4 and TPH2. To our 
knowledge, this is the first sub-Saharan African study to investigate these interactions among 
HIV+ children and adolescents. Results revealed a statistically significant association between 
acute stress and IMDs. This association was found to be moderated by 5-HTTLPR-rs25531 in 
a haplotype-dependent manner. Specifically, in comparison to L-A-L-A haplotype carriers with 
experience of mild acute stress, individuals carrying the S-A-S-A haplotypes were more likely 
to have an IMD under conditions of moderate and severe acute stress. We found no evidence 
for a significant combined interaction of acute stress, chronic stress and 5-HTTLPR-rs25531 
on IMDs. 
 
Stress represents a prevalent environmental risk factor for many mental disorders, including 
depression and anxiety (Popoli et al., 2012; de Kloet et al., 2005). Acute stress has been 
reported to be associated with the likelihood of developing IMDs among samples of adolescent 
school children and exposed adult disaster workers (Brown et al., 2016; O'Connor, Rasmussen, 
& Hawton, 2010; Fullerton, Ursano & Wang, 2004). In line with previous studies, where acute 
stress has been associated with IMDs such as depression and PTSD (Fullerton, Ursano & 
Wang, 2004), and anxiety (Grillon et al., 2007), we found that risk for IMDs increased with 
increasing acute stress and was highest for severe acute stress. Chronic stress was found to 
significantly moderate the association between acute stress and IMDs. Previous studies have 
reported on chronic stress as a risk factor for IMDs (Adelman et al., 2014; Evans, Li, & 
Whipple, 2013; Revenson et al., 2016; Robles, Slatcher, Trombello, & McGinn, 2014; de Kloet 
et al., 2005; Charney & Manji, 2004). Vulnerability to IMDs by chronic stress (through 
interaction with acute stress) could be due to alterations in the functioning of the HPA that 
follow exposure to chronic stress (de Kloet et al., 2005; Fuchs & Flïugge, 2006). In addition, 
chronic stress has been reported to affect serotonergic signaling in the brain (van den Buuse & 
Hale, 2019). As serotonergic systems have been implicated in threat appraisal, 
psychophysiological measures of stress response (skin conductance and startle reactions), and 
attentional bias to negative stimuli, it is possible that alterations in 5-HT signaling due to 




(Klumpers et al., 2015; Klumpp et al., 2014; Pergamin-Hight, Bakermans-Kranenburg, van 
IJzendoorn, & Bar-Haim, 2012).  
 
In contrast to previous findings of associations between 5-HTTLPR and STin2 VNTR and 
IMDs (Xiao et al., 2019; Wang et al., 2016; Smoller et al., 2016; Gressier et al., 2013; Evans, 
Li & Whipple, 2013; Zhao et al., 2012; Battersby et al., 1996), we found no direct association 
between any of the investigated SLC6A4 polymorphisms and IMDs. This may be due to the 
complex genetic etiology of IMDs, where the combination of individual genetic variants each 
of small effect size ultimately contributes to the risk of developing an IMD (Plomin & Davis, 
2009) and thus the effect of one gene may not be strong enough to show significant association. 
Indeed, studies examining the contributions of 5-HTTLPR and STin2 variants have yielded 
inconsistent results with other previously published work similarly failing to find a significant 
association (Xiao et al., 2019; Culverhouse et al., 2018; Munafò et al., 2009a; Munafò et al, 
2009b). In order to resolve these contradictory results, studies looking at the effect of more 
than one gene (GWAS) are required. 
 
Based on the diathesis-stress hypothesis of neuropsychiatric disorders, we postulated that the 
association between acute stress and IMDs would be moderated by genetic polymorphisms, 
chronic stress or a combination of genetic polymorphisms and chronic stress. Results revealed 
chronic stress and the 5-HTTLPR-rs25531 S-A-S-A haplotype to each significantly moderate 
the association between acute stress and IMDs.  
 
The interaction between the 5-HTTLPR and stress has previously been investigated in gene-
environment studies of IMDs (Sharpley et al., 2014; Karg, Burmeister, Shedden & Sen, 2011). 
In contrast to previous studies that have reported the moderating role of 5-HTTLPR on the 
association between stress and IMDs (Conway, Slavich & Hammen, 2014; Sharpley et al., 
2014; Karg, Burmeister, Shedden & Sen, 2011; Caspi et al., 2003), we found no significant 
moderating effect of  5-HTTLPR on the association between acute stress and IMDs.  However, 
our results revealed that the combined 5-HTTLPR-rs25531 haplotype significantly moderates 
the association between acute stress and IMDs. These results revealed the S-A-S-A genotype as 
a vulnerability factor for IMDs. HIV+ children who experienced moderate and severe acute 
stress and possessed the S-A-S-A haplotype were more likely to have an IMD, compared to 




Previous studies have reported the SS genotype to be a risk for different IMD 
psychopathologies including depression (Cervilla et al., 2007; Zalsman et al., 2006; Haberstick 
et al., 2016), anxiety (Armbruster et al., 2009) and IMDs in general (Conway, Slavich & 
Hammen, 2014).  Contrary to meta-analyses that found the S-allele to confer risk for depression 
in subjects experiencing stressful life events (Sharpley et al., 2014; Karg, Burmeister, Shedden 
& Sen, 2011), we found no association between the SS genotype and IMDs in the present study 
and this observation could be due to low power to detect the effect of 5-HTTLPR on the 
association between acute stress and IMDs among our study participants. Our study sample 
size archived a post hoc power of greater than 80% under assumption that there was zero 
correlation of exposure between cases and controls and that the probability of exposure among 
controls was 0.5. There is however a possibility that the probability of exposure could have 
been less than 0.5 among controls, thus reducing the power for the present study. The 
association between SS genotype and IMDs has been suggested to be due to its lower 
transcriptional activity (Seripa et al., 2013; Iurescia et al., 2012; Hu et al., 2006; Baca-García 
et al., 2002). Future functional studies that examine the functional effects of the S-A-S-A 
compared to the L-A-L-A haplotype would be required for us to determine whether lower 5-
HTT levels are driving our results. 
 
A significant association was observed between TPH2 rs1843809 and IMDs. The functional 
role of TPH2 rs1843809 is currently not known.  Being an intronic variant, it is less likely that 
rs1843809 would have marked effect on TPH2 expression or TPH2 structure, as introns are 
spliced during mRNA processing, although potential effects of intronic variants have been 
suggested (Kleinjan & van Heyningen, 2005). It is also possible that rs1843809 is in linkage 
disequilibrium with a causal variant. For example, rs1843809 is in LD with a missense 
rs142055199 SNP among the Luhya, a population that speaks the same Niger-Congo language 
as the population of the present study (Baganda) (Countries & their cultures, 2019). East 
African populations that speak this class of language have been found to be genetically similar 
by principal components analysis on GWAS data from NeuroGAP pilot study (Unpublished 
results provided by Anne Stevenson & Elizabeth Atkinson). The rs142055199 is located in the 
zinc finger C3H1-type containing gene, which modulates interleukin-8 (IL-8) transcription 
(National Center for Biotechnology Information, 2019). Modulation of IL-8 would be of 
interest since IMDs have been associated with inflammatory processes (Wang et al., 2019; Hori 
& Kim, 2019; Musinguzi et al., 2018; Miller, Maletic & Raison, 2009). Further studies will be 





None of the investigated polymorphisms in TPH2 moderated the association between acute 
stress and IMDs. This suggests that although TPH2 is critical in 5-HT biosynthesis (Carkaci-
Salli et al., 2006; Walther et al., 2003), genetic variants may either not necessarily moderate 
an individual’s response to stress or that the investigated polymorphisms may not be the causal 
polymorphisms that moderate an individual’s response to stress.  
 
4.6 Limitations and recommendations 
Although we found the association between acute stress and IMDs to be moderated via 
vulnerability as we had hypothesized, our study presents with the following limitations. We 
defined IMDs as having any depressive disorder, anxiety disorder or PTSD. As much as anxiety 
and PTSD are commonly comorbid with depression, the inclusion of PTSD (n = 60) is 
contentious as it has been excluded from the IMD category in the Diagnostic and Statistical 
Manual of Mental Disorders – 5th edition (DSM-5) (American Psychiatric Association, 2013).  
Although the inclusion of PTSD samples allowed the present study to achieve the desired 
statistical power, a low correlation between genetic risk factors for PTSD and those of 
depression and anxiety would reduce the power to detect true significant associations and 
interactions. Future studies should endeavor to stratify analyses according to IMD although 
this will require larger sample sizes. In addition, both acute and chronic stress indices were 
measured using a number of context-specific indicators. This approach was adopted because 
there is no locally adapted tool for assessing such in this setting and the variables used to 
generate these indices are known stressors in this population. However, this tool remains to be 
validated. Moreover, we did not control for population stratification at analysis. The study 
participants belong to the Bagandan population group, for which principal components analysis 
on a GWAS sample of over 4,700 individuals has shown that they are genetically similar 
(unpublished data).  There is, however, a possibility that some participants were not Bagandan 
even though they could speak Luganda (the main language of Baganda), indicating that we 
may have had an admixed sampled. Future studies should therefore control for population 
stratification, in order to circumvent confounding of results due to possible ancestry associated 
differences in genetic architecture. Also, due to the exploratory nature of the study, multiple 
testing corrections were not done.  Correcting for multiple testing would have rendered the 
interaction analysis non-significant. We therefore acknowledge the dangers of false positive 







Acute stress was found to be associated with an increased risk of IMDs, and this association 
was found to be moderated by the 5-HTTLPR-rs25531 S-A-S-A haplotype and chronic stress 
among Ugandan HIV+ children and adolescents. These results support the diathesis-stress 
model, though the mechanisms through which acute stress interacts with 5-HTTLPR-rs25531 
S-A-S-A haplotype to moderate the risk of IMDs need to be elucidated. This will allow for 
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Figure S4.1 
LD plot showing linkage disequilibrium (LD) for SLC6A4 5-HTTLPR, rs25531 and STin2 VNTR 
 
Linkage disequilibrium map of SLC6A4. D’ values are depicted in the diamonds with darker colors 
depicting stronger LD. The LD map was created using the default Gabriel LD (Gabriel et al., 2002), 
implemented in Haploview, version 4.2 (Barrett, 2009). 1 = rs25531, 2 = 5-HTTLPR, 3 = STin2 
VNTR. 5-HTTLPR and rs25531 were in LD. Location = 5’ to 3’ on chromosome 17. 
Figure S4.2 
 
Linkage disequilibrium map of TPH2. D’ values are depicted in the diamonds with darker colors 
depicting stronger LD. The LD map was created using the default Gabriel LD  
(Gabriel et al., 2002), implemented in Haploview, version 4.2 (Barrett, 2009). 1 = rs4570625, 2 = 
rs1843809 and 3 = rs34517220. None of the SNPs were in LD. Location = 5’ to 3’ strand on 






Table S4.1: Logistic regression analysis for the interaction of acute stress on selected 
serotonin transporter gene and tryptophan hydroxylase 2 gene polymorphisms on IMDs 
Model Variable Odds 
ratio 
P>|Z| 95% CI P-value 
Excluding any 
polymorphism 
Mild acute stress Reference   0.046ƒ 
Moderate acute stress 1.22 0.282 0.848 - 1.761 





 Moderate AS*GA 1.17 0.889 0.125 – 11.004 0.786ƒ 
 Moderate AS*GG 1.88 0.574 0.208 – 17.067 
     
 Severe AS*GA 0.73 0.808 0.056 – 9.508 
 Severe AS*GG 0.94 0.963 0.074 – 11.990 
Including 
rs1843809 
Acute stress*rs1843809     
 Moderate AS*TG 1.93 0.174 0.750 – 4.951 0.198ƒ 
 Moderate AS*TT 3.07 0.031 1.110 – 8.490  
      
 Severe AS*TG 0.99 0.988 0.359 – 2.743  
 Severe AS*TT 1.89 0.253 0.635 – 5.634  
Including 
rs34517220 
Acute stress*rs34517220     
 Moderate AS*GA 1.31 0.544 0.544 – 3.177 0.927ƒ  
 Moderate AS*GG 1.48 0.459 0.527 – 4.138  
      
 Severe AS*GA 1.37 0.491 0.557 – 3.378  
 Severe AS*GG 1.23 0.685 0.446 – 3.419  
Including 
rs4570625 
Acute stress*rs4570625     
 Moderate AS*TG 2.26 0.073 0.926 – 5.532 0.390ƒ  
 Moderate AS*TT 2.41 0.085 0.886 – 6.568  
      
 Severe AS*TG 1.35 0.507 0.554 – 3.299  
 Severe AS*TT 1.21 0.719 0.423 – 3.480  
Including 
rs25531 
Acute stress*rs25531     
 Moderate AS*2 1.88 0.117 0.853 – 4.153 0.487ƒ 
 Moderate AS*3 0.77 0.815 0.082 – 7.172  
      
 Severe AS*2 1.46 0.362 0.647 – 3.298  






Acute stress*5-HTTLPR     
 Moderate AS*LS 1.47 0.346 0.662 – 3.246 0.463ƒ 
 Moderate AS*SS 3.08 0.269 0.419 – 22.654  
      
 Severe AS*LS 1.31 0.521 0.577 – 2.958  
 Severe AS*SS 4.15 0.133 0.647 – 26.574  
Including 
STin2.VNTR 
Acute stress*STin2.VNTR     
 Moderate AS*10/12 1.79 0.432 0.419 – 7.625 0.203ƒ 
 Moderate AS*12/12 1.76 0.429 0.434 – 7140  
      
 Severe AS*10/12 0.53 0.429 0.106 – 2.592  
 Severe AS*12/12 1.14 0.868 0.239 – 5.450  
AS = acute stress, * = interaction, ƒ = p-value for the likelihood-ratio test of interaction 







5.1 Conceptualization of the present study 
Despite the high prevalence of IMDs and the considerable impact they exert on quality of life, 
their etiology remains poorly understood. Stressful life events have been reported to play a 
primary role in the development of depression (Lan, Jia, Lin & Liu, 2019; Cohen et al., 2019; 
Slavich & Irwin, 2014; Hammen & Rudolph, 2003; Kinyanda et al., 2017), anxiety (Miloyan 
et al., 2018; Sheerin et al., 2018; Abbo et al., 2013), and PTSD (Frewen, Zhu & Lanius 2019; 
Bernstein et al., 2005).  
 
The diathesis-stress hypothesis of neuropsychiatric disorders postulates that a lower stress 
threshold is required for psychiatric disease to occur in individuals who harbor certain 
vulnerability factors, which may be genetic and/or acquired (Caspi et al., 2003; Silberg et al., 
2001; Monroe & Simons, 1991). IMDs are heritable, with twin studies indicating an estimated 
genetic heritability of 30–67% (Otte et al., 2016; Smoller et al., 2016; Domschke & Maron, 
2013; Hettema, Neale & Kendler, 2001). However, the genetic risk factors that underlie this 
heritability are currently not conclusively known. The diathesis-stress hypothesis asserts that 
acute stress may interact with underlying genetic risk and result in disease (Monroe & 
Simmons, 1991), hence the importance of studying gene-environment interactions in stress-
related disorders like IMDs (Sharma, Powers, Bradley & Ressler, 2016). 
  
In sub-Saharan Africa, research has been undertaken to understand acquired vulnerability to 
acute stress in the context of IMDs (Kinyanda et al., 2017, 2013, 2011a, b; Abbo et al., 2013). 
However, there has been less focus on investigating the genetic vulnerability factors (Popejoy 
& Fullerton, 2016; Dalvie et al., 2015). Investigating genetic and environmental vulnerability 
(risk) for IMDs amongst African populations is urgently needed: expanding psychiatric 
genetics studies to include populations of more diverse ancestries will allow a more 
comprehensive insight into the genetic architecture of IMDs. In particular, African genomes 
hold a high percentage of private alleles which could be useful in fine-mapping of disease-
causing alleles (Campbell & Tishkoff, 2008). To understand the genetic and environmental risk 
for IMDs in an African population, we elected to study acquired and genetic contributors to 




5.2 Utility of the measure of acute and chronic stress in the present study 
The variables used to create the acute stress index (caregiver mental state, child-caregiver 
relationship and HIV symptoms) and the chronic stress index (orphanhood, having enough 
food, study site and caregiver level of education) in the present study have been shown to be 
associated with IMDs among both children and adolescents in Uganda. For example, food 
security, study site (rural vs. urban) and adverse life events have been associated with increased 
risk for depression among HIV+ adults in Uganda (Kinyanda et al., 2011b, 2017). Similarly, 
living without parents, low parental education levels, guardian unemployment and study site 
were associated with increased risk for both depression and anxiety disorders among children 
and adolescents in Uganda (Abbo et al., 2013; Kinyanda et al., 2011a). In addition, lower CD4 
nadir was a significant predictor of incident depression among participants of the present study 
(Kinyanda et al. submitted to AIDS and Behavior).  
 
In order to generate the acute stress and chronic stress classes in the present study, hierarchical 
cluster analysis was employed. This is an algorithm that groups similar objects into clusters 
whereby each cluster differs from another and the objects within each cluster are nearly similar 
(Ward, 1963). The acute stress index ranged from 0 to 2.46, with a normal distribution, while 
the chronic stress index ranged from 0 to 3.75, with a normal distribution as well. A total of 3 
classes were generated for each type of stress by the hierarchical cluster analysis i.e. mild, 
moderate and severe. For acute stress, the mild class had an acute stress score of less than 0.362, 
the moderate class a score of 0.362 to 0.622, while the severe class a score of greater than 
0.622. For chronic stress, the mild class had a chronic stress score of less than 1.375, the 
moderate class a score of 1.375 to 2.375, while the severe class a score of greater than 2.375. 
 
The derived measure of acute stress associated with IMDs (p = 0.001) while the measure of 
chronic stress showed a trend towards significance (p = 0.067). As desired, these two measures 
were weakly positively correlated with each other (r = 0.157). The trend towards significance 
between the chronic stress index used in this study and IMDs probably reflects a poor fit of the 
variables used to constitute this index; these variables were selected a posteriori from the 
variables of the main CHAKA study. Despite this shortcoming, this approach could provide a 
mechanism of assessing stress in African settings, where culturally adapted measures are 




 5.3 Serotonin and reduced telomere length as likely candidates in internalizing mental 
disorders 
The serotonergic system in the CNS is important in regulating mood and anxiety (Olivier et 
al., 2015) and the 5-HTT is a target for SSRIs (Cipriani et al., 2018; Kristensen et al., 2011). 
We therefore elected to examine genetic variants relevant to 5-HT signaling and availability in 
the brain i.e. SLC6A4 and TPH2, which are responsible for serotonin reuptake and biosynthesis 
respectively (Carkaci-Salli et al., 2006; Walther et al., 2003).  
 
We based our additional analyses on TL shortening, which has been associated with IMDs of  
depression (Verhoeven et al., 2017; Lin, Huang & Hung, 2016; Schutte & Maouff, 2015; 
Garcia-Rizo et al., 2013; Verhoeven et al., 2014; Shalev et al., 2014; Douillard-Guilloux, 
Guiolloux, Lewis & Sibille, 2013; Kinser & Lyon, 2013), anxiety disorders (Verhoeven et al., 
2017; Verhoeven et al., 2015; Kananen et al., 2010) and PTSD (Avetyan, Zakharyan, Petrek 
& Arakelyan, 2019; Roberts et al., 2017; O’Donovan et al., 2011; Zhang et al., 2014), as well 
as frequent comorbid age-related diseases (Sanders & Newman, 2013). Compared with the 
general population, higher mortality rates have been reported among patients with IMDs (Pratt, 
Druss, Manderscheid & Walker, 2016; Druss et al., 2011; Colton & Manderscheid, 2006; 
Cuijpers & Smit, 2002). This higher mortality has been mainly attributed to age-related 
diseases, such as cancer, cardiac and cerebrovascular disease (Druss et al., 2011; Colton & 
Manderscheid, 2006; Cuijpers & Smit, 2002) amongst individuals with IMDs, and it has been 
suggested that IMDs may indeed be risk factors for these age-related diseases (Cohen et al., 
2015).  
 
Shorter telomeres have been described as a risk factor for many age-related chronic conditions 
(Sanders & Newman, 2013). The link between IMDs and these age-related diseases has been 
hypothesized to be mediated via biochemical processes of oxidative stress or inflammation (Yu 
& Woo et al., 2016; Lin et al., 2018), and pro-oxidative environments and inflammation have, 
in turn, been associated with telomere shortening (Wolkowitz et al., 2011a; Wolkowitz et al., 
2011b).  IMDs have been associated with inflammatory processes (Wang et al., 2019; Hori & 
Kim, 2019; Musinguzi et al., 2018; Miller, Maletic & Raison, 2009) and autonomic nervous 
system dysfunction (Kop et al., 2010).  Research on the role of TL in IMDs has attracted 
attention due to the comorbidity of age-related diseases and IMDs (Cohen et al., 2015). The 
nature of the association between TL and IMDs is unknown. Some studies have hypothesized 




have hypothesized that shorter TL and IMDs occur concurrently due to effects of exposure to 
stress (Needham et al., 2015; Zhang et al., 2014) or that TL shortening is due an effect of IMDs 
(Shalev et al., 2014; Schutte & Malouff, 2015; Yu & Woo, 2016). As TL attrition may be 
influenced by these same processes, and is associated with both age-related chronic conditions 
and IMDs, TL is a valid target for investigation in this study. 
 
The present study investigated the genetic and environmental risk for IMDs among Ugandan 
HIV+ children and adolescents, and the approach is based on the diathesis-stress model, 
whereby the risk of developing IMDs is predicated on the presence of vulnerability factors. We 
hypothesized that acute stress leads to IMDs through vulnerability (both genetic and or 
acquired). We investigated chronic stress as the acquired (environmental) vulnerability factor, 
while TL and selected polymorphisms within SLC6A4 and TPH2 were investigated as the 
genetic vulnerability factors. Since the nature of the association between TL and IMDs is 
largely unknown, we opted to investigate it prior to considering TL as a vulnerability factor. 
We hypothesized that the association between TL and IMDs (if any) would be moderated by 
the acquired vulnerability factor of chronic stress and genetic vulnerability by variations in 
TERT and TERC.  
 
5.4 Chronic stress moderates the association between acute stress and internalizing 
mental disorders 
In line with previous studies that have reported stress (Kinyanda et al., 2011a,b, 2013, 2017; 
Abbo et al., 2013; Popoli et al., 2012; de Kloet et al., 2005), acute stress disorder (O'Connor, 
Rasmussen, & Hawton, 2010; Fullerton, Ursano & Wang, 2004) and acute stress (Fullerton, 
Ursano & Wang, 2004; Grillon et al., 2007) as being among the risk factors for IMDs, we 
found a statistically significant association between acute stress (defined in Section 5.2 above) 
and IMDs (Chapter 4, Section 4.3). As expected, increasing acute stress increased the risk for 
IMDs among our study participants. Participants who experienced severe acute stress were 
twice more likely to be a case of IMDs as compared to participants who experienced mild acute 
stress (Chapter 4, section 4.3, Table 4.4). We further observed that the association between 
acute stress and IMDs was significantly moderated by chronic stress. As per the hypothesis 
that acute stress leads to IMDs through acquired vulnerability by chronic stress, severe chronic 
stress interacted with severe acute stress to significantly increase the likelihood of any IMD 
from 1.9 to 4.3. These results are in line with previous studies that have reported chronic stress 





This significant interaction is in agreement with our conceptual framework. HIV+ children and 
adolescents experience various chronic life stressors, such as awareness of their HIV-status, 
increased levels of stigma and poor parental mental health (Betancourt et al., 2014). These 
results could potentially explain the increased occurrence of IMDs among HIV+ children and 
adolescents. Elucidating the mechanisms by which chronic stress confers risk for IMDs could 
offer insights into biological pathways that lead to the development of these disorders. This is 
especially important, considering current challenges, including low efficacy and short windows 
of therapeutic benefit, in treating IMDs (Munkholm, Paludan-Müller & Boesen, 2019; 
Ollendick & King, 1994). For example, fluoxetine is the only antidepressant that might reduce 
depressive symptoms among children and adolescents (Ciprian et al., 2016), yet studies have 
reported a lack of difference between fluoxetine and placebo treated groups (Atkinson et al., 
2014; Emslie et al., 2014). Understanding pathways linking stress exposure and IMDs will 
facilitate the development of new drugs that can better address the symptoms of IMDs.  
 
5.5 Association between internalizing mental disorders and accelerated telomere length 
attrition: the role of chronic stress and genetic variations in telomerase reverse 
transcriptase and telomerase RNA component genes 
In the present study, mean TL at baseline was significantly different from mean TL at 12 
months among a combined sample (cases and controls) of the study participants (Chapter 2, 
Section 2.4). We investigated whether the difference in mean TL between cases and controls 
was moderated by genetic variation in genes implicated in TL biology, namely TERT and TERC 
(Blackburn, Geider & Szostak, 2006). Contrary to our hypothesis and previous studies that 
observed shorter TL among cases of IMDs (Avetyan, Zakharyan, Petrek & Arakelyan, 2019; 
Malouff & Schutte, 2017; Verhoeven et al., 2014, 2015, 2017; Lin, Huang & Hung, 2016; 
Garcia-Rizo et al., 2013; Shalev et al., 2014; Zhang et al., 2014; Douillard-Guiloux et al., 2013; 
Kinser et al., 2013; Kananen et al., 2010; O’Donovan et al., 2011), mean baseline TL was 
longer in cases compared to controls. We have no direct explanation for this observation 
although elevated telomerase levels have been reported among people with depression 
compared to healthy, age- and sex-matched controls (Simon et al., 2015; Chen et al., 2014; 
Wolkowitz et al., 2012; Damjanovic et al., 2007). A potential reason for this could therefore 
be due to increased levels of telomerase activity in individuals with IMDs, although this 




a compensatory effort to prevent the excessive shortening of telomeres that is associated with 
IMDs (Lin et al., 2012; Damjanovic et al., 2007). However, it would be prudent to conduct 
further studies in a similar setting to replicate our results. 
 
On investigating the association between IMDs and TL at 12 months, we found no statistically 
significant difference in mean TL between cases and controls. Given our results at baseline, we 
hypothesized that TL length reduced at an increased rate amongst cases compared to controls 
during the 12 months. It is not known whether the hypothesized accelerated telomere 
shortening is a direct effect of IMDs, whether the development of IMDs and hypothesized 
accelerated shortening of telomeres are simultaneous effects of increased stress exposure or 
whether accelerated telomere shortening is a risk factor for IMDs, as has been hypothesized by 
previous studies (Gotlib et al., 2015; Zhang et al., 2014). Our findings potentially suggest a 
causative role for IMDs in TL shortening, because TL reduced more rapidly in cases compared 
to controls, supporting the school of thought that accelerated shortening is a direct effect of 
IMDs (Yu & Woo, 2016; Lindqvist et al., 2015).  
 
It has been hypothesized that IMDs increase oxidative stress and chronic inflammation through 
either dysregulation of the HPA axis or by acting as a psychological stressor that elevates 
glucocorticoid hormones and lead to reduced antioxidants (Yu & Woo, 2016). Increased 
oxidative stress and chronic inflammation have been reported to cause TL shortening (Lin et 
al., 2018; Lindqvist et al., 2015; Wong et al., 2014; Wolkowitz et al., 2011a; von Zglinicki, 
2002). Despite elevated telomerase levels, faster TL attrition may occur among cases of IMDs. 
A recent review has hypothesized that accelerated TL attrition that is observed among cases of 
IMDs despite the elevated telomerase levels, could be brought about by a faster rate of attrition, 
which supersedes the rate at which telomerase lengthen telomeres (Lindqvist, Simon & 
Wolkowitz, 2019). Although our findings could be influenced by technical errors during 
determination of TLs, we had a fairly large sample size (n = 736) that allowed us to achieve a 
post hoc study power of over 83%, using the formula of sample size and power for difference 
in means in case–control studies, basing on a study by Epel et al., 2004. In order to control for 
intraplate variability, TL for each sample was measured in triplicate and standards were used, 
the slope of which was used to calculate the concentration vs Ct values. Standards were also 
repeated across plates in order to control for interplate variability. GenEx software (GenEx 
User Guide, 2012) was then used to control for both intra- and interplate variability 




correcting for PCR efficiency and normalizing the TL copy number to the HBG copy number. 
It is therefore unlikely that the longer TL observed among cases at baseline or the statistically 
significant difference in mean baseline and 12 months TL (section 2.4.1, Table 2.3) could have 
been due to chance, error or laboratory artefact. 
 
Chronic stress has been described as a risk factor for IMDs (Adelman et al., 2014; Evans, Li, 
& Whipple, 2013; Revenson et al., 2016; Robles, Slatcher, Trombello, & McGinn, 2014; 
Charney & Manji, 2004; de Kloet et al., 2005) and has been associated with shorter TL 
(Damjanovic et al., 2007; Epel et al., 2004; Notterman & Mitchell, 2015; Parks et al., 2009; 
Shalev, 2012; Shalev et al., 2013). These associations suggest that the development of IMDs 
and shortening of TL occur simultaneously following chronic stress exposure. However, the 
present study provides no evidence for this phenomenon as chronic stress neither associated 
with TL nor moderated the association between IMDs and TL. The association between IMDs 
and TL could instead be explained by genetic variation in genes responsible for the formation 
and function of the telomerase enzyme (discussed in Section 5.5.1 below). Since accelerated 
TL attrition was an outcome of the presence of IMDs, we hypothesized that TL is not a risk 
factor for IMDs. Thus we did not include TL in the analyses that investigated the role of 
vulnerability on the association between acute stress and IMDs.  
 
It should be noted that some other factors may have been responsible for the greater TL 
reduction among cases than controls over 12 months. For example, participants were all on 
ART, with the type of ART regimen not accounted for in the analysis. Nucleoside reverse 
transcriptase inhibitors have been reported to inhibit human telomerase in vitro (Hukezalie et 
al., 2012; Leeansyah et al., 2013) and may also inhibit telomerase in vivo. Furthermore, factors 
known to affect TL, such as diet (Shiels et al., 2011) and frequency of physical exercise 
(Abrahin, Cortinhas-Alves, Vieira & Guerreiro, 2019; Stenbäck et al., 2019; Cherkas et al., 
2008) were not accounted for due to unavailability of data. We recommend that future studies 
control for these factors.  
 
Understanding the mechanisms through which IMDs lead to accelerated TL attrition may help 
to unravel the biochemical processes that take place following onset of IMDs, which may aid 
the discovery of new drugs or drug targets for better management of these disorders. 
Furthermore, these mechanisms may also provide insight into the biochemical processes that 





5.5.1 Association between internalizing mental disorders and variants in genes encoding 
telomerase reverse transcriptase and telomerase RNA component genes  
 
The present study investigated whether genetic or acquired vulnerability (chronic stress) or a 
combination of both could moderate the association between IMDs and TL observed among 
our study participants. Significant interactions were observed between two SNPs and IMDs on 
TL.  Specifically, mean TL were not statistically different between cases and controls at 12 
months among individuals with TT and TG genotypes for TERT rs2736100 and among 
individuals with GG and GC genotypes for TERC rs16847897. The significant effect of the 
interaction between IMDs and genetic variations in TERT and TERC on TL could potentially 
explain the lack of association between IMDs and TL at 12 months. We hypothesized that 
biochemical processes that occur as an effect of IMDs are implicated in TL shortening. IMDs 
have been reported to lead to impaired allostatic function, resulting in increased insulin 
resistance, poor mitochondrial health and dysregulation of the autonomic and neuroendocrine 
stress response systems (McEwen, 2007; Wolkowitz et al., 2011b; Epel & Pranther, 2018). 
However, investigation of functional mechanisms involved was beyond the scope of the present 
study. 
 
5.6 Moderating effects of selected polymorphisms in the serotonin transporter gene and 
tryptophan hydroxylase 2 gene on the association between acute stress and internalizing 
mental disorders 
 
We determined the association between selected common polymorphisms within SLC6A4 and 
TPH2 and IMDs. In line with previous studies, we found no association between any of the 
selected SLC6A4 polymorphisms and IMDs (Xiao et al., 2019; Culverhouse et al., 2018; 
Munafò et al., 2009a; Munafò et al, 2009b). The association between acute stress and IMDs 
was found to be significantly moderated by the 5-HTTLPR/rs25531 S-A-S-A haplotype. Our 
finding that the interaction between stress and polymorphisms within the SLC6A4 influences 
IMDs is in line with multiple previous studies (Conway, Slavich & Hammen, 2014; Sharpley 
et al., 2014; Karg, Burmeister, Shedden & Sen, 2011; Caspi et al., 2003), although they 
contradict with findings from a big meta-analysis (n = 38,802) that found no evidence of 
interaction between stress and SLC6A4 polymorphisms on an IMD of depression among 
European-ancestry participants (Culverhouse et al., 2018). The lack of a significant 




common variants exert small effects on IMDs (Plomin & Davis, 2009). However it should be 
noted that another bigger meta-analysis (n = 40,749) found evidence of interaction between 
stress and SLC6A4 polymorphisms on depression (Karg, Burmeister, Shedden & Sen, 2011). 
It should however be noted that there is heterogeneity in terms of the type of the stressors and 
the rating scales for depression in both meta-analyses. There is need for more data with 
homogeneous measures of stress, rating scales for depression and diverse populations including 
Africans to make better deductions.   
 
The lack of direct association between SLC6A4 polymorphisms and IMDs in the present study 
could be due to a below threshold risk of IMDs in the absence of acute stress i.e. the presence 
of acute stress interacts with this underlying risk as per the diathesis-stress model (Monroe & 
Simons, 1991). The 5-HTTLPR SS genotype alone was found to have no moderating effect on 
the association between acute stress and IMDs in the present study, highlighting the importance 
of both 5-HTTLPR and rs25531 in the interaction. The rs25531 has been reported to influence 
SLC6A4 transcription (Ehli et al, 2012; Hu et al., 2006) and thus analyzing 5-HTTLPR together 
with rs25531 may present a better reflection of the transcriptional efficiency of SLC6A4 than 
analyzing 5-HTTLPR alone.  Indeed, considering 5-HTTLPR without rs25531 does not separate 
the L-G from the L-A haplotypes, this could result in individuals being incorrectly classified as 
low risk (Hankin, Jenness, Abela & Smolen, 2011). Future studies should endeavor to analyze 
5-HTTLPR together with rs25531 and functional studies should seek to quantify the risk 
conferred by each individual haplotype. 
 
The 5-HTTLPR SS genotype and rs25531 have been associated with reduced expression of 
SLC6A4. If lower SLC6A4 expression levels indeed interact with stress to increase the risk for 
IMDs, it is worthwhile to note that there are several factors that influence SLC6A4 expression, 
including DNA methylation and RNA interference. These factors may moderate the stress-
associated risk of developing an IMD by increasing genetic vulnerability load (Epel et al., 
2018). Thus, efforts are required to better characterize SLC6A4 transcription in order to unmask 
this underlying risk for IMDs.   
 
A significant association between TPH2 rs1843809 and IMDs was observed where the TG and 
TT genotypes were significantly associated with reduced risk for IMDs, compared to the GG 
genotype. TPH2 is the rate-limiting enzyme in the production of 5-HT, and the TPH2 isoform 




relevance of rs1843809 is not certain. Being an intronic variant, it is less likely that it would 
have a marked effect on TPH2 expression or TPH2 structure, as introns are spliced during 
mRNA processing. However, this SNP may still exert functional effects, as potential effects of 
intronic variants have been suggested (de Almeida et al., 2017; Cooper, 2010; Kleinjan & van 
Heyningen, 2005). In addition, rs1843809 is in LD with a missense rs142055199 SNP among 
the Luhya population. Both the Luhya and Baganda speak the same Niger-Congo language 
(Countries & their cultures, 2019) and East Africa populations that speak this class of language 
have been found to be genetically similar by principal components analysis on GWAS data 
(Unpublished results provided by Anne Stevenson & Elizabeth Atkinson). The rs142055199 is 
located in the zinc finger C3H1-type containing gene, which modulates interleukin-8 (IL-8) 
transcription (National Center for Biotechnology Information, 2019). Modulation of IL-8 
would be of interest since IMDs have been associated with inflammatory processes (Wang et 
al., 2019; Hori & Kim, 2019; Musinguzi et al., 2018; Miller, Maletic & Raison, 2009).  
 
In line with our hypothesis, acute stress significantly associated with IMDs and this association 
was moderated by vulnerability due to chronic stress and 5-HTTLPR/rs25531 respectively. We 
also found an association between rs1843809 with IMDs, however found no moderating role 
of the SNP on the association between acute stress and IMDs was observed.  
 
We also hypothesize that accelerated TL attrition does not confer risk to IMDs but is rather an 
outcome of the biochemical process that accompany IMDs. We further hypothesize that 
accelerated TL attrition is mediated via genetic vulnerability to shorter TL by TERT and TERC. 
We therefore updated our conceptual framework (Figure 5.2) from the earlier conceptual 





Figure 5.1: The original conceptual framework  
The original conceptual framework depicts the serotonin transporter and the tryptophan 
hydroxylase 2 genes as the genetic risk (vulnerability) factors for internalizing mental 
disorders (IMDs) and chronic stress and telomere length as the acquired (environmental) 
vulnerability factors for IMDs. The framework depicts (dashed line) association between TL 
and IMDs whose nature is not unknown but hypothesized to be moderated by chronic stress 
and genetic vulnerability to shorter TL by telomerase reverse transcriptase gene (TERT) and 
telomerase RNA component gene (TERC). 
 
SLC6A4 = serotonin transporter gene 
TERT = telomerase reverse transcriptase gene 
TERC = telomerase RNA component gene 






Figure 5.2: Proposed new conceptual framework depicting findings of the present study 
The new conceptual framework depicts both the serotonin transporter gene and the tryptophan 
hydroxylase 2 gene as the genetic risk (vulnerability) factors for internalizing mental disorders 
(IMDs). It excludes TL and depicts chronic stress as the acquired (environmental) vulnerability 
factors for IMDs. The framework also highlights reduced TL as an outcome of IMDs, an 
association that is not moderated by chronic stress but telomerase reverse transcriptase gene 
(TERT) rs2736100 and telomerase RNA component gene (TERC) rs16847897 single 
nucleotide polymorphisms. 
 
The present study provides evidence that the diathesis-stress model contributes to the etiology 
of IMDs. In line with the model, acute stress is associated with IMD caseness. Acute stress-
associated risk for depression is in turn influenced by chronic stress and 5-HTTLPR/rs25531 
vulnerability factors. The mechanisms through which these vulnerability factors interact with 
acute stress to lead to IMDs are not well known. Understanding these mechanisms will make 




association between TPH2 rs1843809 with IMDs also presents TPH2 as a candidate for 
vulnerability to IMDs. However, this association could not be influenced by acute stress since 
TPH2 rs1843809 did not significantly moderate the association between acute stress and IMDs. 
 
This study further provides evidence that IMD associated TL attrition is moderated by genetic 
variations in TERT and TERC. The mechanisms through which IMDs interact with TERT and 
TERC to influence TL still need to be elucidated. Our original conceptual framework has 
changed such that the bi-directional arrow between IMDs and TL has been replaced by a 
unidirectional arrow indicating the reduced TL is an outcome of IMDs, and TL is removed as 
a vulnerability factor for IMDs (Figure 5.2). 
 
5.7 Limitations and strengths of the present study 
This study has several limitations, which deserve mention. First, both acute and chronic stresses 
were measured using variables that were selected a posteriori because there is currently no 
locally adapted tool for assessing acute and chronic stress. As much as the variables used to 
generate the acute and chronic stress indices are known stressors in this population (Kinyanda 
et al., 2011a, b, 2013, 2017; Abbo et al, 2013), the lack of validation may limit generalizability 
of our findings to other settings. We recommend the local adaptation and validation of 
standardized assessment tools for acute and chronic stress for use in sub-Saharan settings, such 
as Uganda.  
 
Second, we defined our cases as those individuals diagnosed with any depressive disorder or 
anxiety disorder or PTSD. The inclusion of PTSD (n = 60) in this sample is contentious, as the 
disorder has recently been excluded from the IMD category in the DSM-5 (American 
Psychiatric Association, 2013). This may have affected our findings. In order to elucidate the 
independent contribution of each disorder, we recommend that future studies investigate each 
IMD independently.  
 
Third, both the duration and severity of IMDs have been shown to affect TL (Verhoeven et al., 
2014; Lidqvist et al., 2015). We did not assess the duration of IMDs. However, we think that 
this may not have greatly affected our findings because disease severity was not significantly 
associated with TL in the present study. Future studies should, however, account for the 




Fourth, we also measured TL as relative TL using a previously published qPCR method 
(Cawthon, 2002), where mean telomere repeat copy number was normalized to a stably 
expressed single copy HBG, to control for differences in DNA quantity.  
 
A comparison of TL measured as relative TL by qPCR (our measure of TL) with an absolute 
measure of TL (Southern blot analysis) has reported both methods to produce highly 
reproducible results as shown by r2 values of greater than 0.9 for the correlations between 
results obtained by either method on two occasions (Aviv et al., 2011). In addition, the method 
we used to measure TL is well validated (Cawthon, 2002) and the methods used allowed control 
for PCR efficiency and both inter- and intra-plate variations (see section 5.5) using the GenEx 
software (GenEx User Guide, 2012). However, it is noteworthy that the qPCR method has a 
relatively high inter-assay coefficient of variation (6.45%) compared with Southern blots 
(1.74%) (Aviv et al., 2011) and this could affect comparison of TL measured by qPCR to those 
measured by Southern blots.  
 
Fifth, the qPCR efficiencies were outside the optimal range of 90 – 110% (please see addendum 
E for the standard curves and the dissociation graphs) (Čepin, 2017). However, as would be 
expected, the gradient of the slopes for both TL repeats and the single copy reference gene, 
HBG, is negative i.e. the Ct value increases as the sample concentration decreases. Second, the 
Ct values and sample concentrations were moderately correlated for TL and strongly correlated 
for HBG with mean R2 across the 22 plates of 0.485 and 0.808 respectively. In plotting our TL 
graphs, we observed several outlier points. These were predominantly at the highest and lowest 
concentrations in the serial dilution. A thorough explanation for this pattern is available (Čepin, 
2017). Briefly, amplification efficiencies higher than 100% can be caused by polymerase 
inhibition, which may be due to excessive amounts of DNA, or common contaminants 
including heparin, hemoglobin, ethanol and phenol. Inhibition is more likely to occur in 
concentrated samples, increasing the number of amplification cycles required to reach the 
fluorescence threshold and depressing the efficiency plot slope. The ΔCt values between 
samples are thus smaller, resulting in amplification efficiency above 100%. Though 
polymerase inhibition is less of a problem in more dilute samples, the variability in the obtained 
Ct values can be higher due to the relatively low number of target molecules present in the 
sample. In such scenarios, the data obtained at the very highest and lowest concentrations 
should be excluded from the efficiency analyses. Given this reasoning, we chose to exclude 




the dilution series. A similar approach was taken in the HBG analyses, though this was less 
frequently required. Though the rationale for this approach is clear, one consequence of this is 
that the range of concentration and Ct values included in the efficiency calculations is 
substantially reduced. Data preprocessing was performed using GenEx software. According to 
their documentation, they recommend constructing standard curves using 21 standards 
covering a concentration range of approximately 6 logs (GenEx User Guide, 2012). They 
further report that the PCR efficiencies calculated from standard curves with fewer standards 
and a lower spread of concentrations may be unreliable. Inspection of the graphs revealed better 
amplification for the HBG samples compared to the TL repeats. For this reason, we set the 
efficiency correction for TL and HBG data to 75% and 90% respectively. Though the 
amplification efficiencies are certainly a limitation in the analyses, our results did show good 
separation of TL and HBG dissociation curves and the expected inversely linear relationship 
between the log of the sample concentration and the obtained Ct values, giving us greater 
confidence in the validity of our results. 
 
Sixth, we obtained the DNA from blood. As TL has been found to vary across different tissues 
(Demanelis et al., 2019), TL measured in blood may not be a true picture of TL in the brain. 
Nevertheless, whole blood TL has been reported to positively correlate with TL from other 
tissues (Demanelis et al., 2019) and thus can be used as a proxy for TL in other tissues such as 
the brain.  
 
Seventh, we did not control for population stratification at analysis. The study participants 
belong to the Bagandan population group that has been found to be genetically homogeneous, 
given the low genetic variation 0.3 and 0.1% that has been explained by principal components 
1 and 2 respectively (Gurdasani et al., 2019). There is, however, a possibility that some 
participants may not have been Bagandan even though they could speak Luganda (the main 
language of Baganda and the language into which study instruments were translated), 
indicating that we may have had a mildly admixed sample. Future studies should control for 
population stratification in order to circumvent confounding of results due to possible ancestry 
associated differences in genetic architecture. 
 
Strengths of the present study 
This study is the first to investigate genetic and environmental risk for IMDs among HIV+ 




limitations, this study also has a number of strengths. First, the study was carried out among a 
clinically well characterized study population, where IMDs were assessed using the DSM-5 
referenced CASI-5 that was taken through a local adaptation process (Mpango et al., 2017) and 
whose psychometric properties in the Ugandan environment were determined and reported 
(Kinyanda et al., 2019).  
 
Second, the study population represents an understudied population of African ancestry. There 
is a general paucity of data on genetic risk factors for IMDs and psychiatric disorders among 
African populations, which could affect the applicability of genetic risk factors discovered 
among populations of European descent to those of African descent. There is thus an urgent 
need for genomic studies among populations of African ancestry and the present study makes 
an effort towards closing this gap (van der Merwe et al., 2018; Peterson et al., 2019). 
 
 IMDs that arise in childhood and adolescence tend to persist into adulthood and have been 
reported to show a higher familial aggregation (Rapee, 2018; Wickramaratne & Weissman, 
1998; Weissman et al., 1984). This suggests that childhood and adolescent onset IMDs could 
greatly be explained by genetic factors hence their importance in genetics studies.  
 
5.9 Conclusions 
In line with the diathesis-stress model, severe chronic stress and the S-A-S-A haplotype of 5-
HTTLPR/rs25531 are risk factors that interact with acute stress to increase the likelihood of the 
occurrence of IMDs among Ugandan HIV+ children and adolescents. The mechanisms through 
which stress interacts with vulnerability to lead to IMDs will offer insight into the etiology of 
IMDs. TPH2 rs1843809 associated with IMDs where TPH2 rs1843809 TG and TT genotypes 
were found to be protective against IMDs compared to GG genotype. Further studies are 
required to investigate the role of TPH2 variations in IMDs. 
 
Telomere length was longer among cases compared to controls at baseline; however, we found 
no significant association between IMDs and TL at 12 months highlighting that IMDs could 
potentially be responsible for our observations. We caution that other factors may have been 
responsible or could have contributed to this observation. These observations highlight 
accelerated reduction in TL as a potential outcome of IMDs but not a risk factor for IMDs. 




difference in TL between cases and controls after 12 months. Further studies are required to 
fully elucidate these mechanisms. 
 
Future studies are required to understand how acute stress interacts with genetic 
polymorphisms to influence development of IMDs. Future studies should also endeavor to 
understand how IMDs interact with polymorphisms in TERT and TERC to influence TL 
attrition. Understanding the molecular etiology of IMDs is important for future efforts towards 
discovery of new drugs or putative drug targets for IMDs, as well as biomarkers for diagnosis.   
 
IMDs are complex disorders where the gene-environment interactions that are responsible for 
behavioral disturbances involve a large number of genes, with each contributing to phenotypic 
variability to a very small extent (Plomin & Davis, 2009). GWASes and studies on polygenic 
risk scores may provide better insights into the risk underlying the development of IMDs.  
Furthermore, understanding how IMDs interact with genetic polymorphisms to influence TL 
may explain the accelerated aging due to IMDs and may elucidate the nature of the comorbidity 
observed between IMDs and metabolic diseases such as diabetes and cardiovascular disease, 
hence the need for further studies among adults to understand the relationship between IMDs, 
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Genetic loci identified by Wray et al. (2018) 
Arginine-glutamic acid dipeptide repeats (RERE), Solute carrier family 45 member 1 
(SLC45A1), Neuronal Growth Regulator 1 (NEGR1), Long Intergenic Non-Protein Coding 
RNA 1360 (LINC01360), DENN Domain Containing 1B (DENND1B), VRK Serine/Threonine 
Kinase 2 (VRK2), Long Intergenic Non-Protein Coding RNA 1876 (LINC01876), Nuclear 
Receptor Subfamily 4 Group A Member 2 (NR4A2), Glycerol-3-Phosphate Dehydrogenase 2 
(GPD2), Testis And Ovary Specific PAZ Domain Containing 1 (TOPAZ1), T Cell Activation 
Inhibitor, Mitochondrial (TCAIM), Zinc Finger Protein 445 (ZNF445), Arginine And Serine 
Rich Coiled-Coil 1 (RSRC1), Uncharacterized gene (LOC100996447), Myeloid Leukemia 
Factor 1 (MLF1), Solute Carrier Family 30 Member 9 (SLC30A9), Long Intergenic Non-
Protein Coding RNA 682 (LINC00682), DDB1 And CUL4 Associated Factor 4 Like 1 
(DCAF4L1), Long Intergenic Non-Protein Coding RNA 461 (LINC00461), Myocyte-specific 
enhancer factor 2C  (MEF2C), Uncharacterized  (LOC1019), Teneurin Transmembrane Protein 
2 (TENM2), Extended MHC, F-Box And Leucine Rich Repeat Protein 4 (FBXL4), 
Uncharacterized protein C6orf168 (C6orf168), TMEM106B transmembrane protein 106B 
(TMEM106B), Von Willebrand Factor D And EGF Domains (VWDE), Pumilio RNA Binding 
Family Member 3 (PUM3), Long Intergenic Non-Protein Coding RNA 1231 (LINC01231), 
Astrotactin 2 (ASTN2), DENN Domain Containing 1A (DENND1A), LIM Homeobox 2 
(LHX2), Sortilin Related VPS10 Domain Containing Receptor 3 (SORCS3), Uncharacterized 
LOC440034 (DKFZp686K1684), PAX6 Upstream Antisense RNA (PAUPAR),  Elongator 
Acetyltransferase Complex Subunit 4 (ELP4), Paired box protein Pax-6 (PAX6), SRY-Box 5 
(SOX5), Ecto-NOX Disulfide-Thiol Exchanger 1 (ENOX1), Laccase Domain Containing 1 
(LACC1), Coiled-Coil Domain Containing 122 (CCDC122), Olfactomedin 4 (OLFM4), Long 
Intergenic Non-Protein Coding RNA 1065 (LINC01065), Leucine Rich Repeat And 
Fibronectin Type III Domain Containing 5 (LRFN5), Spectrin Repeat Containing Nuclear 
Envelope Protein 2 (SYNE2), MicroRNA 548h-1 (MIR548H1), Estrogen Receptor 2 (ESR2). 
Dihydrolipoamide S-Succinyltransferase (DLST), PROX2 prospero homeobox 2 (PROX2), 
Ribosomal Protein S6 Kinase Like 1 (RPS6KL1), BCL2 Associated Athanogene 5 (BAG5), 
Apoptogenic, mitochondrial 1 (APOPT1), RNA Binding Fox-1 Homolog 1 (RBFOX1), Shisa 
Family Member 9 (SHISA9), Calcineurin Like Phosphoesterase Domain Containing 1 
(CPPED1), Polyamine Modulated Factor 1 Binding Protein 1 (PMFBP1), DEAH-Box 




FMR1 Interacting Protein 2 (NUFIP2), MIR924 host gene (MIR924HG), Deleted in Colorectal 
Cancinona (DCC), MicroRNA 4528 (MIR4528), Member RAS Oncogene Family (RAB27B), 
Coiled-Coil Domain Containing 68 (CCDC68), transcription factor 4 (TCF4), MicroRNA 4529 
(MIR4529), L3MBTL Histone Methyl-Lysine Binding Protein 2 (L3MBTL2), 
EP300 Antisense RNA 1(EP300-AS1), Chondroadherin Like (CHADL) 
Arginine-glutamic acid dipeptide repeats (RERE), Solute carrier family 45 member 1 
(SLC45A1), Neuronal Growth Regulator 1 (NEGR1), Long Intergenic Non-Protein Coding 
RNA 1360 (LINC01360), DENN Domain Containing 1B (DENND1B), VRK Serine/Threonine 
Kinase 2 (VRK2), Long Intergenic Non-Protein Coding RNA 1876 (LINC01876), Nuclear 
Receptor Subfamily 4 Group A Member 2 (NR4A2), Glycerol-3-Phosphate Dehydrogenase 2 
(GPD2), Testis And Ovary Specific PAZ Domain Containing 1 (TOPAZ1), T Cell Activation 
Inhibitor, Mitochondrial (TCAIM), Zinc Finger Protein 445 (ZNF445), Arginine And Serine 
Rich Coiled-Coil 1 (RSRC1), Uncharacterized gene (LOC100996447), Myeloid Leukemia 
Factor 1 (MLF1), Solute Carrier Family 30 Member 9 (SLC30A9), Long Intergenic Non-
Protein Coding RNA 682 (LINC00682), DDB1 And CUL4 Associated Factor 4 Like 1 
(DCAF4L1), Long Intergenic Non-Protein Coding RNA 461 (LINC00461), Myocyte-specific 
enhancer factor 2C  (MEF2C), Uncharacterized  (LOC1019), Teneurin Transmembrane Protein 
2 (TENM2), Extended MHC, F-Box And Leucine Rich Repeat Protein 4 (FBXL4), 
Uncharacterized protein C6orf168 (C6orf168), TMEM106B transmembrane protein 106B 
(TMEM106B), Von Willebrand Factor D And EGF Domains (VWDE), Pumilio RNA Binding 
Family Member 3 (PUM3), Long Intergenic Non-Protein Coding RNA 1231 (LINC01231), 
Astrotactin 2 (ASTN2), DENN Domain Containing 1A (DENND1A), LIM Homeobox 2 
(LHX2), Sortilin Related VPS10 Domain Containing Receptor 3 (SORCS3), Uncharacterized 
LOC440034 (DKFZp686K1684), PAX6 Upstream Antisense RNA (PAUPAR),  Elongator 
Acetyltransferase Complex Subunit 4 (ELP4), Paired box protein Pax-6 (PAX6), SRY-Box 5 
(SOX5), Ecto-NOX Disulfide-Thiol Exchanger 1 (ENOX1), Laccase Domain Containing 1 
(LACC1), Coiled-Coil Domain Containing 122 (CCDC122), Olfactomedin 4 (OLFM4), Long 
Intergenic Non-Protein Coding RNA 1065 (LINC01065), Leucine Rich Repeat And 
Fibronectin Type III Domain Containing 5 (LRFN5), Spectrin Repeat Containing Nuclear 
Envelope Protein 2 (SYNE2), MicroRNA 548h-1 (MIR548H1), Estrogen Receptor 2 (ESR2). 
Dihydrolipoamide S-Succinyltransferase (DLST), PROX2 prospero homeobox 2 (PROX2), 
Ribosomal Protein S6 Kinase Like 1 (RPS6KL1), BCL2 Associated Athanogene 5 (BAG5), 
Apoptogenic, mitochondrial 1 (APOPT1), RNA Binding Fox-1 Homolog 1 (RBFOX1), Shisa 




(CPPED1), Polyamine Modulated Factor 1 Binding Protein 1 (PMFBP1), DEAH-Box Helicase 
38 (DHX38), Crystallin Beta A1 (CRYBA1), Myosin XVIIIA (MYO18A), Nuclear FMR1 
Interacting Protein 2 (NUFIP2), MIR924 host gene (MIR924HG), Deleted in Colorectal 
Cancinona (DCC), MicroRNA 4528 (MIR4528), Member RAS Oncogene Family (RAB27B), 
Coiled-Coil Domain Containing 68 (CCDC68), transcription factor 4 (TCF4), MicroRNA 4529 
(MIR4529), L3MBTL Histone Methyl-Lysine Binding Protein 2 (L3MBTL2), EP300 













Graphs for plot of Ct values against the log of the sample concentration for both TL and HBG, 
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